Kenya eClaims FHIR Implementation Guide
0.1.0 - ci-build
KE
Kenya eClaims FHIR Implementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Active as of 2026-05-19 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="ClaimDiagnosisCodeableConceptCS"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem ClaimDiagnosisCodeableConceptCS</b></p><a name="ClaimDiagnosisCodeableConceptCS"> </a><a name="hcClaimDiagnosisCodeableConceptCS"> </a><p>This case-sensitive code system <code>https://fhir.dha.go.ke/eclaims/CodeSystem/ClaimDiagnosisCodeableConceptCS</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">mms<a name="ClaimDiagnosisCodeableConceptCS-mms"> </a></td><td>ICD-11 for Mortality and Morbidity Statistics</td></tr><tr><td style="white-space:nowrap">1630407678<a name="ClaimDiagnosisCodeableConceptCS-1630407678"> </a></td><td>Neoplasms</td></tr><tr><td style="white-space:nowrap">1766440644<a name="ClaimDiagnosisCodeableConceptCS-1766440644"> </a></td><td>Diseases of the blood or blood-forming organs</td></tr><tr><td style="white-space:nowrap">1954798891<a name="ClaimDiagnosisCodeableConceptCS-1954798891"> </a></td><td>Diseases of the immune system</td></tr><tr><td style="white-space:nowrap">1435254666<a name="ClaimDiagnosisCodeableConceptCS-1435254666"> </a></td><td>Certain infectious or parasitic diseases</td></tr><tr><td style="white-space:nowrap">21500692<a name="ClaimDiagnosisCodeableConceptCS-21500692"> </a></td><td>Endocrine, nutritional or metabolic diseases</td></tr><tr><td style="white-space:nowrap">2A00-2A0Z<a name="ClaimDiagnosisCodeableConceptCS-2A00-2A0Z"> </a></td><td>Neoplasms of central nervous system or related structures</td></tr><tr><td style="white-space:nowrap">2B50-2E2Z<a name="ClaimDiagnosisCodeableConceptCS-2B50-2E2Z"> </a></td><td>Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues</td></tr><tr><td style="white-space:nowrap">2A20-2B3Z<a name="ClaimDiagnosisCodeableConceptCS-2A20-2B3Z"> </a></td><td>Neoplasms of haematopoietic or lymphoid tissues</td></tr><tr><td style="white-space:nowrap">2E60-2E6Z<a name="ClaimDiagnosisCodeableConceptCS-2E60-2E6Z"> </a></td><td>In situ neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues</td></tr><tr><td style="white-space:nowrap">2E80-2F3Z<a name="ClaimDiagnosisCodeableConceptCS-2E80-2F3Z"> </a></td><td>Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues</td></tr><tr><td style="white-space:nowrap">2E62<a name="ClaimDiagnosisCodeableConceptCS-2E62"> </a></td><td>Carcinoma in situ of middle ear or respiratory system</td></tr><tr><td style="white-space:nowrap">2E61<a name="ClaimDiagnosisCodeableConceptCS-2E61"> </a></td><td>Carcinoma in situ of other or unspecified digestive organs</td></tr><tr><td style="white-space:nowrap">2E60<a name="ClaimDiagnosisCodeableConceptCS-2E60"> </a></td><td>Carcinoma in situ of oral cavity, oesophagus or stomach</td></tr><tr><td style="white-space:nowrap">2E90-2F3Z<a name="ClaimDiagnosisCodeableConceptCS-2E90-2F3Z"> </a></td><td>Benign neoplasms except of mesenchymal origin</td></tr><tr><td style="white-space:nowrap">2E80-2E8Z<a name="ClaimDiagnosisCodeableConceptCS-2E80-2E8Z"> </a></td><td>Benign mesenchymal neoplasms</td></tr><tr><td style="white-space:nowrap">1B70-1B7Z<a name="ClaimDiagnosisCodeableConceptCS-1B70-1B7Z"> </a></td><td>Pyogenic bacterial infections of the skin or subcutaneous tissues</td></tr><tr><td style="white-space:nowrap">1B10-1B2Z<a name="ClaimDiagnosisCodeableConceptCS-1B10-1B2Z"> </a></td><td>Mycobacterial diseases</td></tr><tr><td style="white-space:nowrap">1A60-1A9Z<a name="ClaimDiagnosisCodeableConceptCS-1A60-1A9Z"> </a></td><td>Predominantly sexually transmitted infections</td></tr><tr><td style="white-space:nowrap">1A00-1A40.Z<a name="ClaimDiagnosisCodeableConceptCS-1A00-1A40.46Z"> </a></td><td>Gastroenteritis or colitis of infectious origin</td></tr><tr><td style="white-space:nowrap">2E64<a name="ClaimDiagnosisCodeableConceptCS-2E64"> </a></td><td>Carcinoma in situ of skin</td></tr><tr><td style="white-space:nowrap">2E63<a name="ClaimDiagnosisCodeableConceptCS-2E63"> </a></td><td>Melanoma in situ neoplasms</td></tr><tr><td style="white-space:nowrap">1B40-1B5Z<a name="ClaimDiagnosisCodeableConceptCS-1B40-1B5Z"> </a></td><td>Certain staphylococcal or streptococcal diseases</td></tr><tr><td style="white-space:nowrap">5B50-5C3Z<a name="ClaimDiagnosisCodeableConceptCS-5B50-5C3Z"> </a></td><td>Nutritional disorders</td></tr><tr><td style="white-space:nowrap">5C50-5D2Z<a name="ClaimDiagnosisCodeableConceptCS-5C50-5D2Z"> </a></td><td>Metabolic disorders</td></tr><tr><td style="white-space:nowrap">5D40-5D46<a name="ClaimDiagnosisCodeableConceptCS-5D40-5D46"> </a></td><td>Postprocedural endocrine or metabolic disorders</td></tr><tr><td style="white-space:nowrap">5A00-5B3Z<a name="ClaimDiagnosisCodeableConceptCS-5A00-5B3Z"> </a></td><td>Endocrine diseases</td></tr><tr><td style="white-space:nowrap">2E81<a name="ClaimDiagnosisCodeableConceptCS-2E81"> </a></td><td>Benign vascular neoplasms</td></tr><tr><td style="white-space:nowrap">2E84<a name="ClaimDiagnosisCodeableConceptCS-2E84"> </a></td><td>Benign fibrogenic or myofibrogenic tumour</td></tr><tr><td style="white-space:nowrap">2E80<a name="ClaimDiagnosisCodeableConceptCS-2E80"> </a></td><td>Benign lipomatous neoplasm</td></tr><tr><td style="white-space:nowrap">2E92<a name="ClaimDiagnosisCodeableConceptCS-2E92"> </a></td><td>Benign neoplasm of digestive organs</td></tr><tr><td style="white-space:nowrap">2E90<a name="ClaimDiagnosisCodeableConceptCS-2E90"> </a></td><td>Benign neoplasm of lip, oral cavity or pharynx</td></tr><tr><td style="white-space:nowrap">2F00-2F01<a name="ClaimDiagnosisCodeableConceptCS-2F00-2F01"> </a></td><td>Benign neoplasm of middle ear, respiratory or intrathoracic organs</td></tr><tr><td style="white-space:nowrap">2E91<a name="ClaimDiagnosisCodeableConceptCS-2E91"> </a></td><td>Benign neoplasm of major salivary glands</td></tr><tr><td style="white-space:nowrap">1B10-1B1Z<a name="ClaimDiagnosisCodeableConceptCS-1B10-1B1Z"> </a></td><td>Tuberculosis</td></tr><tr><td style="white-space:nowrap">2F10<a name="ClaimDiagnosisCodeableConceptCS-2F10"> </a></td><td>Fibrous benign mesothelioma of omentum</td></tr><tr><td style="white-space:nowrap">2E83<a name="ClaimDiagnosisCodeableConceptCS-2E83"> </a></td><td>Benign osteogenic tumours</td></tr><tr><td style="white-space:nowrap">1B74<a name="ClaimDiagnosisCodeableConceptCS-1B74"> </a></td><td>Superficial bacterial folliculitis</td></tr><tr><td style="white-space:nowrap">2D50-2E2Z<a name="ClaimDiagnosisCodeableConceptCS-2D50-2E2Z"> </a></td><td>Malignant neoplasm metastases</td></tr><tr><td style="white-space:nowrap">1B70<a name="ClaimDiagnosisCodeableConceptCS-1B70"> </a></td><td>Bacterial cellulitis, erysipelas or lymphangitis</td></tr><tr><td style="white-space:nowrap">1B71<a name="ClaimDiagnosisCodeableConceptCS-1B71"> </a></td><td>Necrotising fasciitis</td></tr><tr><td style="white-space:nowrap">1A20-1A2Z<a name="ClaimDiagnosisCodeableConceptCS-1A20-1A2Z"> </a></td><td>Viral intestinal infections</td></tr><tr><td style="white-space:nowrap">1A30-1A3Z<a name="ClaimDiagnosisCodeableConceptCS-1A30-1A3Z"> </a></td><td>Protozoal intestinal infections</td></tr><tr><td style="white-space:nowrap">1B72<a name="ClaimDiagnosisCodeableConceptCS-1B72"> </a></td><td>Impetigo</td></tr><tr><td style="white-space:nowrap">1B73<a name="ClaimDiagnosisCodeableConceptCS-1B73"> </a></td><td>Ecthyma</td></tr><tr><td style="white-space:nowrap">2E82<a name="ClaimDiagnosisCodeableConceptCS-2E82"> </a></td><td>Benign chondrogenic tumours</td></tr><tr><td style="white-space:nowrap">2D40-2D4Z<a name="ClaimDiagnosisCodeableConceptCS-2D40-2D4Z"> </a></td><td>Malignant neoplasms of ill-defined or unspecified primary sites</td></tr><tr><td style="white-space:nowrap">2B50-2D3Z<a name="ClaimDiagnosisCodeableConceptCS-2B50-2D3Z"> </a></td><td>Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues</td></tr><tr><td style="white-space:nowrap">1B21<a name="ClaimDiagnosisCodeableConceptCS-1B21"> </a></td><td>Infections due to non-tuberculous mycobacteria</td></tr><tr><td style="white-space:nowrap">1B20<a name="ClaimDiagnosisCodeableConceptCS-1B20"> </a></td><td>Leprosy</td></tr><tr><td style="white-space:nowrap">2E63.0<a name="ClaimDiagnosisCodeableConceptCS-2E63.460"> </a></td><td>Melanoma in situ of skin</td></tr><tr><td style="white-space:nowrap">1B2Y<a name="ClaimDiagnosisCodeableConceptCS-1B2Y"> </a></td><td>Other specified mycobacterial diseases</td></tr><tr><td style="white-space:nowrap">1B54<a name="ClaimDiagnosisCodeableConceptCS-1B54"> </a></td><td>Staphylococcal spinal meningitis</td></tr><tr><td style="white-space:nowrap">1B50<a name="ClaimDiagnosisCodeableConceptCS-1B50"> </a></td><td>Otitis media in scarlet fever</td></tr><tr><td style="white-space:nowrap">1B53<a name="ClaimDiagnosisCodeableConceptCS-1B53"> </a></td><td>Meningitis due to Streptococcus agalactiae</td></tr><tr><td style="white-space:nowrap">1B40-1B42<a name="ClaimDiagnosisCodeableConceptCS-1B40-1B42"> </a></td><td>Acute rheumatic fever</td></tr><tr><td style="white-space:nowrap">1B51<a name="ClaimDiagnosisCodeableConceptCS-1B51"> </a></td><td>acute streptococcal ulcerated sore throat</td></tr><tr><td style="white-space:nowrap">1A00-1A0Z<a name="ClaimDiagnosisCodeableConceptCS-1A00-1A0Z"> </a></td><td>Bacterial intestinal infections</td></tr><tr><td style="white-space:nowrap">1A10-1A1Z<a name="ClaimDiagnosisCodeableConceptCS-1A10-1A1Z"> </a></td><td>Bacterial foodborne intoxications</td></tr><tr><td style="white-space:nowrap">2E63.1<a name="ClaimDiagnosisCodeableConceptCS-2E63.461"> </a></td><td>Melanoma in situ of conjunctiva</td></tr><tr><td style="white-space:nowrap">2E63.Y<a name="ClaimDiagnosisCodeableConceptCS-2E63.46Y"> </a></td><td>Melanoma in situ neoplasms, other specified site</td></tr><tr><td style="white-space:nowrap">1B2Z<a name="ClaimDiagnosisCodeableConceptCS-1B2Z"> </a></td><td>Mycobacterial diseases, unspecified</td></tr><tr><td style="white-space:nowrap">2E63.Z<a name="ClaimDiagnosisCodeableConceptCS-2E63.46Z"> </a></td><td>precancerous melanosis of unspecified site</td></tr><tr><td style="white-space:nowrap">1A40<a name="ClaimDiagnosisCodeableConceptCS-1A40"> </a></td><td>Gastroenteritis or colitis without specification of infectious agent</td></tr><tr><td style="white-space:nowrap">4A60-4A6Z<a name="ClaimDiagnosisCodeableConceptCS-4A60-4A6Z"> </a></td><td>Autoinflammatory disorders</td></tr><tr><td style="white-space:nowrap">4A20<a name="ClaimDiagnosisCodeableConceptCS-4A20"> </a></td><td>Acquired immunodeficiencies</td></tr><tr><td style="white-space:nowrap">4A80-4A8Z<a name="ClaimDiagnosisCodeableConceptCS-4A80-4A8Z"> </a></td><td>Allergic or hypersensitivity conditions</td></tr><tr><td style="white-space:nowrap">4A40-4A4Z<a name="ClaimDiagnosisCodeableConceptCS-4A40-4A4Z"> </a></td><td>Nonorgan specific systemic autoimmune disorders</td></tr><tr><td style="white-space:nowrap">4A00-4A0Z<a name="ClaimDiagnosisCodeableConceptCS-4A00-4A0Z"> </a></td><td>Primary immunodeficiencies</td></tr><tr><td style="white-space:nowrap">2E61.3<a name="ClaimDiagnosisCodeableConceptCS-2E61.463"> </a></td><td>gallbladder carcinoma in situ</td></tr><tr><td style="white-space:nowrap">2E60.2<a name="ClaimDiagnosisCodeableConceptCS-2E60.462"> </a></td><td>Carcinoma in situ of intraepithelium of stomach</td></tr><tr><td style="white-space:nowrap">2E60.1<a name="ClaimDiagnosisCodeableConceptCS-2E60.461"> </a></td><td>Glandular intraepithelial neoplasia of oesophagus, high grade</td></tr><tr><td style="white-space:nowrap">2E61.0<a name="ClaimDiagnosisCodeableConceptCS-2E61.460"> </a></td><td>Carcinoma in situ of rectosigmoid junction</td></tr><tr><td style="white-space:nowrap">2E61.2<a name="ClaimDiagnosisCodeableConceptCS-2E61.462"> </a></td><td>AIN - [anal intraepithelial neoplasia] high grade</td></tr><tr><td style="white-space:nowrap">2E61.1<a name="ClaimDiagnosisCodeableConceptCS-2E61.461"> </a></td><td>Intraepithelial neoplasia (dysplasia) of rectum, high grade</td></tr><tr><td style="white-space:nowrap">2E61.Y<a name="ClaimDiagnosisCodeableConceptCS-2E61.46Y"> </a></td><td>Carcinoma in situ of tail of pancreas</td></tr><tr><td style="white-space:nowrap">2E62.2<a name="ClaimDiagnosisCodeableConceptCS-2E62.462"> </a></td><td>pulmonary carcinoma in situ</td></tr><tr><td style="white-space:nowrap">2E62.Z<a name="ClaimDiagnosisCodeableConceptCS-2E62.46Z"> </a></td><td>Carcinoma in situ of middle ear or respiratory system</td></tr><tr><td style="white-space:nowrap">2E62.Y<a name="ClaimDiagnosisCodeableConceptCS-2E62.46Y"> </a></td><td>Carcinoma in situ of vestibule of nose</td></tr><tr><td style="white-space:nowrap">2E62.0<a name="ClaimDiagnosisCodeableConceptCS-2E62.460"> </a></td><td>Carcinoma in situ of thyroid cartilage</td></tr><tr><td style="white-space:nowrap">2E60.0<a name="ClaimDiagnosisCodeableConceptCS-2E60.460"> </a></td><td>Carcinoma in situ upper labial sulcus</td></tr><tr><td style="white-space:nowrap">2E62.1<a name="ClaimDiagnosisCodeableConceptCS-2E62.461"> </a></td><td>Intraepithelial neoplasia (dysplasia) of trachea, high grade</td></tr><tr><td style="white-space:nowrap">2A00<a name="ClaimDiagnosisCodeableConceptCS-2A00"> </a></td><td>Primary neoplasms of brain</td></tr><tr><td style="white-space:nowrap">2A02<a name="ClaimDiagnosisCodeableConceptCS-2A02"> </a></td><td>Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system</td></tr><tr><td style="white-space:nowrap">2A0Z<a name="ClaimDiagnosisCodeableConceptCS-2A0Z"> </a></td><td>Nonpolyposis Turcot syndrome</td></tr><tr><td style="white-space:nowrap">2A01<a name="ClaimDiagnosisCodeableConceptCS-2A01"> </a></td><td>primary neoplasm of spinal meninges</td></tr><tr><td style="white-space:nowrap">5B50-5B7Z<a name="ClaimDiagnosisCodeableConceptCS-5B50-5B7Z"> </a></td><td>Undernutrition</td></tr><tr><td style="white-space:nowrap">5C3Y<a name="ClaimDiagnosisCodeableConceptCS-5C3Y"> </a></td><td>Skin disorder attributable to food fads or unhealthy diet</td></tr><tr><td style="white-space:nowrap">5C3Z<a name="ClaimDiagnosisCodeableConceptCS-5C3Z"> </a></td><td>Nutritional liver disease, not elsewhere classified</td></tr><tr><td style="white-space:nowrap">2E64.0<a name="ClaimDiagnosisCodeableConceptCS-2E64.460"> </a></td><td>Intraepidermal squamous cell carcinoma</td></tr><tr><td style="white-space:nowrap">5B80-5C1Z<a name="ClaimDiagnosisCodeableConceptCS-5B80-5C1Z"> </a></td><td>Overweight, obesity or specific nutrient excesses</td></tr><tr><td style="white-space:nowrap">2E64.Z<a name="ClaimDiagnosisCodeableConceptCS-2E64.46Z"> </a></td><td>skin carcinoma in situ</td></tr><tr><td style="white-space:nowrap">2E64.1<a name="ClaimDiagnosisCodeableConceptCS-2E64.461"> </a></td><td>Extramammary Paget disease of anogenital skin</td></tr><tr><td style="white-space:nowrap">2E64.Y<a name="ClaimDiagnosisCodeableConceptCS-2E64.46Y"> </a></td><td>Apocrine adenocarcinoma in situ of unspecified site</td></tr><tr><td style="white-space:nowrap">2E64.2<a name="ClaimDiagnosisCodeableConceptCS-2E64.462"> </a></td><td>High grade squamous intraepithelial lesion of anal margin or perianal skin</td></tr><tr><td style="white-space:nowrap">5D40<a name="ClaimDiagnosisCodeableConceptCS-5D40"> </a></td><td>Postprocedural hypothyroidism</td></tr><tr><td style="white-space:nowrap">5D41<a name="ClaimDiagnosisCodeableConceptCS-5D41"> </a></td><td>Postpancreatectomy hyperglycaemia</td></tr><tr><td style="white-space:nowrap">5A50-5A5Z<a name="ClaimDiagnosisCodeableConceptCS-5A50-5A5Z"> </a></td><td>Disorders of the parathyroids or parathyroid hormone system</td></tr><tr><td style="white-space:nowrap">5D42<a name="ClaimDiagnosisCodeableConceptCS-5D42"> </a></td><td>Parathyroprival tetany</td></tr><tr><td style="white-space:nowrap">5D43<a name="ClaimDiagnosisCodeableConceptCS-5D43"> </a></td><td>Postirradiation hypopituitarism</td></tr><tr><td style="white-space:nowrap">5D44<a name="ClaimDiagnosisCodeableConceptCS-5D44"> </a></td><td>iatrogenic ovarian failure</td></tr><tr><td style="white-space:nowrap">5A40-5A4Z<a name="ClaimDiagnosisCodeableConceptCS-5A40-5A4Z"> </a></td><td>Other disorders of glucose regulation or pancreatic internal secretion</td></tr><tr><td style="white-space:nowrap">5A10-5A2Y<a name="ClaimDiagnosisCodeableConceptCS-5A10-5A2Y"> </a></td><td>Diabetes mellitus</td></tr><tr><td style="white-space:nowrap">5A60-5A6Z<a name="ClaimDiagnosisCodeableConceptCS-5A60-5A6Z"> </a></td><td>Disorders of the pituitary hormone system</td></tr><tr><td style="white-space:nowrap">5A00-5A0Z<a name="ClaimDiagnosisCodeableConceptCS-5A00-5A0Z"> </a></td><td>Disorders of the thyroid gland or thyroid hormones system</td></tr><tr><td style="white-space:nowrap">2E84.0<a name="ClaimDiagnosisCodeableConceptCS-2E84.460"> </a></td><td>Benign fibrogenic or myofibrogenic tumour of skin</td></tr><tr><td style="white-space:nowrap">2E84.Z<a name="ClaimDiagnosisCodeableConceptCS-2E84.46Z"> </a></td><td>Myxoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2E84.Y<a name="ClaimDiagnosisCodeableConceptCS-2E84.46Y"> </a></td><td>Benign fibrogenic or myofibrogenic tumour of other specified sites</td></tr><tr><td style="white-space:nowrap">2E80.Y<a name="ClaimDiagnosisCodeableConceptCS-2E80.46Y"> </a></td><td>Other specified benign lipomatous neoplasm</td></tr><tr><td style="white-space:nowrap">2E80.1<a name="ClaimDiagnosisCodeableConceptCS-2E80.461"> </a></td><td>Lipoblastoma</td></tr><tr><td style="white-space:nowrap">2E80.0<a name="ClaimDiagnosisCodeableConceptCS-2E80.460"> </a></td><td>Lipoma</td></tr><tr><td style="white-space:nowrap">2E80.Z<a name="ClaimDiagnosisCodeableConceptCS-2E80.46Z"> </a></td><td>Benign adipocytic tumour</td></tr><tr><td style="white-space:nowrap">2E92.4<a name="ClaimDiagnosisCodeableConceptCS-2E92.464"> </a></td><td>Benign neoplasm of the large intestine</td></tr><tr><td style="white-space:nowrap">2E92.2<a name="ClaimDiagnosisCodeableConceptCS-2E92.462"> </a></td><td>Other benign neoplasm of duodenum</td></tr><tr><td style="white-space:nowrap">2E92.1<a name="ClaimDiagnosisCodeableConceptCS-2E92.461"> </a></td><td>benign tumour of pylorus</td></tr><tr><td style="white-space:nowrap">2F00<a name="ClaimDiagnosisCodeableConceptCS-2F00"> </a></td><td>Benign neoplasm of middle ear or respiratory system</td></tr><tr><td style="white-space:nowrap">2E90.3<a name="ClaimDiagnosisCodeableConceptCS-2E90.463"> </a></td><td>Benign tumour of internal cheek</td></tr><tr><td style="white-space:nowrap">2E92.0<a name="ClaimDiagnosisCodeableConceptCS-2E92.460"> </a></td><td>benign tumour of upper third of oesophagus</td></tr><tr><td style="white-space:nowrap">2E92.3<a name="ClaimDiagnosisCodeableConceptCS-2E92.463"> </a></td><td>benign tumour of ileal diverticulum</td></tr><tr><td style="white-space:nowrap">2E83.2<a name="ClaimDiagnosisCodeableConceptCS-2E83.462"> </a></td><td>benign neoplasm of vertebra</td></tr><tr><td style="white-space:nowrap">2E90.2<a name="ClaimDiagnosisCodeableConceptCS-2E90.462"> </a></td><td>benign tumour of floor of mouth</td></tr><tr><td style="white-space:nowrap">2E83.3<a name="ClaimDiagnosisCodeableConceptCS-2E83.463"> </a></td><td>benign neoplasm of clavicle</td></tr><tr><td style="white-space:nowrap">2E90.1<a name="ClaimDiagnosisCodeableConceptCS-2E90.461"> </a></td><td>Granular cell myoblastoma of tongue</td></tr><tr><td style="white-space:nowrap">2E90.4<a name="ClaimDiagnosisCodeableConceptCS-2E90.464"> </a></td><td>benign tumour of tonsil</td></tr><tr><td style="white-space:nowrap">1B71.0<a name="ClaimDiagnosisCodeableConceptCS-1B71.460"> </a></td><td>Necrotising fasciitis type 2</td></tr><tr><td style="white-space:nowrap">2E90.0<a name="ClaimDiagnosisCodeableConceptCS-2E90.460"> </a></td><td>Benign tumour of upper labial mucosa</td></tr><tr><td style="white-space:nowrap">2F01<a name="ClaimDiagnosisCodeableConceptCS-2F01"> </a></td><td>Benign neoplasm of visceral pleura</td></tr><tr><td style="white-space:nowrap">2E83.0<a name="ClaimDiagnosisCodeableConceptCS-2E83.460"> </a></td><td>Upper jaw dentinoma</td></tr><tr><td style="white-space:nowrap">2F20-2F2Z<a name="ClaimDiagnosisCodeableConceptCS-2F20-2F2Z"> </a></td><td>Benign cutaneous neoplasms</td></tr><tr><td style="white-space:nowrap">2E83.1<a name="ClaimDiagnosisCodeableConceptCS-2E83.461"> </a></td><td>Periradicular cemental dysplasia of lower jaw</td></tr><tr><td style="white-space:nowrap">2E83.4<a name="ClaimDiagnosisCodeableConceptCS-2E83.464"> </a></td><td>Benign neoplasm of sacrum</td></tr><tr><td style="white-space:nowrap">2D70-2D7Z<a name="ClaimDiagnosisCodeableConceptCS-2D70-2D7Z"> </a></td><td>Malignant neoplasm metastasis in thoracic or respiratory organs</td></tr><tr><td style="white-space:nowrap">1B74.Z<a name="ClaimDiagnosisCodeableConceptCS-1B74.46Z"> </a></td><td>Superficial folliculitis</td></tr><tr><td style="white-space:nowrap">1B74.0<a name="ClaimDiagnosisCodeableConceptCS-1B74.460"> </a></td><td>Follicular impetigo of Bockhart</td></tr><tr><td style="white-space:nowrap">1B71.1<a name="ClaimDiagnosisCodeableConceptCS-1B71.461"> </a></td><td>Progressive bacterial synergistic gangrene</td></tr><tr><td style="white-space:nowrap">1B71.2<a name="ClaimDiagnosisCodeableConceptCS-1B71.462"> </a></td><td>Neonatal streptococcal necrotising fasciitis</td></tr><tr><td style="white-space:nowrap">2D52<a name="ClaimDiagnosisCodeableConceptCS-2D52"> </a></td><td>Malignant neoplasm metastasis in epidural space</td></tr><tr><td style="white-space:nowrap">2D60-2D6Z<a name="ClaimDiagnosisCodeableConceptCS-2D60-2D6Z"> </a></td><td>Malignant neoplasm metastasis in lymph nodes</td></tr><tr><td style="white-space:nowrap">2D50<a name="ClaimDiagnosisCodeableConceptCS-2D50"> </a></td><td>Malignant neoplasm metastasis in choroid plexus</td></tr><tr><td style="white-space:nowrap">1B71.Z<a name="ClaimDiagnosisCodeableConceptCS-1B71.46Z"> </a></td><td>necrotizing fasciitis</td></tr><tr><td style="white-space:nowrap">2D51<a name="ClaimDiagnosisCodeableConceptCS-2D51"> </a></td><td>spinal arachnoid metastasis</td></tr><tr><td style="white-space:nowrap">1B71.Y<a name="ClaimDiagnosisCodeableConceptCS-1B71.46Y"> </a></td><td>Necrotising fasciitis, trunk</td></tr><tr><td style="white-space:nowrap">1A31<a name="ClaimDiagnosisCodeableConceptCS-1A31"> </a></td><td>Colitis due to Giardia lamblia</td></tr><tr><td style="white-space:nowrap">1A33<a name="ClaimDiagnosisCodeableConceptCS-1A33"> </a></td><td>Cystoisosporiasis</td></tr><tr><td style="white-space:nowrap">1B74.Y<a name="ClaimDiagnosisCodeableConceptCS-1B74.46Y"> </a></td><td>Hot tub folliculitis</td></tr><tr><td style="white-space:nowrap">1A34<a name="ClaimDiagnosisCodeableConceptCS-1A34"> </a></td><td>sarcosporidiasis</td></tr><tr><td style="white-space:nowrap">2E82.0<a name="ClaimDiagnosisCodeableConceptCS-2E82.460"> </a></td><td>Benign chondrogenic tumours of bone or articular cartilage of limbs</td></tr><tr><td style="white-space:nowrap">1A32<a name="ClaimDiagnosisCodeableConceptCS-1A32"> </a></td><td>Cryptosporidial colitis</td></tr><tr><td style="white-space:nowrap">1A30<a name="ClaimDiagnosisCodeableConceptCS-1A30"> </a></td><td>Balantidium coli anaemia</td></tr><tr><td style="white-space:nowrap">2E82.Z<a name="ClaimDiagnosisCodeableConceptCS-2E82.46Z"> </a></td><td>giant cell chondromatous tumour of unspecified site</td></tr><tr><td style="white-space:nowrap">2C30-2C3Z<a name="ClaimDiagnosisCodeableConceptCS-2C30-2C3Z"> </a></td><td>Malignant neoplasms of skin</td></tr><tr><td style="white-space:nowrap">2B70-2C1Z<a name="ClaimDiagnosisCodeableConceptCS-2B70-2C1Z"> </a></td><td>Malignant neoplasms of digestive organs</td></tr><tr><td style="white-space:nowrap">2E82.1<a name="ClaimDiagnosisCodeableConceptCS-2E82.461"> </a></td><td>Benign chondrogenic tumours of bone or articular cartilage of other specified sites</td></tr><tr><td style="white-space:nowrap">1B73.Z<a name="ClaimDiagnosisCodeableConceptCS-1B73.46Z"> </a></td><td>Ecthyma</td></tr><tr><td style="white-space:nowrap">1B73.2<a name="ClaimDiagnosisCodeableConceptCS-1B73.462"> </a></td><td>Ecthyma gangrenosum</td></tr><tr><td style="white-space:nowrap">1B73.1<a name="ClaimDiagnosisCodeableConceptCS-1B73.461"> </a></td><td>Staphylococcal ecthyma</td></tr><tr><td style="white-space:nowrap">1B73.0<a name="ClaimDiagnosisCodeableConceptCS-1B73.460"> </a></td><td>Streptococcal ecthyma</td></tr><tr><td style="white-space:nowrap">2B60-2B6Y<a name="ClaimDiagnosisCodeableConceptCS-2B60-2B6Y"> </a></td><td>Malignant neoplasms of lip, oral cavity or pharynx</td></tr><tr><td style="white-space:nowrap">2C20-2C2Z<a name="ClaimDiagnosisCodeableConceptCS-2C20-2C2Z"> </a></td><td>Malignant neoplasms of middle ear, respiratory or intrathoracic organs</td></tr><tr><td style="white-space:nowrap">1B73.Y<a name="ClaimDiagnosisCodeableConceptCS-1B73.46Y"> </a></td><td>Other specified ecthyma</td></tr><tr><td style="white-space:nowrap">2B50-2B5Z<a name="ClaimDiagnosisCodeableConceptCS-2B50-2B5Z"> </a></td><td>Malignant mesenchymal neoplasms</td></tr><tr><td style="white-space:nowrap">1B20.2<a name="ClaimDiagnosisCodeableConceptCS-1B20.462"> </a></td><td>Leprosy reactions</td></tr><tr><td style="white-space:nowrap">1B20.3<a name="ClaimDiagnosisCodeableConceptCS-1B20.463"> </a></td><td>Mycobacterium leprae dacryoadenitis</td></tr><tr><td style="white-space:nowrap">1B20.Z<a name="ClaimDiagnosisCodeableConceptCS-1B20.46Z"> </a></td><td>leprosy unspecified</td></tr><tr><td style="white-space:nowrap">1B20.1<a name="ClaimDiagnosisCodeableConceptCS-1B20.461"> </a></td><td>Hansen disease, diffuse lepromatous</td></tr><tr><td style="white-space:nowrap">2E63.00<a name="ClaimDiagnosisCodeableConceptCS-2E63.4600"> </a></td><td>Hutchinson melanotic freckle</td></tr><tr><td style="white-space:nowrap">2E63.0Z<a name="ClaimDiagnosisCodeableConceptCS-2E63.460Z"> </a></td><td>Radial growth phase malignant melanoma</td></tr><tr><td style="white-space:nowrap">1B5Y<a name="ClaimDiagnosisCodeableConceptCS-1B5Y"> </a></td><td>Staphylococcal pericarditis</td></tr><tr><td style="white-space:nowrap">1B20.0<a name="ClaimDiagnosisCodeableConceptCS-1B20.460"> </a></td><td>BT - [borderline tuberculoid] leprosy</td></tr><tr><td style="white-space:nowrap">1B40<a name="ClaimDiagnosisCodeableConceptCS-1B40"> </a></td><td>Acute rheumatic fever without mention of heart involvement</td></tr><tr><td style="white-space:nowrap">1B41<a name="ClaimDiagnosisCodeableConceptCS-1B41"> </a></td><td>Acute rheumatic fever with heart involvement</td></tr><tr><td style="white-space:nowrap">1B42<a name="ClaimDiagnosisCodeableConceptCS-1B42"> </a></td><td>ST Vitus dance</td></tr><tr><td style="white-space:nowrap">1B5Z<a name="ClaimDiagnosisCodeableConceptCS-1B5Z"> </a></td><td>sepsis due to group B Strep without mention of septic shock</td></tr><tr><td style="white-space:nowrap">4A61<a name="ClaimDiagnosisCodeableConceptCS-4A61"> </a></td><td>SAPHO - [synovitis, acne, pustulosis, hyperostosis, osteitis] syndrome</td></tr><tr><td style="white-space:nowrap">4A6Z<a name="ClaimDiagnosisCodeableConceptCS-4A6Z"> </a></td><td>Autoinflammatory disorders, unspecified</td></tr><tr><td style="white-space:nowrap">4A6Y<a name="ClaimDiagnosisCodeableConceptCS-4A6Y"> </a></td><td>Juvenile chronic recurrent multifocal osteomyelitis</td></tr><tr><td style="white-space:nowrap">4A60<a name="ClaimDiagnosisCodeableConceptCS-4A60"> </a></td><td>Monogenic autoinflammatory syndromes</td></tr><tr><td style="white-space:nowrap">4A20.1<a name="ClaimDiagnosisCodeableConceptCS-4A20.461"> </a></td><td>Acquired immunodeficiency due to protein loss</td></tr><tr><td style="white-space:nowrap">4A62<a name="ClaimDiagnosisCodeableConceptCS-4A62"> </a></td><td>Neurological complications of Behçet disease</td></tr><tr><td style="white-space:nowrap">4A20.Z<a name="ClaimDiagnosisCodeableConceptCS-4A20.46Z"> </a></td><td>Acquired immunodeficiencies</td></tr><tr><td style="white-space:nowrap">4A20.Y<a name="ClaimDiagnosisCodeableConceptCS-4A20.46Y"> </a></td><td>Other specified acquired immunodeficiencies</td></tr><tr><td style="white-space:nowrap">4A84<a name="ClaimDiagnosisCodeableConceptCS-4A84"> </a></td><td>Anaphylaxis</td></tr><tr><td style="white-space:nowrap">4A80<a name="ClaimDiagnosisCodeableConceptCS-4A80"> </a></td><td>Allergic or hypersensitivity disorders involving the respiratory tract</td></tr><tr><td style="white-space:nowrap">4A20.0<a name="ClaimDiagnosisCodeableConceptCS-4A20.460"> </a></td><td>Adult-onset immunodeficiency</td></tr><tr><td style="white-space:nowrap">4A83<a name="ClaimDiagnosisCodeableConceptCS-4A83"> </a></td><td>Allergic or hypersensitivity disorders involving the gastrointestinal tract</td></tr><tr><td style="white-space:nowrap">4A82<a name="ClaimDiagnosisCodeableConceptCS-4A82"> </a></td><td>Arthus phenomenon</td></tr><tr><td style="white-space:nowrap">4A81<a name="ClaimDiagnosisCodeableConceptCS-4A81"> </a></td><td>Ocular allergy</td></tr><tr><td style="white-space:nowrap">4A41<a name="ClaimDiagnosisCodeableConceptCS-4A41"> </a></td><td>Idiopathic inflammatory myopathy</td></tr><tr><td style="white-space:nowrap">4A43<a name="ClaimDiagnosisCodeableConceptCS-4A43"> </a></td><td>Overlap or undifferentiated nonorgan specific systemic autoimmune disease</td></tr><tr><td style="white-space:nowrap">4A42<a name="ClaimDiagnosisCodeableConceptCS-4A42"> </a></td><td>Systemic sclerosis</td></tr><tr><td style="white-space:nowrap">4A44<a name="ClaimDiagnosisCodeableConceptCS-4A44"> </a></td><td>Vasculitis</td></tr><tr><td style="white-space:nowrap">4A40<a name="ClaimDiagnosisCodeableConceptCS-4A40"> </a></td><td>Lupus erythematosus</td></tr><tr><td style="white-space:nowrap">2E61.Z<a name="ClaimDiagnosisCodeableConceptCS-2E61.46Z"> </a></td><td>Carcinoma in situ of other or unspecified digestive organs</td></tr><tr><td style="white-space:nowrap">4A0Y<a name="ClaimDiagnosisCodeableConceptCS-4A0Y"> </a></td><td>Lymphocyte function antigen-1 [LFA-1] defect</td></tr><tr><td style="white-space:nowrap">4A0Z<a name="ClaimDiagnosisCodeableConceptCS-4A0Z"> </a></td><td>Primary immunodeficiencies, unspecified</td></tr><tr><td style="white-space:nowrap">4A01<a name="ClaimDiagnosisCodeableConceptCS-4A01"> </a></td><td>Primary immunodeficiencies due to disorders of adaptive immunity</td></tr><tr><td style="white-space:nowrap">4A00<a name="ClaimDiagnosisCodeableConceptCS-4A00"> </a></td><td>Primary immunodeficiencies due to disorders of innate immunity</td></tr><tr><td style="white-space:nowrap">1A90<a name="ClaimDiagnosisCodeableConceptCS-1A90"> </a></td><td>Chancroidal lymphadenitis</td></tr><tr><td style="white-space:nowrap">1A91<a name="ClaimDiagnosisCodeableConceptCS-1A91"> </a></td><td>Osteomyelitis due to Klebsiella granuloma inguinale</td></tr><tr><td style="white-space:nowrap">1A70-1A7Z<a name="ClaimDiagnosisCodeableConceptCS-1A70-1A7Z"> </a></td><td>Gonococcal infection</td></tr><tr><td style="white-space:nowrap">1A60-1A6Z<a name="ClaimDiagnosisCodeableConceptCS-1A60-1A6Z"> </a></td><td>Syphilis</td></tr><tr><td style="white-space:nowrap">1A80-1A8Z<a name="ClaimDiagnosisCodeableConceptCS-1A80-1A8Z"> </a></td><td>Sexually transmissible infections due to chlamydia</td></tr><tr><td style="white-space:nowrap">2A00.3<a name="ClaimDiagnosisCodeableConceptCS-2A00.463"> </a></td><td>Central neurocytoma of brain</td></tr><tr><td style="white-space:nowrap">2A00.4<a name="ClaimDiagnosisCodeableConceptCS-2A00.464"> </a></td><td>astroblastoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2A00.2<a name="ClaimDiagnosisCodeableConceptCS-2A00.462"> </a></td><td>Tumours of neuroepithelial tissue of brain</td></tr><tr><td style="white-space:nowrap">2A00.1<a name="ClaimDiagnosisCodeableConceptCS-2A00.461"> </a></td><td>Embryonal tumours of brain</td></tr><tr><td style="white-space:nowrap">2A00.0<a name="ClaimDiagnosisCodeableConceptCS-2A00.460"> </a></td><td>Gliomas of brain</td></tr><tr><td style="white-space:nowrap">2A02.4<a name="ClaimDiagnosisCodeableConceptCS-2A02.464"> </a></td><td>Benign neoplasm of cauda equina</td></tr><tr><td style="white-space:nowrap">2A02.0<a name="ClaimDiagnosisCodeableConceptCS-2A02.460"> </a></td><td>Gliomas of spinal cord, cranial or paraspinal nerves</td></tr><tr><td style="white-space:nowrap">2A02.2<a name="ClaimDiagnosisCodeableConceptCS-2A02.462"> </a></td><td>primary malignant neoplasm of cauda equina</td></tr><tr><td style="white-space:nowrap">2A01.0<a name="ClaimDiagnosisCodeableConceptCS-2A01.460"> </a></td><td>Meningiomas</td></tr><tr><td style="white-space:nowrap">2A02.1<a name="ClaimDiagnosisCodeableConceptCS-2A02.461"> </a></td><td>Tumours of cranial or paraspinal nerves</td></tr><tr><td style="white-space:nowrap">2A02.3<a name="ClaimDiagnosisCodeableConceptCS-2A02.463"> </a></td><td>acoustic neurinoma</td></tr><tr><td style="white-space:nowrap">2A01.2<a name="ClaimDiagnosisCodeableConceptCS-2A01.462"> </a></td><td>Neoplasm of uncertain or unknown behaviour of spinal meninges</td></tr><tr><td style="white-space:nowrap">2A01.1<a name="ClaimDiagnosisCodeableConceptCS-2A01.461"> </a></td><td>Mesenchymal tumours of meninges</td></tr><tr><td style="white-space:nowrap">2A20-2A2Z<a name="ClaimDiagnosisCodeableConceptCS-2A20-2A2Z"> </a></td><td>Myeloproliferative neoplasms</td></tr><tr><td style="white-space:nowrap">2A40-2A4Z<a name="ClaimDiagnosisCodeableConceptCS-2A40-2A4Z"> </a></td><td>Myelodysplastic and myeloproliferative neoplasms</td></tr><tr><td style="white-space:nowrap">2A60<a name="ClaimDiagnosisCodeableConceptCS-2A60"> </a></td><td>Acute myeloid leukaemias and related precursor neoplasms</td></tr><tr><td style="white-space:nowrap">2A30-2A3Z<a name="ClaimDiagnosisCodeableConceptCS-2A30-2A3Z"> </a></td><td>Myelodysplastic syndromes</td></tr><tr><td style="white-space:nowrap">2A50-2A5Z<a name="ClaimDiagnosisCodeableConceptCS-2A50-2A5Z"> </a></td><td>Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1</td></tr><tr><td style="white-space:nowrap">2E91.0<a name="ClaimDiagnosisCodeableConceptCS-2E91.460"> </a></td><td>benign tumour of parotid gland</td></tr><tr><td style="white-space:nowrap">2E91.Z<a name="ClaimDiagnosisCodeableConceptCS-2E91.46Z"> </a></td><td>Warthin tumour of unspecified site</td></tr><tr><td style="white-space:nowrap">1B12<a name="ClaimDiagnosisCodeableConceptCS-1B12"> </a></td><td>Tuberculosis of other systems and organs</td></tr><tr><td style="white-space:nowrap">1B13<a name="ClaimDiagnosisCodeableConceptCS-1B13"> </a></td><td>Miliary tuberculosis</td></tr><tr><td style="white-space:nowrap">1B11<a name="ClaimDiagnosisCodeableConceptCS-1B11"> </a></td><td>Tuberculosis of the nervous system</td></tr><tr><td style="white-space:nowrap">2E91.1<a name="ClaimDiagnosisCodeableConceptCS-2E91.461"> </a></td><td>Benign neoplasm of submaxillary gland</td></tr><tr><td style="white-space:nowrap">1B14<a name="ClaimDiagnosisCodeableConceptCS-1B14"> </a></td><td>Carrier of Mycobacterium tuberculosis</td></tr><tr><td style="white-space:nowrap">1B10<a name="ClaimDiagnosisCodeableConceptCS-1B10"> </a></td><td>Tuberculosis of the respiratory system</td></tr><tr><td style="white-space:nowrap">1B70.0<a name="ClaimDiagnosisCodeableConceptCS-1B70.460"> </a></td><td>Erysipelas</td></tr><tr><td style="white-space:nowrap">1B70.2<a name="ClaimDiagnosisCodeableConceptCS-1B70.462"> </a></td><td>Staphylococcal cellulitis of skin</td></tr><tr><td style="white-space:nowrap">1B70.3<a name="ClaimDiagnosisCodeableConceptCS-1B70.463"> </a></td><td>Ascending bacterial lymphangitis due to Staphylococcus aureus</td></tr><tr><td style="white-space:nowrap">1B70.Y<a name="ClaimDiagnosisCodeableConceptCS-1B70.46Y"> </a></td><td>Bacterial cellulitis or lymphangitis due to other specified bacterium</td></tr><tr><td style="white-space:nowrap">1B70.1<a name="ClaimDiagnosisCodeableConceptCS-1B70.461"> </a></td><td>Streptococcal cellulitis of the vulva and vagina</td></tr><tr><td style="white-space:nowrap">1A22<a name="ClaimDiagnosisCodeableConceptCS-1A22"> </a></td><td>rotaviral enteritis</td></tr><tr><td style="white-space:nowrap">1A20<a name="ClaimDiagnosisCodeableConceptCS-1A20"> </a></td><td>Adenoviral enteritis</td></tr><tr><td style="white-space:nowrap">1A24<a name="ClaimDiagnosisCodeableConceptCS-1A24"> </a></td><td>Gastroenteritis due to Cytomegalovirus</td></tr><tr><td style="white-space:nowrap">1A21<a name="ClaimDiagnosisCodeableConceptCS-1A21"> </a></td><td>infections due to Astrovirus</td></tr><tr><td style="white-space:nowrap">2D44<a name="ClaimDiagnosisCodeableConceptCS-2D44"> </a></td><td>metastatic cancer, unknown origin, so stated</td></tr><tr><td style="white-space:nowrap">2D41<a name="ClaimDiagnosisCodeableConceptCS-2D41"> </a></td><td>Metastatic carcinoma [primary carcinoma spreading elsewhere]</td></tr><tr><td style="white-space:nowrap">1A23<a name="ClaimDiagnosisCodeableConceptCS-1A23"> </a></td><td>Noroviral enteritis</td></tr><tr><td style="white-space:nowrap">2D43<a name="ClaimDiagnosisCodeableConceptCS-2D43"> </a></td><td>Malignant neoplasms of independent, multiple primary sites</td></tr><tr><td style="white-space:nowrap">2D40<a name="ClaimDiagnosisCodeableConceptCS-2D40"> </a></td><td>Villous adenocarcinoma in adenoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2D42<a name="ClaimDiagnosisCodeableConceptCS-2D42"> </a></td><td>calf cancer</td></tr><tr><td style="white-space:nowrap">2E64.00<a name="ClaimDiagnosisCodeableConceptCS-2E64.4600"> </a></td><td>Bowen type intraepidermal squamous cell carcinoma</td></tr><tr><td style="white-space:nowrap">2E64.0Y<a name="ClaimDiagnosisCodeableConceptCS-2E64.460Y"> </a></td><td>Other specified intraepidermal squamous cell carcinoma</td></tr><tr><td style="white-space:nowrap">2E64.01<a name="ClaimDiagnosisCodeableConceptCS-2E64.4601"> </a></td><td>Intraepidermal squamous cell carcinoma arising from actinic keratosis</td></tr><tr><td style="white-space:nowrap">2E64.0Z<a name="ClaimDiagnosisCodeableConceptCS-2E64.460Z"> </a></td><td>IEC - [intraepidermal carcinoma]</td></tr><tr><td style="white-space:nowrap">5B90-5B9Z<a name="ClaimDiagnosisCodeableConceptCS-5B90-5B9Z"> </a></td><td>Certain specified nutrient excesses</td></tr><tr><td style="white-space:nowrap">5B80-5B81.Z<a name="ClaimDiagnosisCodeableConceptCS-5B80-5B81.46Z"> </a></td><td>Overweight or obesity</td></tr><tr><td style="white-space:nowrap">5C1Z<a name="ClaimDiagnosisCodeableConceptCS-5C1Z"> </a></td><td>Overweight, obesity or specific nutrient excesses, unspecified</td></tr><tr><td style="white-space:nowrap">5C1Y<a name="ClaimDiagnosisCodeableConceptCS-5C1Y"> </a></td><td>late effect of hyperalimentation</td></tr><tr><td style="white-space:nowrap">5D40.Y<a name="ClaimDiagnosisCodeableConceptCS-5D40.46Y"> </a></td><td>Other specified postprocedural hypothyroidism</td></tr><tr><td style="white-space:nowrap">5D40.0<a name="ClaimDiagnosisCodeableConceptCS-5D40.460"> </a></td><td>Postirridation hypothyroidism</td></tr><tr><td style="white-space:nowrap">5D40.Z<a name="ClaimDiagnosisCodeableConceptCS-5D40.46Z"> </a></td><td>hypothyroidism due to absence of thyroid</td></tr><tr><td style="white-space:nowrap">5D45<a name="ClaimDiagnosisCodeableConceptCS-5D45"> </a></td><td>Postprocedural testicular hypofunction</td></tr><tr><td style="white-space:nowrap">5D46<a name="ClaimDiagnosisCodeableConceptCS-5D46"> </a></td><td>adrenalectomy status</td></tr><tr><td style="white-space:nowrap">5A60<a name="ClaimDiagnosisCodeableConceptCS-5A60"> </a></td><td>Hyperfunction of pituitary gland</td></tr><tr><td style="white-space:nowrap">5A61<a name="ClaimDiagnosisCodeableConceptCS-5A61"> </a></td><td>hypothalamic lesion</td></tr><tr><td style="white-space:nowrap">5A6Z<a name="ClaimDiagnosisCodeableConceptCS-5A6Z"> </a></td><td>Disorders of the pituitary hormone system, unspecified</td></tr><tr><td style="white-space:nowrap">5A11<a name="ClaimDiagnosisCodeableConceptCS-5A11"> </a></td><td>insulin resistant diabetes</td></tr><tr><td style="white-space:nowrap">5A10<a name="ClaimDiagnosisCodeableConceptCS-5A10"> </a></td><td>SPIDDM - [Slowly progressive insulin-dependent diabetes mellitus]</td></tr><tr><td style="white-space:nowrap">5A13<a name="ClaimDiagnosisCodeableConceptCS-5A13"> </a></td><td>Other specified Diabetes mellitus, not Type 1 and not Type 2</td></tr><tr><td style="white-space:nowrap">5A14<a name="ClaimDiagnosisCodeableConceptCS-5A14"> </a></td><td>Diabetes without mention of type of diabetes mellitus</td></tr><tr><td style="white-space:nowrap">5A00<a name="ClaimDiagnosisCodeableConceptCS-5A00"> </a></td><td>Hypothyroidism</td></tr><tr><td style="white-space:nowrap">5A02<a name="ClaimDiagnosisCodeableConceptCS-5A02"> </a></td><td>Thyrotoxicosis</td></tr><tr><td style="white-space:nowrap">5A12<a name="ClaimDiagnosisCodeableConceptCS-5A12"> </a></td><td>malnutrition-related diabetes mellitus without complications</td></tr><tr><td style="white-space:nowrap">5A04<a name="ClaimDiagnosisCodeableConceptCS-5A04"> </a></td><td>C-cell hyperplasia of thyroid</td></tr><tr><td style="white-space:nowrap">5A03<a name="ClaimDiagnosisCodeableConceptCS-5A03"> </a></td><td>Thyroiditis</td></tr><tr><td style="white-space:nowrap">5A01<a name="ClaimDiagnosisCodeableConceptCS-5A01"> </a></td><td>Nontoxic goitre</td></tr><tr><td style="white-space:nowrap">2E85<a name="ClaimDiagnosisCodeableConceptCS-2E85"> </a></td><td>Benign fibrohistiocytic tumour</td></tr><tr><td style="white-space:nowrap">2E80.00<a name="ClaimDiagnosisCodeableConceptCS-2E80.4600"> </a></td><td>Superficial subcutaneous lipoma</td></tr><tr><td style="white-space:nowrap">2E80.0Y<a name="ClaimDiagnosisCodeableConceptCS-2E80.460Y"> </a></td><td>Lipoma, other specified site</td></tr><tr><td style="white-space:nowrap">2E80.01<a name="ClaimDiagnosisCodeableConceptCS-2E80.4601"> </a></td><td>Benign lipoma of spermatic cord</td></tr><tr><td style="white-space:nowrap">2E80.02<a name="ClaimDiagnosisCodeableConceptCS-2E80.4602"> </a></td><td>Deep internal benign lipoma of retroperitoneum</td></tr><tr><td style="white-space:nowrap">2E80.0Z<a name="ClaimDiagnosisCodeableConceptCS-2E80.460Z"> </a></td><td>Spindle cell lipoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2E92.4Z<a name="ClaimDiagnosisCodeableConceptCS-2E92.464Z"> </a></td><td>benign tumor of large intestine</td></tr><tr><td style="white-space:nowrap">2E92.40<a name="ClaimDiagnosisCodeableConceptCS-2E92.4640"> </a></td><td>HMPS - [hereditary mixed polyposis syndrome]</td></tr><tr><td style="white-space:nowrap">2E92.4Y<a name="ClaimDiagnosisCodeableConceptCS-2E92.464Y"> </a></td><td>Tubular adenoma of sigmoid</td></tr><tr><td style="white-space:nowrap">2F00.Z<a name="ClaimDiagnosisCodeableConceptCS-2F00.46Z"> </a></td><td>Benign neoplasm of middle ear or respiratory system</td></tr><tr><td style="white-space:nowrap">2F00.0<a name="ClaimDiagnosisCodeableConceptCS-2F00.460"> </a></td><td>Middle ear neuroendocrine tumour</td></tr><tr><td style="white-space:nowrap">2F00.1<a name="ClaimDiagnosisCodeableConceptCS-2F00.461"> </a></td><td>Recurrent respiratory papillomatosis</td></tr><tr><td style="white-space:nowrap">2E92.5<a name="ClaimDiagnosisCodeableConceptCS-2E92.465"> </a></td><td>Benign anorectal neoplasm</td></tr><tr><td style="white-space:nowrap">2E92.6<a name="ClaimDiagnosisCodeableConceptCS-2E92.466"> </a></td><td>Other benign neoplasms of gallbladder, extrahepatic bile duct or ampulla of Vater</td></tr><tr><td style="white-space:nowrap">2F00.2<a name="ClaimDiagnosisCodeableConceptCS-2F00.462"> </a></td><td>Laryngeal neuroendocrine tumour</td></tr><tr><td style="white-space:nowrap">2E92.7<a name="ClaimDiagnosisCodeableConceptCS-2E92.467"> </a></td><td>biliary ductal cystadenoma</td></tr><tr><td style="white-space:nowrap">2F00.Y<a name="ClaimDiagnosisCodeableConceptCS-2F00.46Y"> </a></td><td>Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia</td></tr><tr><td style="white-space:nowrap">2E90.5<a name="ClaimDiagnosisCodeableConceptCS-2E90.465"> </a></td><td>Benign tumour of mesopharynx</td></tr><tr><td style="white-space:nowrap">2E83.5<a name="ClaimDiagnosisCodeableConceptCS-2E83.465"> </a></td><td>Benign neoplasm of patella</td></tr><tr><td style="white-space:nowrap">2E90.6<a name="ClaimDiagnosisCodeableConceptCS-2E90.466"> </a></td><td>Benign neoplasm of the pharyngeal tonsil</td></tr><tr><td style="white-space:nowrap">2F21<a name="ClaimDiagnosisCodeableConceptCS-2F21"> </a></td><td>Benign keratinocytic acanthomas</td></tr><tr><td style="white-space:nowrap">2F20<a name="ClaimDiagnosisCodeableConceptCS-2F20"> </a></td><td>Benign cutaneous melanocytic neoplasms</td></tr><tr><td style="white-space:nowrap">2F23<a name="ClaimDiagnosisCodeableConceptCS-2F23"> </a></td><td>Benign dermal fibrous or fibrohistiocytic neoplasms</td></tr><tr><td style="white-space:nowrap">2F24<a name="ClaimDiagnosisCodeableConceptCS-2F24"> </a></td><td>Cellular neurothekeoma</td></tr><tr><td style="white-space:nowrap">2E83.Y<a name="ClaimDiagnosisCodeableConceptCS-2E83.46Y"> </a></td><td>Benign osteogenic tumour of other specified site</td></tr><tr><td style="white-space:nowrap">2D71<a name="ClaimDiagnosisCodeableConceptCS-2D71"> </a></td><td>mediastinum metastasis</td></tr><tr><td style="white-space:nowrap">2D72<a name="ClaimDiagnosisCodeableConceptCS-2D72"> </a></td><td>pleural metastasis</td></tr><tr><td style="white-space:nowrap">2D7Y<a name="ClaimDiagnosisCodeableConceptCS-2D7Y"> </a></td><td>tracheal cartilage metastasis</td></tr><tr><td style="white-space:nowrap">2F22<a name="ClaimDiagnosisCodeableConceptCS-2F22"> </a></td><td>Tubular papillary adenoma</td></tr><tr><td style="white-space:nowrap">2D70<a name="ClaimDiagnosisCodeableConceptCS-2D70"> </a></td><td>Metastatic carcinoma in lung</td></tr><tr><td style="white-space:nowrap">2D73<a name="ClaimDiagnosisCodeableConceptCS-2D73"> </a></td><td>Malignant neoplasm metastasis in false vocal cord</td></tr><tr><td style="white-space:nowrap">2E83.Z<a name="ClaimDiagnosisCodeableConceptCS-2E83.46Z"> </a></td><td>Osteoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2D90-2D91<a name="ClaimDiagnosisCodeableConceptCS-2D90-2D91"> </a></td><td>Malignant neoplasm metastasis in retroperitoneum or peritoneum</td></tr><tr><td style="white-space:nowrap">2D80-2D8Z<a name="ClaimDiagnosisCodeableConceptCS-2D80-2D8Z"> </a></td><td>Malignant neoplasm metastasis in digestive system</td></tr><tr><td style="white-space:nowrap">2E00-2E0Y<a name="ClaimDiagnosisCodeableConceptCS-2E00-2E0Y"> </a></td><td>Malignant neoplasm metastasis in other specified sites</td></tr><tr><td style="white-space:nowrap">1A33.0<a name="ClaimDiagnosisCodeableConceptCS-1A33.460"> </a></td><td>Infection due to Isopora belli</td></tr><tr><td style="white-space:nowrap">1A33.1<a name="ClaimDiagnosisCodeableConceptCS-1A33.461"> </a></td><td>coccidial colitis</td></tr><tr><td style="white-space:nowrap">1B75<a name="ClaimDiagnosisCodeableConceptCS-1B75"> </a></td><td>Deep bacterial folliculitis or pyogenic abscess of the skin</td></tr><tr><td style="white-space:nowrap">1A35<a name="ClaimDiagnosisCodeableConceptCS-1A35"> </a></td><td>Blastocystosis</td></tr><tr><td style="white-space:nowrap">1A33.Y<a name="ClaimDiagnosisCodeableConceptCS-1A33.46Y"> </a></td><td>Other specified cystoisosporiasis</td></tr><tr><td style="white-space:nowrap">1A36<a name="ClaimDiagnosisCodeableConceptCS-1A36"> </a></td><td>Amoebiasis</td></tr><tr><td style="white-space:nowrap">1A33.Z<a name="ClaimDiagnosisCodeableConceptCS-1A33.46Z"> </a></td><td>Isosporiasis</td></tr><tr><td style="white-space:nowrap">1A3Z<a name="ClaimDiagnosisCodeableConceptCS-1A3Z"> </a></td><td>Protozoal intestinal infections, unspecified</td></tr><tr><td style="white-space:nowrap">1A3Y<a name="ClaimDiagnosisCodeableConceptCS-1A3Y"> </a></td><td>embadomonas dysentery</td></tr><tr><td style="white-space:nowrap">2E86<a name="ClaimDiagnosisCodeableConceptCS-2E86"> </a></td><td>Benign smooth muscle or skeletal muscle tumour</td></tr><tr><td style="white-space:nowrap">1B7Y<a name="ClaimDiagnosisCodeableConceptCS-1B7Y"> </a></td><td>Skin infection classified elsewhere due to hospital-acquired MRSA</td></tr><tr><td style="white-space:nowrap">1B20.20<a name="ClaimDiagnosisCodeableConceptCS-1B20.4620"> </a></td><td>Leprosy upgrading reaction</td></tr><tr><td style="white-space:nowrap">1B20.21<a name="ClaimDiagnosisCodeableConceptCS-1B20.4621"> </a></td><td>Lucio phenomenon</td></tr><tr><td style="white-space:nowrap">2E65<a name="ClaimDiagnosisCodeableConceptCS-2E65"> </a></td><td>Carcinoma in situ of breast</td></tr><tr><td style="white-space:nowrap">1B40.0<a name="ClaimDiagnosisCodeableConceptCS-1B40.460"> </a></td><td>acute articular rheumatism</td></tr><tr><td style="white-space:nowrap">1B40.Z<a name="ClaimDiagnosisCodeableConceptCS-1B40.46Z"> </a></td><td>subacute rheumatic fever</td></tr><tr><td style="white-space:nowrap">1B40.Y<a name="ClaimDiagnosisCodeableConceptCS-1B40.46Y"> </a></td><td>rheumatic pneumonitis</td></tr><tr><td style="white-space:nowrap">2E81.Y<a name="ClaimDiagnosisCodeableConceptCS-2E81.46Y"> </a></td><td>Other specified benign vascular neoplasms</td></tr><tr><td style="white-space:nowrap">2E81.2<a name="ClaimDiagnosisCodeableConceptCS-2E81.462"> </a></td><td>Benign vascular neoplasms of infancy or childhood</td></tr><tr><td style="white-space:nowrap">2E81.0<a name="ClaimDiagnosisCodeableConceptCS-2E81.460"> </a></td><td>Neoplastic haemangioma</td></tr><tr><td style="white-space:nowrap">2E81.Z<a name="ClaimDiagnosisCodeableConceptCS-2E81.46Z"> </a></td><td>Benign vascular neoplasms</td></tr><tr><td style="white-space:nowrap">2E81.1<a name="ClaimDiagnosisCodeableConceptCS-2E81.461"> </a></td><td>Benign lymphatic neoplasms</td></tr><tr><td style="white-space:nowrap">4A60.2<a name="ClaimDiagnosisCodeableConceptCS-4A60.462"> </a></td><td>Tumour necrosis factor receptor 1 associated periodic syndrome with amyloidosis</td></tr><tr><td style="white-space:nowrap">4A60.1<a name="ClaimDiagnosisCodeableConceptCS-4A60.461"> </a></td><td>Muckle Wells Syndrome with neurosensorial hearing loss</td></tr><tr><td style="white-space:nowrap">4A60.0<a name="ClaimDiagnosisCodeableConceptCS-4A60.460"> </a></td><td>Familial Mediterranean fever with amyloidosis</td></tr><tr><td style="white-space:nowrap">4A60.Z<a name="ClaimDiagnosisCodeableConceptCS-4A60.46Z"> </a></td><td>Monogenic autoinflammatory syndromes</td></tr><tr><td style="white-space:nowrap">4A60.Y<a name="ClaimDiagnosisCodeableConceptCS-4A60.46Y"> </a></td><td>NLRP12-associated hereditary periodic fever syndrome</td></tr><tr><td style="white-space:nowrap">4A84.0<a name="ClaimDiagnosisCodeableConceptCS-4A84.460"> </a></td><td>Anaphylactic shock due to allergic food reaction</td></tr><tr><td style="white-space:nowrap">4A84.3<a name="ClaimDiagnosisCodeableConceptCS-4A84.463"> </a></td><td>Anaphylaxis provoked by physical factors</td></tr><tr><td style="white-space:nowrap">4A84.2<a name="ClaimDiagnosisCodeableConceptCS-4A84.462"> </a></td><td>Insect venom allergen-induced anaphylaxis</td></tr><tr><td style="white-space:nowrap">4A84.4<a name="ClaimDiagnosisCodeableConceptCS-4A84.464"> </a></td><td>Inhaled allergen-induced anaphylaxis</td></tr><tr><td style="white-space:nowrap">4A84.1<a name="ClaimDiagnosisCodeableConceptCS-4A84.461"> </a></td><td>medicament-induced anaphylaxis</td></tr><tr><td style="white-space:nowrap">4B00-4B0Z<a name="ClaimDiagnosisCodeableConceptCS-4B00-4B0Z"> </a></td><td>Immune system disorders involving white cell lineages</td></tr><tr><td style="white-space:nowrap">4A80.Y<a name="ClaimDiagnosisCodeableConceptCS-4A80.46Y"> </a></td><td>Other specified allergic or hypersensitivity disorders involving the respiratory tract</td></tr><tr><td style="white-space:nowrap">4A80.1<a name="ClaimDiagnosisCodeableConceptCS-4A80.461"> </a></td><td>Food-induced wheezing</td></tr><tr><td style="white-space:nowrap">4A80.Z<a name="ClaimDiagnosisCodeableConceptCS-4A80.46Z"> </a></td><td>Allergic or hypersensitivity disorders involving the respiratory tract</td></tr><tr><td style="white-space:nowrap">4A80.0<a name="ClaimDiagnosisCodeableConceptCS-4A80.460"> </a></td><td>medicament-induced bronchospasm</td></tr><tr><td style="white-space:nowrap">4A83.1<a name="ClaimDiagnosisCodeableConceptCS-4A83.461"> </a></td><td>Food-induced eosinophilic oesophagitis</td></tr><tr><td style="white-space:nowrap">4A83.Y<a name="ClaimDiagnosisCodeableConceptCS-4A83.46Y"> </a></td><td>Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract</td></tr><tr><td style="white-space:nowrap">4A83.Z<a name="ClaimDiagnosisCodeableConceptCS-4A83.46Z"> </a></td><td>Allergic or hypersensitivity disorders involving the gastrointestinal tract</td></tr><tr><td style="white-space:nowrap">4A83.0<a name="ClaimDiagnosisCodeableConceptCS-4A83.460"> </a></td><td>Food-induced eosinophilic gastroenteritis</td></tr><tr><td style="white-space:nowrap">4A85<a name="ClaimDiagnosisCodeableConceptCS-4A85"> </a></td><td>Complex allergic or hypersensitivity conditions</td></tr><tr><td style="white-space:nowrap">4A8Y<a name="ClaimDiagnosisCodeableConceptCS-4A8Y"> </a></td><td>Allergic or hypersensitivity conditions of other specified type</td></tr><tr><td style="white-space:nowrap">4A41.0<a name="ClaimDiagnosisCodeableConceptCS-4A41.460"> </a></td><td>Dermatomyositis</td></tr><tr><td style="white-space:nowrap">4A41.Y<a name="ClaimDiagnosisCodeableConceptCS-4A41.46Y"> </a></td><td>Focal myositis</td></tr><tr><td style="white-space:nowrap">4A41.2<a name="ClaimDiagnosisCodeableConceptCS-4A41.462"> </a></td><td>Inclusion body myopathy</td></tr><tr><td style="white-space:nowrap">4A41.1<a name="ClaimDiagnosisCodeableConceptCS-4A41.461"> </a></td><td>Polymyositis</td></tr><tr><td style="white-space:nowrap">4A41.Z<a name="ClaimDiagnosisCodeableConceptCS-4A41.46Z"> </a></td><td>Idiopathic inflammatory myopathy</td></tr><tr><td style="white-space:nowrap">4A43.2<a name="ClaimDiagnosisCodeableConceptCS-4A43.462"> </a></td><td>Sjögren syndrome</td></tr><tr><td style="white-space:nowrap">4A43.3<a name="ClaimDiagnosisCodeableConceptCS-4A43.463"> </a></td><td>Paediatric-onset MCTD - [mixed connective tissue disease]</td></tr><tr><td style="white-space:nowrap">4A44.2<a name="ClaimDiagnosisCodeableConceptCS-4A44.462"> </a></td><td>Giant cell arteritis without polymyalgia rheumatica</td></tr><tr><td style="white-space:nowrap">4A43.1<a name="ClaimDiagnosisCodeableConceptCS-4A43.461"> </a></td><td>Mikulicz disease</td></tr><tr><td style="white-space:nowrap">4A43.0<a name="ClaimDiagnosisCodeableConceptCS-4A43.460"> </a></td><td>Cholangitis of IgG4-related sclerosing disease</td></tr><tr><td style="white-space:nowrap">4A43.4<a name="ClaimDiagnosisCodeableConceptCS-4A43.464"> </a></td><td>Diffuse fasciitis</td></tr><tr><td style="white-space:nowrap">4A40.1<a name="ClaimDiagnosisCodeableConceptCS-4A40.461"> </a></td><td>drug-induced systemic lupus erythematosus</td></tr><tr><td style="white-space:nowrap">4A44.0<a name="ClaimDiagnosisCodeableConceptCS-4A44.460"> </a></td><td>Rhizomelic pseudopolyarthritis</td></tr><tr><td style="white-space:nowrap">4A44.3<a name="ClaimDiagnosisCodeableConceptCS-4A44.463"> </a></td><td>Single organ vasculitis</td></tr><tr><td style="white-space:nowrap">4A40.Y<a name="ClaimDiagnosisCodeableConceptCS-4A40.46Y"> </a></td><td>Lupus erythematosus of oral mucosa</td></tr><tr><td style="white-space:nowrap">4A40.0<a name="ClaimDiagnosisCodeableConceptCS-4A40.460"> </a></td><td>Systemic lupus erythematosus</td></tr><tr><td style="white-space:nowrap">4A44.4<a name="ClaimDiagnosisCodeableConceptCS-4A44.464"> </a></td><td>Periarteritis nodosa with necrosis</td></tr><tr><td style="white-space:nowrap">4A44.1<a name="ClaimDiagnosisCodeableConceptCS-4A44.461"> </a></td><td>young female aortic arch arteritis syndrome</td></tr><tr><td style="white-space:nowrap">4A40.Z<a name="ClaimDiagnosisCodeableConceptCS-4A40.46Z"> </a></td><td>LE - [lupus erythematosus]</td></tr><tr><td style="white-space:nowrap">4A01.1<a name="ClaimDiagnosisCodeableConceptCS-4A01.461"> </a></td><td>Combined immunodeficiencies</td></tr><tr><td style="white-space:nowrap">4A01.2<a name="ClaimDiagnosisCodeableConceptCS-4A01.462"> </a></td><td>Diseases of immune dysregulation</td></tr><tr><td style="white-space:nowrap">4A01.0<a name="ClaimDiagnosisCodeableConceptCS-4A01.460"> </a></td><td>Immunodeficiencies with predominantly antibody defects</td></tr><tr><td style="white-space:nowrap">4A01.Z<a name="ClaimDiagnosisCodeableConceptCS-4A01.46Z"> </a></td><td>Primary immunodeficiencies due to disorders of adaptive immunity</td></tr><tr><td style="white-space:nowrap">4A01.3<a name="ClaimDiagnosisCodeableConceptCS-4A01.463"> </a></td><td>Other well-defined immunodeficiency syndromes due to defects in adaptive immunity</td></tr><tr><td style="white-space:nowrap">4A00.1<a name="ClaimDiagnosisCodeableConceptCS-4A00.461"> </a></td><td>Defects in the complement system</td></tr><tr><td style="white-space:nowrap">4A00.3<a name="ClaimDiagnosisCodeableConceptCS-4A00.463"> </a></td><td>Immunodeficiency with NK-cell - [natural-killer cell] deficiency</td></tr><tr><td style="white-space:nowrap">4A00.Y<a name="ClaimDiagnosisCodeableConceptCS-4A00.46Y"> </a></td><td>Warts - hypogammaglobulinaemia - infections - myelokathexis</td></tr><tr><td style="white-space:nowrap">4A00.2<a name="ClaimDiagnosisCodeableConceptCS-4A00.462"> </a></td><td>Pyogenic bacterial infections due to MyD88 deficiency</td></tr><tr><td style="white-space:nowrap">4A00.0<a name="ClaimDiagnosisCodeableConceptCS-4A00.460"> </a></td><td>Functional neutrophil defects</td></tr><tr><td style="white-space:nowrap">1A93<a name="ClaimDiagnosisCodeableConceptCS-1A93"> </a></td><td>Sexually transmissible infestations</td></tr><tr><td style="white-space:nowrap">1A92<a name="ClaimDiagnosisCodeableConceptCS-1A92"> </a></td><td>Trichomonal cervicitis</td></tr><tr><td style="white-space:nowrap">1A60<a name="ClaimDiagnosisCodeableConceptCS-1A60"> </a></td><td>Congenital syphilis</td></tr><tr><td style="white-space:nowrap">1A61<a name="ClaimDiagnosisCodeableConceptCS-1A61"> </a></td><td>Early syphilis</td></tr><tr><td style="white-space:nowrap">1A63<a name="ClaimDiagnosisCodeableConceptCS-1A63"> </a></td><td>Positive Wassermann test</td></tr><tr><td style="white-space:nowrap">1A6Z<a name="ClaimDiagnosisCodeableConceptCS-1A6Z"> </a></td><td>Female syphilitic pelvic inflammatory disease</td></tr><tr><td style="white-space:nowrap">1A62<a name="ClaimDiagnosisCodeableConceptCS-1A62"> </a></td><td>Late syphilis</td></tr><tr><td style="white-space:nowrap">1B72.0<a name="ClaimDiagnosisCodeableConceptCS-1B72.460"> </a></td><td>Blistering distal dactylitis</td></tr><tr><td style="white-space:nowrap">1B72.Y<a name="ClaimDiagnosisCodeableConceptCS-1B72.46Y"> </a></td><td>Other specified impetigo</td></tr><tr><td style="white-space:nowrap">1B72.1<a name="ClaimDiagnosisCodeableConceptCS-1B72.461"> </a></td><td>Non-bullous impetigo</td></tr><tr><td style="white-space:nowrap">1B21.1<a name="ClaimDiagnosisCodeableConceptCS-1B21.461"> </a></td><td>Non-tuberculous mycobacterial lymphadenitis</td></tr><tr><td style="white-space:nowrap">1B21.0<a name="ClaimDiagnosisCodeableConceptCS-1B21.460"> </a></td><td>Pulmonary infection due to Mycobacterium malmoense</td></tr><tr><td style="white-space:nowrap">1B21.4<a name="ClaimDiagnosisCodeableConceptCS-1B21.464"> </a></td><td>Non-tuberculous mycobacterial colitis</td></tr><tr><td style="white-space:nowrap">2A00.20<a name="ClaimDiagnosisCodeableConceptCS-2A00.4620"> </a></td><td>Pineocytoma</td></tr><tr><td style="white-space:nowrap">2A00.21<a name="ClaimDiagnosisCodeableConceptCS-2A00.4621"> </a></td><td>Lhermitte-Duclos disease</td></tr><tr><td style="white-space:nowrap">2A00.22<a name="ClaimDiagnosisCodeableConceptCS-2A00.4622"> </a></td><td>choroid plexus carcinoma (grade 3 lesion)</td></tr><tr><td style="white-space:nowrap">2A00.2Y<a name="ClaimDiagnosisCodeableConceptCS-2A00.462Y"> </a></td><td>Other specified tumours of neuroepithelial tissue of brain</td></tr><tr><td style="white-space:nowrap">2A00.0Z<a name="ClaimDiagnosisCodeableConceptCS-2A00.460Z"> </a></td><td>glioma NOS</td></tr><tr><td style="white-space:nowrap">2A00.2Z<a name="ClaimDiagnosisCodeableConceptCS-2A00.462Z"> </a></td><td>Tumours of neuroepithelial tissue of brain</td></tr><tr><td style="white-space:nowrap">2A00.5<a name="ClaimDiagnosisCodeableConceptCS-2A00.465"> </a></td><td>benign brain tumour NOS</td></tr><tr><td style="white-space:nowrap">2A00.1Y<a name="ClaimDiagnosisCodeableConceptCS-2A00.461Y"> </a></td><td>Yolk sac tumour of the central nervous system</td></tr><tr><td style="white-space:nowrap">1B21.3<a name="ClaimDiagnosisCodeableConceptCS-1B21.463"> </a></td><td>DMAC - [disseminated mycobacterium avium-intracellulare complex infection]</td></tr><tr><td style="white-space:nowrap">2A02.00<a name="ClaimDiagnosisCodeableConceptCS-2A02.4600"> </a></td><td>Glioblastoma of spinal cord, cranial or paraspinal nerves</td></tr><tr><td style="white-space:nowrap">2A02.0Z<a name="ClaimDiagnosisCodeableConceptCS-2A02.460Z"> </a></td><td>Gliomas of spinal cord, cranial or paraspinal nerves</td></tr><tr><td style="white-space:nowrap">2A02.0Y<a name="ClaimDiagnosisCodeableConceptCS-2A02.460Y"> </a></td><td>Malignant astrocytomas of spinal cord, cranial or paraspinal nerves</td></tr><tr><td style="white-space:nowrap">2A00.00<a name="ClaimDiagnosisCodeableConceptCS-2A00.4600"> </a></td><td>Spongioblastoma multiforme of unspecified site</td></tr><tr><td style="white-space:nowrap">2A00.10<a name="ClaimDiagnosisCodeableConceptCS-2A00.4610"> </a></td><td>Neuroepithelioma</td></tr><tr><td style="white-space:nowrap">2A00.1Z<a name="ClaimDiagnosisCodeableConceptCS-2A00.461Z"> </a></td><td>Embryonal tumours of brain</td></tr><tr><td style="white-space:nowrap">2A00.0Y<a name="ClaimDiagnosisCodeableConceptCS-2A00.460Y"> </a></td><td>Subependymal glioma, unspecified site</td></tr><tr><td style="white-space:nowrap">2A02.10<a name="ClaimDiagnosisCodeableConceptCS-2A02.4610"> </a></td><td>neurofibrosarcoma</td></tr><tr><td style="white-space:nowrap">2A00.11<a name="ClaimDiagnosisCodeableConceptCS-2A00.4611"> </a></td><td>Teratoid medulloepithelioma of unspecified site</td></tr><tr><td style="white-space:nowrap">2A20<a name="ClaimDiagnosisCodeableConceptCS-2A20"> </a></td><td>Non mast cell myeloproliferative neoplasms</td></tr><tr><td style="white-space:nowrap">2A60.4<a name="ClaimDiagnosisCodeableConceptCS-2A60.464"> </a></td><td>Myeloid proliferation associated with Down syndrome</td></tr><tr><td style="white-space:nowrap">2A60.1<a name="ClaimDiagnosisCodeableConceptCS-2A60.461"> </a></td><td>Acute myeloid leukaemia with multilineage dysplasia in complete remission</td></tr><tr><td style="white-space:nowrap">2A60.2<a name="ClaimDiagnosisCodeableConceptCS-2A60.462"> </a></td><td>Therapy-related myeloid neoplasms</td></tr><tr><td style="white-space:nowrap">2A40<a name="ClaimDiagnosisCodeableConceptCS-2A40"> </a></td><td>CMML-2 - [chronic myelomonocytic leukaemia Type 2]</td></tr><tr><td style="white-space:nowrap">2A60.0<a name="ClaimDiagnosisCodeableConceptCS-2A60.460"> </a></td><td>Acute myeloid leukemia with t(8;21)(q22;q22) translocation</td></tr><tr><td style="white-space:nowrap">2A41<a name="ClaimDiagnosisCodeableConceptCS-2A41"> </a></td><td>Atypical chronic myeloid leukaemia, BCR-ABL1-negative in complete remission</td></tr><tr><td style="white-space:nowrap">1B12.2<a name="ClaimDiagnosisCodeableConceptCS-1B12.462"> </a></td><td>Tuberculosis of inner ear</td></tr><tr><td style="white-space:nowrap">1B12.0<a name="ClaimDiagnosisCodeableConceptCS-1B12.460"> </a></td><td>tuberculous pericarditis</td></tr><tr><td style="white-space:nowrap">2A01.0Z<a name="ClaimDiagnosisCodeableConceptCS-2A01.460Z"> </a></td><td>benign meningioma (deprecated)</td></tr><tr><td style="white-space:nowrap">2A2Z<a name="ClaimDiagnosisCodeableConceptCS-2A2Z"> </a></td><td>myeloproliferative disorder</td></tr><tr><td style="white-space:nowrap">1B1Y<a name="ClaimDiagnosisCodeableConceptCS-1B1Y"> </a></td><td>Disorders of kidney or ureter in tuberculosis</td></tr><tr><td style="white-space:nowrap">1B11.1<a name="ClaimDiagnosisCodeableConceptCS-1B11.461"> </a></td><td>Tuberculous meningoencephalitis</td></tr><tr><td style="white-space:nowrap">2A60.3<a name="ClaimDiagnosisCodeableConceptCS-2A60.463"> </a></td><td>Acute myeloid leukaemia, not elsewhere classified by criteria of other types</td></tr><tr><td style="white-space:nowrap">1B11.2<a name="ClaimDiagnosisCodeableConceptCS-1B11.462"> </a></td><td>Tuberculoma of spinal meninges</td></tr><tr><td style="white-space:nowrap">2A43<a name="ClaimDiagnosisCodeableConceptCS-2A43"> </a></td><td>RARS-T [Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis](provisional)</td></tr><tr><td style="white-space:nowrap">2A42<a name="ClaimDiagnosisCodeableConceptCS-2A42"> </a></td><td>Juvenile myelomonocytic leukaemia</td></tr><tr><td style="white-space:nowrap">2A44<a name="ClaimDiagnosisCodeableConceptCS-2A44"> </a></td><td>Myeloproliferative and myelodysplastic disease, unclassifiable in complete remission</td></tr><tr><td style="white-space:nowrap">2A51<a name="ClaimDiagnosisCodeableConceptCS-2A51"> </a></td><td>Myeloid neoplasms with PDGFRB rearrangement</td></tr><tr><td style="white-space:nowrap">2A02.Z<a name="ClaimDiagnosisCodeableConceptCS-2A02.46Z"> </a></td><td>Epidural cancer NOS</td></tr><tr><td style="white-space:nowrap">1B13.2<a name="ClaimDiagnosisCodeableConceptCS-1B13.462"> </a></td><td>Acute miliary tuberculosis, unspecified site</td></tr><tr><td style="white-space:nowrap">1B13.1<a name="ClaimDiagnosisCodeableConceptCS-1B13.461"> </a></td><td>tuberculous polyserositis</td></tr><tr><td style="white-space:nowrap">1B13.Y<a name="ClaimDiagnosisCodeableConceptCS-1B13.46Y"> </a></td><td>Chronic multiple tuberculosis</td></tr><tr><td style="white-space:nowrap">1B13.Z<a name="ClaimDiagnosisCodeableConceptCS-1B13.46Z"> </a></td><td>disseminated tuberculosis</td></tr><tr><td style="white-space:nowrap">1B11.3<a name="ClaimDiagnosisCodeableConceptCS-1B11.463"> </a></td><td>tuberculoma of brain</td></tr><tr><td style="white-space:nowrap">1B11.0<a name="ClaimDiagnosisCodeableConceptCS-1B11.460"> </a></td><td>spinal meningeal TBC - [tuberculosis]</td></tr><tr><td style="white-space:nowrap">1B11.Y<a name="ClaimDiagnosisCodeableConceptCS-1B11.46Y"> </a></td><td>tuberculous cerebrum arteritis</td></tr><tr><td style="white-space:nowrap">2A01.0Y<a name="ClaimDiagnosisCodeableConceptCS-2A01.460Y"> </a></td><td>Syncytial meningioma of unspecified site</td></tr><tr><td style="white-space:nowrap">2A2Y<a name="ClaimDiagnosisCodeableConceptCS-2A2Y"> </a></td><td>chronic myeloproliferative disease NOS</td></tr><tr><td style="white-space:nowrap">1A40.0<a name="ClaimDiagnosisCodeableConceptCS-1A40.460"> </a></td><td>jejunal inflammation</td></tr><tr><td style="white-space:nowrap">2E92.8<a name="ClaimDiagnosisCodeableConceptCS-2E92.468"> </a></td><td>benign tumour of tail of pancreas</td></tr><tr><td style="white-space:nowrap">1A40.Z<a name="ClaimDiagnosisCodeableConceptCS-1A40.46Z"> </a></td><td>intestinal infections without specification of infectious agent</td></tr><tr><td style="white-space:nowrap">1B13.0<a name="ClaimDiagnosisCodeableConceptCS-1B13.460"> </a></td><td>Acute miliary lung TBC - [tuberculosis]</td></tr><tr><td style="white-space:nowrap">2F30<a name="ClaimDiagnosisCodeableConceptCS-2F30"> </a></td><td>Benign neoplasm of breast</td></tr><tr><td style="white-space:nowrap">1B10.0<a name="ClaimDiagnosisCodeableConceptCS-1B10.460"> </a></td><td>Tuberculous sinusitis of any sinus, with bacteriological and histological confirmation</td></tr><tr><td style="white-space:nowrap">1B7Z<a name="ClaimDiagnosisCodeableConceptCS-1B7Z"> </a></td><td>suppurative dermatitis</td></tr><tr><td style="white-space:nowrap">1B12.5<a name="ClaimDiagnosisCodeableConceptCS-1B12.465"> </a></td><td>Tuberculosis of breast</td></tr><tr><td style="white-space:nowrap">1B10.Z<a name="ClaimDiagnosisCodeableConceptCS-1B10.46Z"> </a></td><td>Tuberculous pansinusitis</td></tr><tr><td style="white-space:nowrap">2D61<a name="ClaimDiagnosisCodeableConceptCS-2D61"> </a></td><td>Malignant neoplasm metastasis in lymph nodes of multiple regions by adenocarcinoma</td></tr><tr><td style="white-space:nowrap">2D6Z<a name="ClaimDiagnosisCodeableConceptCS-2D6Z"> </a></td><td>lymphatic vessel metastasis</td></tr><tr><td style="white-space:nowrap">1B70.Z<a name="ClaimDiagnosisCodeableConceptCS-1B70.46Z"> </a></td><td>Cellulitis not otherwise specified</td></tr><tr><td style="white-space:nowrap">2E81.2Y<a name="ClaimDiagnosisCodeableConceptCS-2E81.462Y"> </a></td><td>Diffuse neonatal haemangiomatosis</td></tr><tr><td style="white-space:nowrap">2E90.7<a name="ClaimDiagnosisCodeableConceptCS-2E90.467"> </a></td><td>Benign tumour of pharyngoesophageal junction</td></tr><tr><td style="white-space:nowrap">1A2Z<a name="ClaimDiagnosisCodeableConceptCS-1A2Z"> </a></td><td>Viral gastroenteropathy NOS</td></tr><tr><td style="white-space:nowrap">2E81.21<a name="ClaimDiagnosisCodeableConceptCS-2E81.4621"> </a></td><td>Multiple strawberry haemangiomata</td></tr><tr><td style="white-space:nowrap">1B12.6<a name="ClaimDiagnosisCodeableConceptCS-1B12.466"> </a></td><td>TB - [tuberculosis] axillary gland</td></tr><tr><td style="white-space:nowrap">2B63<a name="ClaimDiagnosisCodeableConceptCS-2B63"> </a></td><td>Malignant neoplasms of gum</td></tr><tr><td style="white-space:nowrap">2B64<a name="ClaimDiagnosisCodeableConceptCS-2B64"> </a></td><td>Malignant neoplasms of floor of mouth</td></tr><tr><td style="white-space:nowrap">2B61<a name="ClaimDiagnosisCodeableConceptCS-2B61"> </a></td><td>Malignant neoplasms of base of tongue</td></tr><tr><td style="white-space:nowrap">2E66<a name="ClaimDiagnosisCodeableConceptCS-2E66"> </a></td><td>Carcinoma in situ of cervix uteri</td></tr><tr><td style="white-space:nowrap">2D60<a name="ClaimDiagnosisCodeableConceptCS-2D60"> </a></td><td>Malignant neoplasm metastasis in lymph node of a single region</td></tr><tr><td style="white-space:nowrap">5B80<a name="ClaimDiagnosisCodeableConceptCS-5B80"> </a></td><td>Overweight or localised adiposity</td></tr><tr><td style="white-space:nowrap">5B81<a name="ClaimDiagnosisCodeableConceptCS-5B81"> </a></td><td>Obesity</td></tr><tr><td style="white-space:nowrap">5B90<a name="ClaimDiagnosisCodeableConceptCS-5B90"> </a></td><td>Vitamin excesses</td></tr><tr><td style="white-space:nowrap">1A2Y<a name="ClaimDiagnosisCodeableConceptCS-1A2Y"> </a></td><td>Enteritis due to coxsackievirus</td></tr><tr><td style="white-space:nowrap">1B12.8<a name="ClaimDiagnosisCodeableConceptCS-1B12.468"> </a></td><td>Tuberculous gumma</td></tr><tr><td style="white-space:nowrap">5A05<a name="ClaimDiagnosisCodeableConceptCS-5A05"> </a></td><td>Refetoff syndrome</td></tr><tr><td style="white-space:nowrap">2F20.Y<a name="ClaimDiagnosisCodeableConceptCS-2F20.46Y"> </a></td><td>Unclassifiable benign cutaneous melanocytic proliferation</td></tr><tr><td style="white-space:nowrap">5B91<a name="ClaimDiagnosisCodeableConceptCS-5B91"> </a></td><td>Mineral excesses</td></tr><tr><td style="white-space:nowrap">5B9Z<a name="ClaimDiagnosisCodeableConceptCS-5B9Z"> </a></td><td>Nutrient excesses, unspecified</td></tr><tr><td style="white-space:nowrap">2D4Z<a name="ClaimDiagnosisCodeableConceptCS-2D4Z"> </a></td><td>Cancer in polyp</td></tr><tr><td style="white-space:nowrap">2B60<a name="ClaimDiagnosisCodeableConceptCS-2B60"> </a></td><td>Malignant neoplasms of lip</td></tr><tr><td style="white-space:nowrap">2B62<a name="ClaimDiagnosisCodeableConceptCS-2B62"> </a></td><td>Malignant neoplasms of other or unspecified parts of tongue</td></tr><tr><td style="white-space:nowrap">5A00.0<a name="ClaimDiagnosisCodeableConceptCS-5A00.460"> </a></td><td>Congenital hypothyroidism</td></tr><tr><td style="white-space:nowrap">5A00.Z<a name="ClaimDiagnosisCodeableConceptCS-5A00.46Z"> </a></td><td>Subclinical hypothyroidism</td></tr><tr><td style="white-space:nowrap">5A00.1<a name="ClaimDiagnosisCodeableConceptCS-5A00.461"> </a></td><td>Iodine-deficiency-related thyroid disorders or allied conditions</td></tr><tr><td style="white-space:nowrap">5A20-5A2Y<a name="ClaimDiagnosisCodeableConceptCS-5A20-5A2Y"> </a></td><td>Acute complications of diabetes mellitus</td></tr><tr><td style="white-space:nowrap">4A43.Y<a name="ClaimDiagnosisCodeableConceptCS-4A43.46Y"> </a></td><td>Other specified non-organ specific systemic autoimmune disorders, not elsewhere classified, associated with anti-RNP antibodies</td></tr><tr><td style="white-space:nowrap">2E87<a name="ClaimDiagnosisCodeableConceptCS-2E87"> </a></td><td>GIST - [gastrointestinal stromal tumour] of appendix</td></tr><tr><td style="white-space:nowrap">5D40.0Z<a name="ClaimDiagnosisCodeableConceptCS-5D40.460Z"> </a></td><td>Postirridation hypothyroidism</td></tr><tr><td style="white-space:nowrap">2F20.2<a name="ClaimDiagnosisCodeableConceptCS-2F20.462"> </a></td><td>Congenital melanocytic naevus</td></tr><tr><td style="white-space:nowrap">2F20.3<a name="ClaimDiagnosisCodeableConceptCS-2F20.463"> </a></td><td>Generalised eruptive melanocytic naevi</td></tr><tr><td style="white-space:nowrap">2F20.1<a name="ClaimDiagnosisCodeableConceptCS-2F20.461"> </a></td><td>Melanocytic naevus with mild to moderate dysplasia</td></tr><tr><td style="white-space:nowrap">2F20.Z<a name="ClaimDiagnosisCodeableConceptCS-2F20.46Z"> </a></td><td>Naevus pigmentosus</td></tr><tr><td style="white-space:nowrap">5B9Y<a name="ClaimDiagnosisCodeableConceptCS-5B9Y"> </a></td><td>Other specified nutrient excesses</td></tr><tr><td style="white-space:nowrap">2E92.Y<a name="ClaimDiagnosisCodeableConceptCS-2E92.46Y"> </a></td><td>Benign neoplasm of other specified digestive organs</td></tr><tr><td style="white-space:nowrap">4A42.Z<a name="ClaimDiagnosisCodeableConceptCS-4A42.46Z"> </a></td><td>Myopathy in scleroderma</td></tr><tr><td style="white-space:nowrap">2F21.0<a name="ClaimDiagnosisCodeableConceptCS-2F21.460"> </a></td><td>Traumatized seborrhoeic keratosis</td></tr><tr><td style="white-space:nowrap">2F25<a name="ClaimDiagnosisCodeableConceptCS-2F25"> </a></td><td>de Morgan's spots</td></tr><tr><td style="white-space:nowrap">2F23.0<a name="ClaimDiagnosisCodeableConceptCS-2F23.460"> </a></td><td>Subepidermal nodular fibrosis</td></tr><tr><td style="white-space:nowrap">2F23.Y<a name="ClaimDiagnosisCodeableConceptCS-2F23.46Y"> </a></td><td>Fibrous papule of nose</td></tr><tr><td style="white-space:nowrap">2E90.8<a name="ClaimDiagnosisCodeableConceptCS-2E90.468"> </a></td><td>benign tumour of Waldeyer ring</td></tr><tr><td style="white-space:nowrap">2E88<a name="ClaimDiagnosisCodeableConceptCS-2E88"> </a></td><td>Stromal nodule</td></tr><tr><td style="white-space:nowrap">2E92.Z<a name="ClaimDiagnosisCodeableConceptCS-2E92.46Z"> </a></td><td>benign tumour of intestine NOS</td></tr><tr><td style="white-space:nowrap">4A42.2<a name="ClaimDiagnosisCodeableConceptCS-4A42.462"> </a></td><td>CRST - [calcinosis, Raynaud phenomenon, sclerodactyly and telangiectasia] syndrome</td></tr><tr><td style="white-space:nowrap">2D80<a name="ClaimDiagnosisCodeableConceptCS-2D80"> </a></td><td>Secondary malignant neoplasm of liver or intrahepatic bile duct</td></tr><tr><td style="white-space:nowrap">2D84<a name="ClaimDiagnosisCodeableConceptCS-2D84"> </a></td><td>duodenal metastasis</td></tr><tr><td style="white-space:nowrap">2D82<a name="ClaimDiagnosisCodeableConceptCS-2D82"> </a></td><td>metastasis to ductus choledochus</td></tr><tr><td style="white-space:nowrap">2F26<a name="ClaimDiagnosisCodeableConceptCS-2F26"> </a></td><td>Pyogenic granuloma</td></tr><tr><td style="white-space:nowrap">1A70<a name="ClaimDiagnosisCodeableConceptCS-1A70"> </a></td><td>Gonococcal genitourinary infection</td></tr><tr><td style="white-space:nowrap">2D90<a name="ClaimDiagnosisCodeableConceptCS-2D90"> </a></td><td>secondary malignant neoplasm of retroperitoneum</td></tr><tr><td style="white-space:nowrap">1B75.0<a name="ClaimDiagnosisCodeableConceptCS-1B75.460"> </a></td><td>Boil</td></tr><tr><td style="white-space:nowrap">1B75.2<a name="ClaimDiagnosisCodeableConceptCS-1B75.462"> </a></td><td>Furunculosis</td></tr><tr><td style="white-space:nowrap">2D91<a name="ClaimDiagnosisCodeableConceptCS-2D91"> </a></td><td>malignant ascites NOS</td></tr><tr><td style="white-space:nowrap">4A01.30<a name="ClaimDiagnosisCodeableConceptCS-4A01.4630"> </a></td><td>Immunodeficiency due to absence of thymus</td></tr><tr><td style="white-space:nowrap">4A01.32<a name="ClaimDiagnosisCodeableConceptCS-4A01.4632"> </a></td><td>Schimke syndrome</td></tr><tr><td style="white-space:nowrap">2E86.2<a name="ClaimDiagnosisCodeableConceptCS-2E86.462"> </a></td><td>Glycogenic rhabdomyoma</td></tr><tr><td style="white-space:nowrap">1A72<a name="ClaimDiagnosisCodeableConceptCS-1A72"> </a></td><td>Gonococcal infection of other sites</td></tr><tr><td style="white-space:nowrap">1A36.Z<a name="ClaimDiagnosisCodeableConceptCS-1A36.46Z"> </a></td><td>amoebiasis, unspecified</td></tr><tr><td style="white-space:nowrap">1A7Z<a name="ClaimDiagnosisCodeableConceptCS-1A7Z"> </a></td><td>Infection due to Neisseria gonorrhoeae</td></tr><tr><td style="white-space:nowrap">2D7Z<a name="ClaimDiagnosisCodeableConceptCS-2D7Z"> </a></td><td>thorax metastasis</td></tr><tr><td style="white-space:nowrap">4A01.33<a name="ClaimDiagnosisCodeableConceptCS-4A01.4633"> </a></td><td>VODI - [Veno-occlusive disease immunodeficiency] syndrome</td></tr><tr><td style="white-space:nowrap">4A01.31<a name="ClaimDiagnosisCodeableConceptCS-4A01.4631"> </a></td><td>ATLD - [Ataxia-telangiectasia-like disorder]</td></tr><tr><td style="white-space:nowrap">4A01.34<a name="ClaimDiagnosisCodeableConceptCS-4A01.4634"> </a></td><td>Hyperimmunoglobulin E syndrome due to TYK2 deficiency</td></tr><tr><td style="white-space:nowrap">2E86.Z<a name="ClaimDiagnosisCodeableConceptCS-2E86.46Z"> </a></td><td>myoma of unspecified site</td></tr><tr><td style="white-space:nowrap">1A36.0<a name="ClaimDiagnosisCodeableConceptCS-1A36.460"> </a></td><td>Intestinal infections due to Entamoeba</td></tr><tr><td style="white-space:nowrap">2D86<a name="ClaimDiagnosisCodeableConceptCS-2D86"> </a></td><td>anal canal metastasis</td></tr><tr><td style="white-space:nowrap">1B75.3<a name="ClaimDiagnosisCodeableConceptCS-1B75.463"> </a></td><td>abscess NOS</td></tr><tr><td style="white-space:nowrap">1B75.1<a name="ClaimDiagnosisCodeableConceptCS-1B75.461"> </a></td><td>Carbuncle</td></tr><tr><td style="white-space:nowrap">3A00-3A9Z<a name="ClaimDiagnosisCodeableConceptCS-3A00-3A9Z"> </a></td><td>Anaemias or other erythrocyte disorders</td></tr><tr><td style="white-space:nowrap">2A30<a name="ClaimDiagnosisCodeableConceptCS-2A30"> </a></td><td>refractory anaemia without sideroblasts</td></tr><tr><td style="white-space:nowrap">3B10-3B6Z<a name="ClaimDiagnosisCodeableConceptCS-3B10-3B6Z"> </a></td><td>Coagulation defects, purpura or other haemorrhagic or related conditions</td></tr><tr><td style="white-space:nowrap">3B80-3B8Z<a name="ClaimDiagnosisCodeableConceptCS-3B80-3B8Z"> </a></td><td>Diseases of spleen</td></tr><tr><td style="white-space:nowrap">2A01.00<a name="ClaimDiagnosisCodeableConceptCS-2A01.4600"> </a></td><td>Familial multiple meningioma</td></tr><tr><td style="white-space:nowrap">1A10<a name="ClaimDiagnosisCodeableConceptCS-1A10"> </a></td><td>staphylococcus poisoning</td></tr><tr><td style="white-space:nowrap">1A00<a name="ClaimDiagnosisCodeableConceptCS-1A00"> </a></td><td>Cholera due to Vibrio cholerae O139</td></tr><tr><td style="white-space:nowrap">1B21.2<a name="ClaimDiagnosisCodeableConceptCS-1B21.462"> </a></td><td>Cutaneous non-tuberculous mycobacterial infection</td></tr><tr><td style="white-space:nowrap">1A71<a name="ClaimDiagnosisCodeableConceptCS-1A71"> </a></td><td>Gonococcal ovarian abscess</td></tr><tr><td style="white-space:nowrap">1A12<a name="ClaimDiagnosisCodeableConceptCS-1A12"> </a></td><td>pigbel</td></tr><tr><td style="white-space:nowrap">2B50<a name="ClaimDiagnosisCodeableConceptCS-2B50"> </a></td><td>Chondrosarcoma, primary site</td></tr><tr><td style="white-space:nowrap">2A32<a name="ClaimDiagnosisCodeableConceptCS-2A32"> </a></td><td>Refractory thrombocytopenia</td></tr><tr><td style="white-space:nowrap">2A31<a name="ClaimDiagnosisCodeableConceptCS-2A31"> </a></td><td>Refractory neutropaenia</td></tr><tr><td style="white-space:nowrap">2B52<a name="ClaimDiagnosisCodeableConceptCS-2B52"> </a></td><td>Ewing sarcoma, primary site</td></tr><tr><td style="white-space:nowrap">1A70.0<a name="ClaimDiagnosisCodeableConceptCS-1A70.460"> </a></td><td>Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess</td></tr><tr><td style="white-space:nowrap">2A21<a name="ClaimDiagnosisCodeableConceptCS-2A21"> </a></td><td>Mastocytosis</td></tr><tr><td style="white-space:nowrap">1A70.1<a name="ClaimDiagnosisCodeableConceptCS-1A70.461"> </a></td><td>Gonococcal abscess of penis</td></tr><tr><td style="white-space:nowrap">1A02<a name="ClaimDiagnosisCodeableConceptCS-1A02"> </a></td><td>Sepsis due to shigella with septic shock</td></tr><tr><td style="white-space:nowrap">1A81<a name="ClaimDiagnosisCodeableConceptCS-1A81"> </a></td><td>Non-ulcerative sexually transmitted chlamydial infection</td></tr><tr><td style="white-space:nowrap">1A60.1<a name="ClaimDiagnosisCodeableConceptCS-1A60.461"> </a></td><td>Early congenital syphilis, latent</td></tr><tr><td style="white-space:nowrap">1A8Y<a name="ClaimDiagnosisCodeableConceptCS-1A8Y"> </a></td><td>Other specified sexually transmissible infections due to chlamydia</td></tr><tr><td style="white-space:nowrap">1A01<a name="ClaimDiagnosisCodeableConceptCS-1A01"> </a></td><td>Infections due to Vibrio vulnificus</td></tr><tr><td style="white-space:nowrap">1A80<a name="ClaimDiagnosisCodeableConceptCS-1A80"> </a></td><td>chlamydial lymphogranuloma venereum</td></tr><tr><td style="white-space:nowrap">1B10.1<a name="ClaimDiagnosisCodeableConceptCS-1B10.461"> </a></td><td>tuberculous pleural effusion, not confirmed</td></tr><tr><td style="white-space:nowrap">1A11<a name="ClaimDiagnosisCodeableConceptCS-1A11"> </a></td><td>Botulism</td></tr><tr><td style="white-space:nowrap">1A72.1<a name="ClaimDiagnosisCodeableConceptCS-1A72.461"> </a></td><td>Infection of the rectum due to Neisseria gonorrhoeae</td></tr><tr><td style="white-space:nowrap">1A72.2<a name="ClaimDiagnosisCodeableConceptCS-1A72.462"> </a></td><td>Infection of the anus due to Neisseria gonorrhoeae</td></tr><tr><td style="white-space:nowrap">2A02.11<a name="ClaimDiagnosisCodeableConceptCS-2A02.4611"> </a></td><td>paraspinous neuroblastoma</td></tr><tr><td style="white-space:nowrap">1A70.Y<a name="ClaimDiagnosisCodeableConceptCS-1A70.46Y"> </a></td><td>Chronic gonococcal prostatitis</td></tr><tr><td style="white-space:nowrap">2B71<a name="ClaimDiagnosisCodeableConceptCS-2B71"> </a></td><td>Malignant neoplasms of oesophagogastric junction</td></tr><tr><td style="white-space:nowrap">1A72.0<a name="ClaimDiagnosisCodeableConceptCS-1A72.460"> </a></td><td>Gonococcal spondylitis</td></tr><tr><td style="white-space:nowrap">1A61.1<a name="ClaimDiagnosisCodeableConceptCS-1A61.461"> </a></td><td>primary syphilis of anus</td></tr><tr><td style="white-space:nowrap">2B72<a name="ClaimDiagnosisCodeableConceptCS-2B72"> </a></td><td>Malignant neoplasms of stomach</td></tr><tr><td style="white-space:nowrap">2A02.12<a name="ClaimDiagnosisCodeableConceptCS-2A02.4612"> </a></td><td>Other specified malignant neoplasms of optic nerve</td></tr><tr><td style="white-space:nowrap">2B70<a name="ClaimDiagnosisCodeableConceptCS-2B70"> </a></td><td>Malignant neoplasms of oesophagus</td></tr><tr><td style="white-space:nowrap">2A42.0<a name="ClaimDiagnosisCodeableConceptCS-2A42.460"> </a></td><td>Juvenile myelomonocytic leukaemia in complete remission</td></tr><tr><td style="white-space:nowrap">2A20.0<a name="ClaimDiagnosisCodeableConceptCS-2A20.460"> </a></td><td>Chronic myelogenous leukaemia, BCR-ABL1-positive</td></tr><tr><td style="white-space:nowrap">1A61.2<a name="ClaimDiagnosisCodeableConceptCS-1A61.462"> </a></td><td>primary syphilitic tonsils</td></tr><tr><td style="white-space:nowrap">1B21.Y<a name="ClaimDiagnosisCodeableConceptCS-1B21.46Y"> </a></td><td>mycobacteriosis NOS</td></tr><tr><td style="white-space:nowrap">2A20.1<a name="ClaimDiagnosisCodeableConceptCS-2A20.461"> </a></td><td>Chronic neutrophilic leukaemia</td></tr><tr><td style="white-space:nowrap">2A20.2<a name="ClaimDiagnosisCodeableConceptCS-2A20.462"> </a></td><td>megakaryocytic myeloid metaplasia</td></tr><tr><td style="white-space:nowrap">2A4Y<a name="ClaimDiagnosisCodeableConceptCS-2A4Y"> </a></td><td>Other specified myelodysplastic and myeloproliferative neoplasms</td></tr><tr><td style="white-space:nowrap">2A02.1Y<a name="ClaimDiagnosisCodeableConceptCS-2A02.461Y"> </a></td><td>Olfactory groove meningioma</td></tr><tr><td style="white-space:nowrap">2D4Y<a name="ClaimDiagnosisCodeableConceptCS-2D4Y"> </a></td><td>Small cell carcinoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2A4Z<a name="ClaimDiagnosisCodeableConceptCS-2A4Z"> </a></td><td>Myelodysplastic and myeloproliferative neoplasms, unspecified</td></tr><tr><td style="white-space:nowrap">2B62.0<a name="ClaimDiagnosisCodeableConceptCS-2B62.460"> </a></td><td>Squamous cell carcinoma of tongue NOS</td></tr><tr><td style="white-space:nowrap">2B51<a name="ClaimDiagnosisCodeableConceptCS-2B51"> </a></td><td>Osteosarcoma, primary site</td></tr><tr><td style="white-space:nowrap">2D60.2<a name="ClaimDiagnosisCodeableConceptCS-2D60.462"> </a></td><td>spleen lymph gland metastasis</td></tr><tr><td style="white-space:nowrap">1A60.2<a name="ClaimDiagnosisCodeableConceptCS-1A60.462"> </a></td><td>Late congenital syphilitic chorioretinitis</td></tr><tr><td style="white-space:nowrap">1B12.4<a name="ClaimDiagnosisCodeableConceptCS-1B12.464"> </a></td><td>Tuberculosis of the musculoskeletal system</td></tr><tr><td style="white-space:nowrap">2D81<a name="ClaimDiagnosisCodeableConceptCS-2D81"> </a></td><td>secondary malignant neoplasm of pancreas</td></tr><tr><td style="white-space:nowrap">1B21.Z<a name="ClaimDiagnosisCodeableConceptCS-1B21.46Z"> </a></td><td>MOTT - [mycobacteria other than tubercle bacilli]</td></tr><tr><td style="white-space:nowrap">1A61.0<a name="ClaimDiagnosisCodeableConceptCS-1A61.460"> </a></td><td>Urethral chancre</td></tr><tr><td style="white-space:nowrap">1A60.0<a name="ClaimDiagnosisCodeableConceptCS-1A60.460"> </a></td><td>Early congenital visceral syphilis</td></tr><tr><td style="white-space:nowrap">2A42.Z<a name="ClaimDiagnosisCodeableConceptCS-2A42.46Z"> </a></td><td>juvenile myelomonocytic leukaemia without mention of remission</td></tr><tr><td style="white-space:nowrap">2A42.Y<a name="ClaimDiagnosisCodeableConceptCS-2A42.46Y"> </a></td><td>Other specified juvenile myelomonocytic leukaemia</td></tr><tr><td style="white-space:nowrap">2B61.Y<a name="ClaimDiagnosisCodeableConceptCS-2B61.46Y"> </a></td><td>Other specified malignant neoplasms of base of tongue</td></tr><tr><td style="white-space:nowrap">1B12.1<a name="ClaimDiagnosisCodeableConceptCS-1B12.461"> </a></td><td>Tuberculous chorioretinitis</td></tr><tr><td style="white-space:nowrap">1A62.1<a name="ClaimDiagnosisCodeableConceptCS-1A62.461"> </a></td><td>Syphilitic pulmonary aneurysm</td></tr><tr><td style="white-space:nowrap">2B61.0<a name="ClaimDiagnosisCodeableConceptCS-2B61.460"> </a></td><td>Squamous cell carcinoma of the base of the tongue</td></tr><tr><td style="white-space:nowrap">2D60.0<a name="ClaimDiagnosisCodeableConceptCS-2D60.460"> </a></td><td>Supraclavicular lymph gland metastasis</td></tr><tr><td style="white-space:nowrap">2B62.1<a name="ClaimDiagnosisCodeableConceptCS-2B62.461"> </a></td><td>Malignant neoplasms of lingual tonsil</td></tr><tr><td style="white-space:nowrap">1A62.2<a name="ClaimDiagnosisCodeableConceptCS-1A62.462"> </a></td><td>Symptomatic late syphilis of other sites</td></tr><tr><td style="white-space:nowrap">1A62.0<a name="ClaimDiagnosisCodeableConceptCS-1A62.460"> </a></td><td>Neurosyphilis</td></tr><tr><td style="white-space:nowrap">2B60.1<a name="ClaimDiagnosisCodeableConceptCS-2B60.461"> </a></td><td>Squamous cell carcinoma of lip</td></tr><tr><td style="white-space:nowrap">2D60.1<a name="ClaimDiagnosisCodeableConceptCS-2D60.461"> </a></td><td>Pulmonary lymph gland metastasis</td></tr><tr><td style="white-space:nowrap">2B61.Z<a name="ClaimDiagnosisCodeableConceptCS-2B61.46Z"> </a></td><td>malignant neoplasm of anterior two-thirds of tongue, dorsal surface</td></tr><tr><td style="white-space:nowrap">2D83<a name="ClaimDiagnosisCodeableConceptCS-2D83"> </a></td><td>secondary malignant neoplasm of hepatopancreatic ampulla</td></tr><tr><td style="white-space:nowrap">2B60.0<a name="ClaimDiagnosisCodeableConceptCS-2B60.460"> </a></td><td>Basal cell carcinoma of lip</td></tr><tr><td style="white-space:nowrap">2B62.Y<a name="ClaimDiagnosisCodeableConceptCS-2B62.46Y"> </a></td><td>Other specified malignant neoplasms of other or unspecified parts of tongue</td></tr><tr><td style="white-space:nowrap">1A36.1<a name="ClaimDiagnosisCodeableConceptCS-1A36.461"> </a></td><td>Extraintestinal infections due to Entamoeba</td></tr><tr><td style="white-space:nowrap">2D80.0<a name="ClaimDiagnosisCodeableConceptCS-2D80.460"> </a></td><td>hepatic metastases</td></tr><tr><td style="white-space:nowrap">2D80.1<a name="ClaimDiagnosisCodeableConceptCS-2D80.461"> </a></td><td>intrahepatic gall ductal metastasis</td></tr><tr><td style="white-space:nowrap">2B60.Y<a name="ClaimDiagnosisCodeableConceptCS-2B60.46Y"> </a></td><td>Other specified malignant neoplasms of lip</td></tr><tr><td style="white-space:nowrap">1B11.Z<a name="ClaimDiagnosisCodeableConceptCS-1B11.46Z"> </a></td><td>CNS - [central nervous system] TB - [tuberculosis]</td></tr><tr><td style="white-space:nowrap">1B12.3<a name="ClaimDiagnosisCodeableConceptCS-1B12.463"> </a></td><td>Tuberculosis of pituitary gland</td></tr><tr><td style="white-space:nowrap">2E00<a name="ClaimDiagnosisCodeableConceptCS-2E00"> </a></td><td>renal pelvis metastasis</td></tr><tr><td style="white-space:nowrap">2E02<a name="ClaimDiagnosisCodeableConceptCS-2E02"> </a></td><td>ureteral metastasis</td></tr><tr><td style="white-space:nowrap">1A36.00<a name="ClaimDiagnosisCodeableConceptCS-1A36.4600"> </a></td><td>Acute nondysenteric amebic enteritis</td></tr><tr><td style="white-space:nowrap">2E01<a name="ClaimDiagnosisCodeableConceptCS-2E01"> </a></td><td>urinary bladder metastasis</td></tr><tr><td style="white-space:nowrap">1A36.01<a name="ClaimDiagnosisCodeableConceptCS-1A36.4601"> </a></td><td>Amoeboma of large intestine</td></tr><tr><td style="white-space:nowrap">1A36.0Y<a name="ClaimDiagnosisCodeableConceptCS-1A36.460Y"> </a></td><td>nondysenteric amebic diarrhoea</td></tr><tr><td style="white-space:nowrap">3A00-3A03.Y<a name="ClaimDiagnosisCodeableConceptCS-3A00-3A03.46Y"> </a></td><td>Nutritional or metabolic anaemias</td></tr><tr><td style="white-space:nowrap">3A10-3A4Z<a name="ClaimDiagnosisCodeableConceptCS-3A10-3A4Z"> </a></td><td>Haemolytic anaemias</td></tr><tr><td style="white-space:nowrap">3A50<a name="ClaimDiagnosisCodeableConceptCS-3A50"> </a></td><td>Thalassaemias</td></tr><tr><td style="white-space:nowrap">2A33<a name="ClaimDiagnosisCodeableConceptCS-2A33"> </a></td><td>Refractory anaemia with hemochromatosis</td></tr><tr><td style="white-space:nowrap">1A13<a name="ClaimDiagnosisCodeableConceptCS-1A13"> </a></td><td>Foodborne intoxication due to Bacillus cereus</td></tr><tr><td style="white-space:nowrap">3B81<a name="ClaimDiagnosisCodeableConceptCS-3B81"> </a></td><td>Acquired disorders of spleen</td></tr><tr><td style="white-space:nowrap">3B8Z<a name="ClaimDiagnosisCodeableConceptCS-3B8Z"> </a></td><td>splenopathy</td></tr><tr><td style="white-space:nowrap">3B80<a name="ClaimDiagnosisCodeableConceptCS-3B80"> </a></td><td>Congenital disorders of spleen</td></tr><tr><td style="white-space:nowrap">2A21.0<a name="ClaimDiagnosisCodeableConceptCS-2A21.460"> </a></td><td>Systemic mastocytosis</td></tr><tr><td style="white-space:nowrap">1A1Y<a name="ClaimDiagnosisCodeableConceptCS-1A1Y"> </a></td><td>Foodborne Vibrio parahaemolyticus intoxication</td></tr><tr><td style="white-space:nowrap">2A21.1<a name="ClaimDiagnosisCodeableConceptCS-2A21.461"> </a></td><td>Cutaneous mastocytosis</td></tr><tr><td style="white-space:nowrap">1A60.3<a name="ClaimDiagnosisCodeableConceptCS-1A60.463"> </a></td><td>Late congenital syphilitic polyneuropathy</td></tr><tr><td style="white-space:nowrap">2A21.2<a name="ClaimDiagnosisCodeableConceptCS-2A21.462"> </a></td><td>Mast cell sarcoma</td></tr><tr><td style="white-space:nowrap">1A70.Z<a name="ClaimDiagnosisCodeableConceptCS-1A70.46Z"> </a></td><td>Gonococcal genitourinary infection</td></tr><tr><td style="white-space:nowrap">1A03<a name="ClaimDiagnosisCodeableConceptCS-1A03"> </a></td><td>Intestinal infections due to Escherichia coli</td></tr><tr><td style="white-space:nowrap">1A04<a name="ClaimDiagnosisCodeableConceptCS-1A04"> </a></td><td>megacolon due to Clostridium difficile</td></tr><tr><td style="white-space:nowrap">2A34<a name="ClaimDiagnosisCodeableConceptCS-2A34"> </a></td><td>refractory anaemia with sideroblasts with transformation</td></tr><tr><td style="white-space:nowrap">1A8Z<a name="ClaimDiagnosisCodeableConceptCS-1A8Z"> </a></td><td>Sexually transmissible infections due to chlamydia, unspecified</td></tr><tr><td style="white-space:nowrap">2B52.1<a name="ClaimDiagnosisCodeableConceptCS-2B52.461"> </a></td><td>Ewing sarcoma of bone or articular cartilage of pelvis</td></tr><tr><td style="white-space:nowrap">2A35<a name="ClaimDiagnosisCodeableConceptCS-2A35"> </a></td><td>RAEB 2 - [Refractory anaemia with excess of blasts type 2]</td></tr><tr><td style="white-space:nowrap">2B52.0<a name="ClaimDiagnosisCodeableConceptCS-2B52.460"> </a></td><td>Ewing sarcoma of bone or articular cartilage of limbs</td></tr><tr><td style="white-space:nowrap">2B52.2<a name="ClaimDiagnosisCodeableConceptCS-2B52.462"> </a></td><td>Ewing sarcoma of bone or articular cartilage of ribs</td></tr><tr><td style="white-space:nowrap">1A05<a name="ClaimDiagnosisCodeableConceptCS-1A05"> </a></td><td>Colitis due to Yersinia enterocolitica</td></tr><tr><td style="white-space:nowrap">1A72.3<a name="ClaimDiagnosisCodeableConceptCS-1A72.463"> </a></td><td>Acute gonococcal pharyngitis</td></tr><tr><td style="white-space:nowrap">1A72.4<a name="ClaimDiagnosisCodeableConceptCS-1A72.464"> </a></td><td>Keratitis blennorrhagica</td></tr><tr><td style="white-space:nowrap">1A11.1<a name="ClaimDiagnosisCodeableConceptCS-1A11.461"> </a></td><td>Toxin-mediated infectious botulism</td></tr><tr><td style="white-space:nowrap">2A02.1Z<a name="ClaimDiagnosisCodeableConceptCS-2A02.461Z"> </a></td><td>Primary malignant neoplasm of vagus nerve</td></tr><tr><td style="white-space:nowrap">1A11.Z<a name="ClaimDiagnosisCodeableConceptCS-1A11.46Z"> </a></td><td>Disorders of the neuromuscular junction in botulism</td></tr><tr><td style="white-space:nowrap">1A11.0<a name="ClaimDiagnosisCodeableConceptCS-1A11.460"> </a></td><td>Foodborne Clostridium botulinum toxin intoxication</td></tr><tr><td style="white-space:nowrap">1A61.3<a name="ClaimDiagnosisCodeableConceptCS-1A61.463"> </a></td><td>Syphilitic alopecia</td></tr><tr><td style="white-space:nowrap">1B1Z<a name="ClaimDiagnosisCodeableConceptCS-1B1Z"> </a></td><td>Tuberculosis attributable to Mycobacterium tuberculosis</td></tr><tr><td style="white-space:nowrap">1A61.4<a name="ClaimDiagnosisCodeableConceptCS-1A61.464"> </a></td><td>Secondary syphilitic lymphadenitis</td></tr><tr><td style="white-space:nowrap">2A20.3<a name="ClaimDiagnosisCodeableConceptCS-2A20.463"> </a></td><td>Chronic eosinophilic leukaemia, not elsewhere classified</td></tr><tr><td style="white-space:nowrap">2B51.0<a name="ClaimDiagnosisCodeableConceptCS-2B51.460"> </a></td><td>Osseous sarcomas of bone and articular cartilage of mandible</td></tr><tr><td style="white-space:nowrap">2B51.2<a name="ClaimDiagnosisCodeableConceptCS-2B51.462"> </a></td><td>Osseous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx</td></tr><tr><td style="white-space:nowrap">2B62.Z<a name="ClaimDiagnosisCodeableConceptCS-2B62.46Z"> </a></td><td>primary malignant neoplasm of tongue</td></tr><tr><td style="white-space:nowrap">2B51.1<a name="ClaimDiagnosisCodeableConceptCS-2B51.461"> </a></td><td>Osteosarcoma of bone or articular cartilage of limbs</td></tr><tr><td style="white-space:nowrap">1B12.4Y<a name="ClaimDiagnosisCodeableConceptCS-1B12.464Y"> </a></td><td>Tuberculosis of other specified part of the musculoskeletal system</td></tr><tr><td style="white-space:nowrap">1A60.4<a name="ClaimDiagnosisCodeableConceptCS-1A60.464"> </a></td><td>Congenital syphilitic stigmata</td></tr><tr><td style="white-space:nowrap">1B12.41<a name="ClaimDiagnosisCodeableConceptCS-1B12.4641"> </a></td><td>Tuberculosis of skeletal muscle</td></tr><tr><td style="white-space:nowrap">2D60.3<a name="ClaimDiagnosisCodeableConceptCS-2D60.463"> </a></td><td>Malignant neoplasm metastasis in axillary or arm lymph nodes by other or unspecified epithelial neoplasm</td></tr><tr><td style="white-space:nowrap">1A61.5<a name="ClaimDiagnosisCodeableConceptCS-1A61.465"> </a></td><td>latent syphilis, positive serology, early or less than 2 years after infection</td></tr><tr><td style="white-space:nowrap">2D85<a name="ClaimDiagnosisCodeableConceptCS-2D85"> </a></td><td>ileocecum metastasis</td></tr><tr><td style="white-space:nowrap">1A60.5<a name="ClaimDiagnosisCodeableConceptCS-1A60.465"> </a></td><td>Late congenital syphilis, latent</td></tr><tr><td style="white-space:nowrap">2A50<a name="ClaimDiagnosisCodeableConceptCS-2A50"> </a></td><td>Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement</td></tr><tr><td style="white-space:nowrap">2A52<a name="ClaimDiagnosisCodeableConceptCS-2A52"> </a></td><td>Myeloid or lymphoid neoplasms with FGFR1 abnormalities</td></tr><tr><td style="white-space:nowrap">1B12.40<a name="ClaimDiagnosisCodeableConceptCS-1B12.4640"> </a></td><td>Tuberculous rheumatism</td></tr><tr><td style="white-space:nowrap">2A5Z<a name="ClaimDiagnosisCodeableConceptCS-2A5Z"> </a></td><td>Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified</td></tr><tr><td style="white-space:nowrap">2D60.4<a name="ClaimDiagnosisCodeableConceptCS-2D60.464"> </a></td><td>Malignant neoplasm metastasis in inguinal or leg lymph nodes by other or unspecified epithelial neoplasm</td></tr><tr><td style="white-space:nowrap">2B62.10<a name="ClaimDiagnosisCodeableConceptCS-2B62.4610"> </a></td><td>Squamous cell carcinoma of lingual tonsil</td></tr><tr><td style="white-space:nowrap">2B62.1Z<a name="ClaimDiagnosisCodeableConceptCS-2B62.461Z"> </a></td><td>primary malignant neoplasm of lingual tonsil</td></tr><tr><td style="white-space:nowrap">1A62.20<a name="ClaimDiagnosisCodeableConceptCS-1A62.4620"> </a></td><td>Late syphilitic chorioretinitis</td></tr><tr><td style="white-space:nowrap">1A62.00<a name="ClaimDiagnosisCodeableConceptCS-1A62.4600"> </a></td><td>Asymptomatic neurosyphilis</td></tr><tr><td style="white-space:nowrap">1A62.0Z<a name="ClaimDiagnosisCodeableConceptCS-1A62.460Z"> </a></td><td>tertiary central nervous system syphilis</td></tr><tr><td style="white-space:nowrap">1A62.22<a name="ClaimDiagnosisCodeableConceptCS-1A62.4622"> </a></td><td>Syphilitic gumma</td></tr><tr><td style="white-space:nowrap">2D60.5<a name="ClaimDiagnosisCodeableConceptCS-2D60.465"> </a></td><td>Iliac lymph gland metastasis</td></tr><tr><td style="white-space:nowrap">1A62.01<a name="ClaimDiagnosisCodeableConceptCS-1A62.4601"> </a></td><td>Syphilitic paraplegia</td></tr><tr><td style="white-space:nowrap">1A62.21<a name="ClaimDiagnosisCodeableConceptCS-1A62.4621"> </a></td><td>Syphilis, stage unspecified, of synovium</td></tr><tr><td style="white-space:nowrap">2B60.Z<a name="ClaimDiagnosisCodeableConceptCS-2B60.46Z"> </a></td><td>malignant neoplasm of lip, unspecified</td></tr><tr><td style="white-space:nowrap">2D8Z<a name="ClaimDiagnosisCodeableConceptCS-2D8Z"> </a></td><td>Malignant neoplasm metastasis in unspecified digestive system organ</td></tr><tr><td style="white-space:nowrap">2B63.0<a name="ClaimDiagnosisCodeableConceptCS-2B63.460"> </a></td><td>Squamous cell carcinoma of gum</td></tr><tr><td style="white-space:nowrap">2D8Y<a name="ClaimDiagnosisCodeableConceptCS-2D8Y"> </a></td><td>submandibular glandular metastasis</td></tr><tr><td style="white-space:nowrap">2B63.Y<a name="ClaimDiagnosisCodeableConceptCS-2B63.46Y"> </a></td><td>Malignant neoplasm of alveolar ridge mucosa</td></tr><tr><td style="white-space:nowrap">2B63.Z<a name="ClaimDiagnosisCodeableConceptCS-2B63.46Z"> </a></td><td>primary malignant neoplasm of gum</td></tr><tr><td style="white-space:nowrap">1A36.10<a name="ClaimDiagnosisCodeableConceptCS-1A36.4610"> </a></td><td>amoebic hepatitis</td></tr><tr><td style="white-space:nowrap">1A36.11<a name="ClaimDiagnosisCodeableConceptCS-1A36.4611"> </a></td><td>Amoebic abscess of lung and liver</td></tr><tr><td style="white-space:nowrap">1A36.12<a name="ClaimDiagnosisCodeableConceptCS-1A36.4612"> </a></td><td>Amoebic ulcer of skin</td></tr><tr><td style="white-space:nowrap">3B50-3B51<a name="ClaimDiagnosisCodeableConceptCS-3B50-3B51"> </a></td><td>Fibrinolytic defects</td></tr><tr><td style="white-space:nowrap">3B10-3B4Z<a name="ClaimDiagnosisCodeableConceptCS-3B10-3B4Z"> </a></td><td>Coagulation defects</td></tr><tr><td style="white-space:nowrap">3B60<a name="ClaimDiagnosisCodeableConceptCS-3B60"> </a></td><td>Non-thrombocytopenic purpura</td></tr><tr><td style="white-space:nowrap">2E04<a name="ClaimDiagnosisCodeableConceptCS-2E04"> </a></td><td>Malignant neoplasm metastasis in soft tissue of abdominal wall</td></tr><tr><td style="white-space:nowrap">2E03<a name="ClaimDiagnosisCodeableConceptCS-2E03"> </a></td><td>Metastatic fracture of unspecified site</td></tr><tr><td style="white-space:nowrap">1A36.0Z<a name="ClaimDiagnosisCodeableConceptCS-1A36.460Z"> </a></td><td>Intestinal infections due to Entamoeba</td></tr><tr><td style="white-space:nowrap">2E05<a name="ClaimDiagnosisCodeableConceptCS-2E05"> </a></td><td>Malignant neoplasm metastasis in female reproductive system</td></tr><tr><td style="white-space:nowrap">2B50.0<a name="ClaimDiagnosisCodeableConceptCS-2B50.460"> </a></td><td>Chondrosarcoma of bone or articular cartilage of limbs</td></tr><tr><td style="white-space:nowrap">2B50.1<a name="ClaimDiagnosisCodeableConceptCS-2B50.461"> </a></td><td>Chondromatous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx</td></tr><tr><td style="white-space:nowrap">2B50.2<a name="ClaimDiagnosisCodeableConceptCS-2B50.462"> </a></td><td>Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle</td></tr><tr><td style="white-space:nowrap">1A70.00<a name="ClaimDiagnosisCodeableConceptCS-1A70.4600"> </a></td><td>Gonococcal lymphangitis of penis</td></tr><tr><td style="white-space:nowrap">1A70.0Z<a name="ClaimDiagnosisCodeableConceptCS-1A70.460Z"> </a></td><td>gonorrhoeal condyloma</td></tr><tr><td style="white-space:nowrap">3A00<a name="ClaimDiagnosisCodeableConceptCS-3A00"> </a></td><td>Iron deficiency anaemia</td></tr><tr><td style="white-space:nowrap">1A70.0Y<a name="ClaimDiagnosisCodeableConceptCS-1A70.460Y"> </a></td><td>Gonococcal vulvovaginitis</td></tr><tr><td style="white-space:nowrap">3A02<a name="ClaimDiagnosisCodeableConceptCS-3A02"> </a></td><td>Folate deficiency anaemia</td></tr><tr><td style="white-space:nowrap">3A01<a name="ClaimDiagnosisCodeableConceptCS-3A01"> </a></td><td>Megaloblastic anaemia due to vitamin B12 deficiency</td></tr><tr><td style="white-space:nowrap">3A10-3A1Y<a name="ClaimDiagnosisCodeableConceptCS-3A10-3A1Y"> </a></td><td>Congenital haemolytic anaemia</td></tr><tr><td style="white-space:nowrap">3A20-3A2Z<a name="ClaimDiagnosisCodeableConceptCS-3A20-3A2Z"> </a></td><td>Acquired haemolytic anaemia</td></tr><tr><td style="white-space:nowrap">3A4Z<a name="ClaimDiagnosisCodeableConceptCS-3A4Z"> </a></td><td>Haemolytic anaemias, unspecified</td></tr><tr><td style="white-space:nowrap">2B71.0<a name="ClaimDiagnosisCodeableConceptCS-2B71.460"> </a></td><td>Adenocarcinoma of oesophagogastric junction</td></tr><tr><td style="white-space:nowrap">2B71.Z<a name="ClaimDiagnosisCodeableConceptCS-2B71.46Z"> </a></td><td>primary malignant neoplasm of cardia of stomach</td></tr><tr><td style="white-space:nowrap">3A50.1<a name="ClaimDiagnosisCodeableConceptCS-3A50.461"> </a></td><td>Alpha-thalassaemia intellectual disability syndrome linked to chromosome 16</td></tr><tr><td style="white-space:nowrap">3A50.0<a name="ClaimDiagnosisCodeableConceptCS-3A50.460"> </a></td><td>Alpha thalassaemia</td></tr><tr><td style="white-space:nowrap">3A50.2<a name="ClaimDiagnosisCodeableConceptCS-3A50.462"> </a></td><td>Beta-thalassemia-X-linked thrombocytopenia syndrome</td></tr><tr><td style="white-space:nowrap">2B70.1<a name="ClaimDiagnosisCodeableConceptCS-2B70.461"> </a></td><td>Squamous cell carcinomas of overlapping lesion of oesophagus</td></tr><tr><td style="white-space:nowrap">2B70.0<a name="ClaimDiagnosisCodeableConceptCS-2B70.460"> </a></td><td>Adenocarcinoma of oesophagus</td></tr><tr><td style="white-space:nowrap">1A1Z<a name="ClaimDiagnosisCodeableConceptCS-1A1Z"> </a></td><td>food infection</td></tr><tr><td style="white-space:nowrap">2B71.Y<a name="ClaimDiagnosisCodeableConceptCS-2B71.46Y"> </a></td><td>Other specified malignant neoplasm of oesophagogastric junction</td></tr><tr><td style="white-space:nowrap">2A36<a name="ClaimDiagnosisCodeableConceptCS-2A36"> </a></td><td>5 q- syndrome</td></tr><tr><td style="white-space:nowrap">2B72.Y<a name="ClaimDiagnosisCodeableConceptCS-2B72.46Y"> </a></td><td>metastatic gastric carcinoma [primary gastric carcinoma spreading elsewhere]</td></tr><tr><td style="white-space:nowrap">2B72.0<a name="ClaimDiagnosisCodeableConceptCS-2B72.460"> </a></td><td>Adenocarcinoma involving overlapping sites of stomach</td></tr><tr><td style="white-space:nowrap">2B72.1<a name="ClaimDiagnosisCodeableConceptCS-2B72.461"> </a></td><td>Gastrointestinal APUDomas</td></tr><tr><td style="white-space:nowrap">2B70.Y<a name="ClaimDiagnosisCodeableConceptCS-2B70.46Y"> </a></td><td>Metastatic oesophageal carcinoma [primary oesophageal carcinoma spreading elsewhere]</td></tr><tr><td style="white-space:nowrap">3B81.1<a name="ClaimDiagnosisCodeableConceptCS-3B81.461"> </a></td><td>acquired absence of spleen</td></tr><tr><td style="white-space:nowrap">3B81.0<a name="ClaimDiagnosisCodeableConceptCS-3B81.460"> </a></td><td>SANT - [Sclerosing angiomatoid nodular transformation]</td></tr><tr><td style="white-space:nowrap">3B81.2<a name="ClaimDiagnosisCodeableConceptCS-3B81.462"> </a></td><td>Degenerative diseases of the spleen</td></tr><tr><td style="white-space:nowrap">2A20.4<a name="ClaimDiagnosisCodeableConceptCS-2A20.464"> </a></td><td>primary polycythaemia</td></tr><tr><td style="white-space:nowrap">2A21.00<a name="ClaimDiagnosisCodeableConceptCS-2A21.4600"> </a></td><td>Mast cell leukaemia in complete remission</td></tr><tr><td style="white-space:nowrap">2A21.0Y<a name="ClaimDiagnosisCodeableConceptCS-2A21.460Y"> </a></td><td>Lymphoadenopathic mastocytosis with eosinophilia</td></tr><tr><td style="white-space:nowrap">2A21.3<a name="ClaimDiagnosisCodeableConceptCS-2A21.463"> </a></td><td>Extracutaneous mastocytoma</td></tr><tr><td style="white-space:nowrap">2A21.0Z<a name="ClaimDiagnosisCodeableConceptCS-2A21.460Z"> </a></td><td>systemic tissue mast cell disease</td></tr><tr><td style="white-space:nowrap">2A21.10<a name="ClaimDiagnosisCodeableConceptCS-2A21.4610"> </a></td><td>Maculopapular cutaneous mastocytosis</td></tr><tr><td style="white-space:nowrap">2A21.1Z<a name="ClaimDiagnosisCodeableConceptCS-2A21.461Z"> </a></td><td>Cutaneous mastocytosis</td></tr><tr><td style="white-space:nowrap">3B80.0<a name="ClaimDiagnosisCodeableConceptCS-3B80.460"> </a></td><td>Splenomegaly in storage diseases</td></tr><tr><td style="white-space:nowrap">2A21.1Y<a name="ClaimDiagnosisCodeableConceptCS-2A21.461Y"> </a></td><td>Pseudoxanthomatous nodular cutaneous mastocytosis</td></tr><tr><td style="white-space:nowrap">1A60.Z<a name="ClaimDiagnosisCodeableConceptCS-1A60.46Z"> </a></td><td>Late congenital syphilis</td></tr><tr><td style="white-space:nowrap">1A03.0<a name="ClaimDiagnosisCodeableConceptCS-1A03.460"> </a></td><td>Colitis in enteropathogenic Escherichia coli infection</td></tr><tr><td style="white-space:nowrap">2A37<a name="ClaimDiagnosisCodeableConceptCS-2A37"> </a></td><td>Myelodysplastic syndrome, unclassifiable</td></tr><tr><td style="white-space:nowrap">1A03.1<a name="ClaimDiagnosisCodeableConceptCS-1A03.461"> </a></td><td>Colitis in enterotoxigenic Escherichia coli infection</td></tr><tr><td style="white-space:nowrap">1A03.2<a name="ClaimDiagnosisCodeableConceptCS-1A03.462"> </a></td><td>Colitis in enteroinvasive Escherichia coli infection</td></tr><tr><td style="white-space:nowrap">2B52.3<a name="ClaimDiagnosisCodeableConceptCS-2B52.463"> </a></td><td>Malignant peripheral neuroectodermal tumour of cervix uteri</td></tr><tr><td style="white-space:nowrap">2B52.Y<a name="ClaimDiagnosisCodeableConceptCS-2B52.46Y"> </a></td><td>Extraosseous Ewing sarcoma</td></tr><tr><td style="white-space:nowrap">2B52.Z<a name="ClaimDiagnosisCodeableConceptCS-2B52.46Z"> </a></td><td>Ewing's sarcoma/peripheral neuroectodermal tumour [PNET]</td></tr><tr><td style="white-space:nowrap">2A38<a name="ClaimDiagnosisCodeableConceptCS-2A38"> </a></td><td>Refractory cytopenia of childhood</td></tr><tr><td style="white-space:nowrap">1A72.Y<a name="ClaimDiagnosisCodeableConceptCS-1A72.46Y"> </a></td><td>Gonococcal skin lesions</td></tr><tr><td style="white-space:nowrap">2E65.1<a name="ClaimDiagnosisCodeableConceptCS-2E65.461"> </a></td><td>Lobular carcinoma in situ of breast, pleomorphic subtype</td></tr><tr><td style="white-space:nowrap">1A61.Y<a name="ClaimDiagnosisCodeableConceptCS-1A61.46Y"> </a></td><td>Other specified early syphilis</td></tr><tr><td style="white-space:nowrap">2E65.0<a name="ClaimDiagnosisCodeableConceptCS-2E65.460"> </a></td><td>Lobular carcinoma in situ of right breast</td></tr><tr><td style="white-space:nowrap">2E65.2<a name="ClaimDiagnosisCodeableConceptCS-2E65.462"> </a></td><td>Intraductal carcinoma in situ of left breast</td></tr><tr><td style="white-space:nowrap">2E66.Y<a name="ClaimDiagnosisCodeableConceptCS-2E66.46Y"> </a></td><td>Squamous cell carcinoma in situ with questionable stromal invasion of unspecified site</td></tr><tr><td style="white-space:nowrap">2E66.Z<a name="ClaimDiagnosisCodeableConceptCS-2E66.46Z"> </a></td><td>Carcinoma in situ of other parts of cervix</td></tr><tr><td style="white-space:nowrap">2E67<a name="ClaimDiagnosisCodeableConceptCS-2E67"> </a></td><td>Carcinoma in situ of other or unspecified genital organs</td></tr><tr><td style="white-space:nowrap">2E66.2<a name="ClaimDiagnosisCodeableConceptCS-2E66.462"> </a></td><td>cervical intraepithelial neoplasia grade II</td></tr><tr><td style="white-space:nowrap">2A20.5<a name="ClaimDiagnosisCodeableConceptCS-2A20.465"> </a></td><td>Non mast cell myeloproliferative neoplasm, unclassifiable</td></tr><tr><td style="white-space:nowrap">1A61.Z<a name="ClaimDiagnosisCodeableConceptCS-1A61.46Z"> </a></td><td>general syphilis</td></tr><tr><td style="white-space:nowrap">1A73<a name="ClaimDiagnosisCodeableConceptCS-1A73"> </a></td><td>Disseminated infection due to Neisseria gonorrhoeae</td></tr><tr><td style="white-space:nowrap">2B51.Y<a name="ClaimDiagnosisCodeableConceptCS-2B51.46Y"> </a></td><td>Li-Fraumeni syndrome</td></tr><tr><td style="white-space:nowrap">2B51.Z<a name="ClaimDiagnosisCodeableConceptCS-2B51.46Z"> </a></td><td>osteogenic sarcoma</td></tr><tr><td style="white-space:nowrap">1B12.4Z<a name="ClaimDiagnosisCodeableConceptCS-1B12.464Z"> </a></td><td>Tuberculosis of the musculoskeletal system</td></tr><tr><td style="white-space:nowrap">2D60.Y<a name="ClaimDiagnosisCodeableConceptCS-2D60.46Y"> </a></td><td>Other specified malignant neoplasm metastasis in lymph node of a single region</td></tr><tr><td style="white-space:nowrap">2A60.20<a name="ClaimDiagnosisCodeableConceptCS-2A60.4620"> </a></td><td>Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor</td></tr><tr><td style="white-space:nowrap">2A60.2Z<a name="ClaimDiagnosisCodeableConceptCS-2A60.462Z"> </a></td><td>therapy-related myelodysplastic syndromes</td></tr><tr><td style="white-space:nowrap">2A60.2Y<a name="ClaimDiagnosisCodeableConceptCS-2A60.462Y"> </a></td><td>Other specified therapy-related myeloid neoplasms</td></tr><tr><td style="white-space:nowrap">2A60.31<a name="ClaimDiagnosisCodeableConceptCS-2A60.4631"> </a></td><td>Acute myeloblastic leukaemia without maturation</td></tr><tr><td style="white-space:nowrap">2A60.30<a name="ClaimDiagnosisCodeableConceptCS-2A60.4630"> </a></td><td>Minimally differentiated acute myeloblastic leukaemia</td></tr><tr><td style="white-space:nowrap">2A60.40<a name="ClaimDiagnosisCodeableConceptCS-2A60.4640"> </a></td><td>Transient abnormal myelopoiesis</td></tr><tr><td style="white-space:nowrap">2A60.32<a name="ClaimDiagnosisCodeableConceptCS-2A60.4632"> </a></td><td>Acute myeloblastic leukaemia with maturation</td></tr><tr><td style="white-space:nowrap">2A60.41<a name="ClaimDiagnosisCodeableConceptCS-2A60.4641"> </a></td><td>Myeloid leukaemia associated with Down syndrome</td></tr><tr><td style="white-space:nowrap">2A60.4Y<a name="ClaimDiagnosisCodeableConceptCS-2A60.464Y"> </a></td><td>Other specified myeloid proliferation associated with Down syndrome</td></tr><tr><td style="white-space:nowrap">2D60.Z<a name="ClaimDiagnosisCodeableConceptCS-2D60.46Z"> </a></td><td>Malignant neoplasm metastasis in lymph node of a single region</td></tr><tr><td style="white-space:nowrap">1B21.20<a name="ClaimDiagnosisCodeableConceptCS-1B21.4620"> </a></td><td>Buruli ulcer</td></tr><tr><td style="white-space:nowrap">1B21.2Z<a name="ClaimDiagnosisCodeableConceptCS-1B21.462Z"> </a></td><td>Atypical mycobacterial infection of the skin</td></tr><tr><td style="white-space:nowrap">1B21.2Y<a name="ClaimDiagnosisCodeableConceptCS-1B21.462Y"> </a></td><td>Cutaneous Mycobacterium kansasii infection</td></tr><tr><td style="white-space:nowrap">2B64.0<a name="ClaimDiagnosisCodeableConceptCS-2B64.460"> </a></td><td>Squamous cell carcinoma of floor of mouth</td></tr><tr><td style="white-space:nowrap">2B64.Z<a name="ClaimDiagnosisCodeableConceptCS-2B64.46Z"> </a></td><td>primary malignant neoplasm of floor of mouth</td></tr><tr><td style="white-space:nowrap">2B64.Y<a name="ClaimDiagnosisCodeableConceptCS-2B64.46Y"> </a></td><td>Other specified malignant neoplasm of floor of mouth</td></tr><tr><td style="white-space:nowrap">1A62.2Z<a name="ClaimDiagnosisCodeableConceptCS-1A62.462Z"> </a></td><td>Symptomatic late syphilis of other sites</td></tr><tr><td style="white-space:nowrap">1A62.2Y<a name="ClaimDiagnosisCodeableConceptCS-1A62.462Y"> </a></td><td>Late syphilitic peritonitis</td></tr><tr><td style="white-space:nowrap">1A62.Y<a name="ClaimDiagnosisCodeableConceptCS-1A62.46Y"> </a></td><td>Syphilis positive serology, late or 2 years or more after infection</td></tr><tr><td style="white-space:nowrap">2B65<a name="ClaimDiagnosisCodeableConceptCS-2B65"> </a></td><td>Malignant neoplasms of palate</td></tr><tr><td style="white-space:nowrap">2B66<a name="ClaimDiagnosisCodeableConceptCS-2B66"> </a></td><td>Malignant neoplasms of other or unspecified parts of mouth</td></tr><tr><td style="white-space:nowrap">1A36.1Y<a name="ClaimDiagnosisCodeableConceptCS-1A36.461Y"> </a></td><td>Amoebic vulvovaginitis</td></tr><tr><td style="white-space:nowrap">3B50<a name="ClaimDiagnosisCodeableConceptCS-3B50"> </a></td><td>Inherited fibrinolytic defects</td></tr><tr><td style="white-space:nowrap">3B51<a name="ClaimDiagnosisCodeableConceptCS-3B51"> </a></td><td>Fibrinolytic disorder due to administration of other drugs</td></tr><tr><td style="white-space:nowrap">3B10-3B1Z<a name="ClaimDiagnosisCodeableConceptCS-3B10-3B1Z"> </a></td><td>Congenital or constitutional haemorrhagic condition</td></tr><tr><td style="white-space:nowrap">3B20-3B2Y<a name="ClaimDiagnosisCodeableConceptCS-3B20-3B2Y"> </a></td><td>Haemorrhagic diseases due to acquired coagulation factor defects</td></tr><tr><td style="white-space:nowrap">3B4Z<a name="ClaimDiagnosisCodeableConceptCS-3B4Z"> </a></td><td>coagulopathy NOS</td></tr><tr><td style="white-space:nowrap">2E06<a name="ClaimDiagnosisCodeableConceptCS-2E06"> </a></td><td>Malignant neoplasm metastasis in penis</td></tr><tr><td style="white-space:nowrap">2E05.Z<a name="ClaimDiagnosisCodeableConceptCS-2E05.46Z"> </a></td><td>Malignant neoplasm metastasis in female reproductive system</td></tr><tr><td style="white-space:nowrap">2E05.0<a name="ClaimDiagnosisCodeableConceptCS-2E05.460"> </a></td><td>Secondary mucinous adenocarcinoma of ovary</td></tr><tr><td style="white-space:nowrap">2E05.Y<a name="ClaimDiagnosisCodeableConceptCS-2E05.46Y"> </a></td><td>vaginovesical septum metastasis</td></tr><tr><td style="white-space:nowrap">2E07<a name="ClaimDiagnosisCodeableConceptCS-2E07"> </a></td><td>suprarenal gland metastasis</td></tr><tr><td style="white-space:nowrap">1B12.7<a name="ClaimDiagnosisCodeableConceptCS-1B12.467"> </a></td><td>Tuberculous ascites</td></tr><tr><td style="white-space:nowrap">2B50.Z<a name="ClaimDiagnosisCodeableConceptCS-2B50.46Z"> </a></td><td>chondrosarcoma NOS</td></tr><tr><td style="white-space:nowrap">2B50.Y<a name="ClaimDiagnosisCodeableConceptCS-2B50.46Y"> </a></td><td>Chondromatous sarcomas of bone and articular cartilage of vertebral column</td></tr><tr><td style="white-space:nowrap">3A00.0<a name="ClaimDiagnosisCodeableConceptCS-3A00.460"> </a></td><td>Acquired iron deficiency anaemia due to blood loss</td></tr><tr><td style="white-space:nowrap">3A00.1<a name="ClaimDiagnosisCodeableConceptCS-3A00.461"> </a></td><td>Iron deficiency anaemia due to malnutrition</td></tr><tr><td style="white-space:nowrap">3A00.2<a name="ClaimDiagnosisCodeableConceptCS-3A00.462"> </a></td><td>Acquired iron deficiency anaemia due to coeliac disease</td></tr><tr><td style="white-space:nowrap">1A06<a name="ClaimDiagnosisCodeableConceptCS-1A06"> </a></td><td>Colitis due to Campylobacter</td></tr><tr><td style="white-space:nowrap">3A02.0<a name="ClaimDiagnosisCodeableConceptCS-3A02.460"> </a></td><td>Hereditary folate deficiency anaemia</td></tr><tr><td style="white-space:nowrap">3A02.2<a name="ClaimDiagnosisCodeableConceptCS-3A02.462"> </a></td><td>Acquired megaloblastic anaemia associated with psoriasis</td></tr><tr><td style="white-space:nowrap">3A02.1<a name="ClaimDiagnosisCodeableConceptCS-3A02.461"> </a></td><td>megaloblastic anaemia due to poor nutrition</td></tr><tr><td style="white-space:nowrap">3A01.1<a name="ClaimDiagnosisCodeableConceptCS-3A01.461"> </a></td><td>Nutritional vitamin B12 deficiency due to maternal vitamin B12 deficiency in breast-fed infants</td></tr><tr><td style="white-space:nowrap">3A01.0<a name="ClaimDiagnosisCodeableConceptCS-3A01.460"> </a></td><td>Anaemia due to selective hereditary vitamin B12 malabsorption with proteinuria</td></tr><tr><td style="white-space:nowrap">3A01.2<a name="ClaimDiagnosisCodeableConceptCS-3A01.462"> </a></td><td>vegan anaemia NOS</td></tr><tr><td style="white-space:nowrap">3A1Y<a name="ClaimDiagnosisCodeableConceptCS-3A1Y"> </a></td><td>congenital heinz body haemolytic anaemia</td></tr><tr><td style="white-space:nowrap">3A10<a name="ClaimDiagnosisCodeableConceptCS-3A10"> </a></td><td>Hereditary haemolytic anaemia</td></tr><tr><td style="white-space:nowrap">3A20<a name="ClaimDiagnosisCodeableConceptCS-3A20"> </a></td><td>Acquired haemolytic anaemia, immune</td></tr><tr><td style="white-space:nowrap">3A21<a name="ClaimDiagnosisCodeableConceptCS-3A21"> </a></td><td>Acquired haemolytic anaemia, non-immune</td></tr><tr><td style="white-space:nowrap">3A2Z<a name="ClaimDiagnosisCodeableConceptCS-3A2Z"> </a></td><td>haemoglobinaemia</td></tr><tr><td style="white-space:nowrap">3A50.3<a name="ClaimDiagnosisCodeableConceptCS-3A50.463"> </a></td><td>Haemoglobin Lepore</td></tr><tr><td style="white-space:nowrap">2B70.Z<a name="ClaimDiagnosisCodeableConceptCS-2B70.46Z"> </a></td><td>Metastatic oesophageal cancer [primary oesophageal cancer spreading elsewhere]</td></tr><tr><td style="white-space:nowrap">2B70.00<a name="ClaimDiagnosisCodeableConceptCS-2B70.4600"> </a></td><td>Barrett adenocarcinoma</td></tr><tr><td style="white-space:nowrap">2B70.0Z<a name="ClaimDiagnosisCodeableConceptCS-2B70.460Z"> </a></td><td>oesophageal adenocarcinoma</td></tr><tr><td style="white-space:nowrap">2B70.0Y<a name="ClaimDiagnosisCodeableConceptCS-2B70.460Y"> </a></td><td>Adenocarcinoma involving overlapping sites of oesophagus</td></tr><tr><td style="white-space:nowrap">2B80-2C0Z<a name="ClaimDiagnosisCodeableConceptCS-2B80-2C0Z"> </a></td><td>Malignant neoplasms of intestine</td></tr><tr><td style="white-space:nowrap">2A3Y<a name="ClaimDiagnosisCodeableConceptCS-2A3Y"> </a></td><td>Refractory anaemia with excess blasts in childhood</td></tr><tr><td style="white-space:nowrap">2B72.Z<a name="ClaimDiagnosisCodeableConceptCS-2B72.46Z"> </a></td><td>cancer of pylorus of stomach</td></tr><tr><td style="white-space:nowrap">3B81.5<a name="ClaimDiagnosisCodeableConceptCS-3B81.465"> </a></td><td>Splenic cyst or pseudocyst</td></tr><tr><td style="white-space:nowrap">3B81.3<a name="ClaimDiagnosisCodeableConceptCS-3B81.463"> </a></td><td>Nontraumatic laceration or rupture of spleen</td></tr><tr><td style="white-space:nowrap">3B81.4<a name="ClaimDiagnosisCodeableConceptCS-3B81.464"> </a></td><td>Splenosis</td></tr><tr><td style="white-space:nowrap">2A20.Y<a name="ClaimDiagnosisCodeableConceptCS-2A20.46Y"> </a></td><td>Other specified non mast cell myeloproliferative neoplasms</td></tr><tr><td style="white-space:nowrap">2A21.Y<a name="ClaimDiagnosisCodeableConceptCS-2A21.46Y"> </a></td><td>Other specified mastocytosis</td></tr><tr><td style="white-space:nowrap">2A21.Z<a name="ClaimDiagnosisCodeableConceptCS-2A21.46Z"> </a></td><td>malignant mastocytosis</td></tr><tr><td style="white-space:nowrap">1A03.3<a name="ClaimDiagnosisCodeableConceptCS-1A03.463"> </a></td><td>Colitis in enterohaemorrhagic Escherichia coli infection</td></tr><tr><td style="white-space:nowrap">2A3Z<a name="ClaimDiagnosisCodeableConceptCS-2A3Z"> </a></td><td>preleukaemic syndrome</td></tr><tr><td style="white-space:nowrap">1A03.Y<a name="ClaimDiagnosisCodeableConceptCS-1A03.46Y"> </a></td><td>EAEC - [Enteroaggregative Escherichia coli] infection</td></tr><tr><td style="white-space:nowrap">1A03.Z<a name="ClaimDiagnosisCodeableConceptCS-1A03.46Z"> </a></td><td>Escherichia coli enteritis, not otherwise specified</td></tr><tr><td style="white-space:nowrap">2B53<a name="ClaimDiagnosisCodeableConceptCS-2B53"> </a></td><td>Fibroblastic or myofibroblastic tumour, primary site</td></tr><tr><td style="white-space:nowrap">2E65.3<a name="ClaimDiagnosisCodeableConceptCS-2E65.463"> </a></td><td>Ductal carcinoma in situ of breast, comedo subtype</td></tr><tr><td style="white-space:nowrap">2E65.4<a name="ClaimDiagnosisCodeableConceptCS-2E65.464"> </a></td><td>lobular with intraductal carcinoma in situ</td></tr><tr><td style="white-space:nowrap">2A20.02<a name="ClaimDiagnosisCodeableConceptCS-2A20.4602"> </a></td><td>Chronic myelogenous leukaemia, t(9:22)(q34; q11)</td></tr><tr><td style="white-space:nowrap">2A20.01<a name="ClaimDiagnosisCodeableConceptCS-2A20.4601"> </a></td><td>Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive</td></tr><tr><td style="white-space:nowrap">2A20.00<a name="ClaimDiagnosisCodeableConceptCS-2A20.4600"> </a></td><td>Chronic myelogenous leukaemia with blast crisis</td></tr><tr><td style="white-space:nowrap">2A20.Z<a name="ClaimDiagnosisCodeableConceptCS-2A20.46Z"> </a></td><td>Non mast cell myeloproliferative neoplasms</td></tr><tr><td style="white-space:nowrap">2E68<a name="ClaimDiagnosisCodeableConceptCS-2E68"> </a></td><td>carcinoma in situ of urinary bladder</td></tr><tr><td style="white-space:nowrap">2B54<a name="ClaimDiagnosisCodeableConceptCS-2B54"> </a></td><td>Undifferentiated pleomorphic sarcoma, primary site</td></tr><tr><td style="white-space:nowrap">1B12.Y<a name="ClaimDiagnosisCodeableConceptCS-1B12.46Y"> </a></td><td>Tuberculosis of adenoids, with bacteriological and histological confirmation</td></tr><tr><td style="white-space:nowrap">2A60.5<a name="ClaimDiagnosisCodeableConceptCS-2A60.465"> </a></td><td>agranular CD4+ NK leukaemia</td></tr><tr><td style="white-space:nowrap">2A60.33<a name="ClaimDiagnosisCodeableConceptCS-2A60.4633"> </a></td><td>Acute myelomonocytic leukaemia in complete remission</td></tr><tr><td style="white-space:nowrap">2A60.4Z<a name="ClaimDiagnosisCodeableConceptCS-2A60.464Z"> </a></td><td>Myeloid proliferation associated with Down syndrome</td></tr><tr><td style="white-space:nowrap">2A60.34<a name="ClaimDiagnosisCodeableConceptCS-2A60.4634"> </a></td><td>AML M5b</td></tr><tr><td style="white-space:nowrap">2A60.35<a name="ClaimDiagnosisCodeableConceptCS-2A60.4635"> </a></td><td>Acute erythroid leukaemia in complete remission</td></tr><tr><td style="white-space:nowrap">2E2Z<a name="ClaimDiagnosisCodeableConceptCS-2E2Z"> </a></td><td>Secondary carcinoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2B67<a name="ClaimDiagnosisCodeableConceptCS-2B67"> </a></td><td>Malignant neoplasms of parotid gland</td></tr><tr><td style="white-space:nowrap">1A62.Z<a name="ClaimDiagnosisCodeableConceptCS-1A62.46Z"> </a></td><td>late tertiary syphilis</td></tr><tr><td style="white-space:nowrap">1A07<a name="ClaimDiagnosisCodeableConceptCS-1A07"> </a></td><td>Typhoid fever</td></tr><tr><td style="white-space:nowrap">3B10<a name="ClaimDiagnosisCodeableConceptCS-3B10"> </a></td><td>Hereditary factor VIII deficiency</td></tr><tr><td style="white-space:nowrap">3B50.0<a name="ClaimDiagnosisCodeableConceptCS-3B50.460"> </a></td><td>Congenital alpha2 antiplasmin deficiency</td></tr><tr><td style="white-space:nowrap">3B11<a name="ClaimDiagnosisCodeableConceptCS-3B11"> </a></td><td>Hereditary factor IX deficiency</td></tr><tr><td style="white-space:nowrap">3B50.Y<a name="ClaimDiagnosisCodeableConceptCS-3B50.46Y"> </a></td><td>Excessive release of tPA - [tissue-type plasminogen activator]</td></tr><tr><td style="white-space:nowrap">3B50.1<a name="ClaimDiagnosisCodeableConceptCS-3B50.461"> </a></td><td>Congenital PAI-1 - [plasminogen activator inhibitor type 1] deficiency</td></tr><tr><td style="white-space:nowrap">3B12<a name="ClaimDiagnosisCodeableConceptCS-3B12"> </a></td><td>Von Willebrand disease type 3</td></tr><tr><td style="white-space:nowrap">2E08<a name="ClaimDiagnosisCodeableConceptCS-2E08"> </a></td><td>Malignant metastasis neoplasm involving skin of abdominal wall</td></tr><tr><td style="white-space:nowrap">3A50.02<a name="ClaimDiagnosisCodeableConceptCS-3A50.4602"> </a></td><td>Alpha thalassaemia intermedia</td></tr><tr><td style="white-space:nowrap">3A50.00<a name="ClaimDiagnosisCodeableConceptCS-3A50.4600"> </a></td><td>Heterozygous non-deletional alpha thalassaemia (αTα/αα and ααT/αα included)</td></tr><tr><td style="white-space:nowrap">3A50.01<a name="ClaimDiagnosisCodeableConceptCS-3A50.4601"> </a></td><td>Haemoglobin Constant Spring</td></tr><tr><td style="white-space:nowrap">2E09<a name="ClaimDiagnosisCodeableConceptCS-2E09"> </a></td><td>Malignant neoplasm metastasis in peripheral nervous system</td></tr><tr><td style="white-space:nowrap">2E0Y<a name="ClaimDiagnosisCodeableConceptCS-2E0Y"> </a></td><td>orbit metastasis</td></tr><tr><td style="white-space:nowrap">2B55<a name="ClaimDiagnosisCodeableConceptCS-2B55"> </a></td><td>Rhabdomyosarcoma, primary site</td></tr><tr><td style="white-space:nowrap">3A00.3<a name="ClaimDiagnosisCodeableConceptCS-3A00.463"> </a></td><td>Acquired iron deficiency anaemia due to increased requirement in pregnancy</td></tr><tr><td style="white-space:nowrap">3A00.Y<a name="ClaimDiagnosisCodeableConceptCS-3A00.46Y"> </a></td><td>microcytic anaemia NOS</td></tr><tr><td style="white-space:nowrap">3A02.3<a name="ClaimDiagnosisCodeableConceptCS-3A02.463"> </a></td><td>Megaloblastic anaemia due to decreased intestinal absorption of folate</td></tr><tr><td style="white-space:nowrap">3A02.4<a name="ClaimDiagnosisCodeableConceptCS-3A02.464"> </a></td><td>megaloblastic anaemia due to drug-induced folate deficiency</td></tr><tr><td style="white-space:nowrap">1A08<a name="ClaimDiagnosisCodeableConceptCS-1A08"> </a></td><td>Colitis due to paratyphoid fever C</td></tr><tr><td style="white-space:nowrap">3A01.3<a name="ClaimDiagnosisCodeableConceptCS-3A01.463"> </a></td><td>Vitamin B12 deficiency anaemia due to intrinsic factor deficiency</td></tr><tr><td style="white-space:nowrap">3A02.Y<a name="ClaimDiagnosisCodeableConceptCS-3A02.46Y"> </a></td><td>Tropical macrocytic anaemia</td></tr><tr><td style="white-space:nowrap">3A20.2<a name="ClaimDiagnosisCodeableConceptCS-3A20.462"> </a></td><td>Autoimmune haemolytic anaemia, mixed type, cold and warm</td></tr><tr><td style="white-space:nowrap">3A01.4<a name="ClaimDiagnosisCodeableConceptCS-3A01.464"> </a></td><td>Acquired megaloblastic anaemia due to vitamin B12 deficiency secondary to intestinal disease</td></tr><tr><td style="white-space:nowrap">3A20.0<a name="ClaimDiagnosisCodeableConceptCS-3A20.460"> </a></td><td>acute Lederer haemolytic anaemia</td></tr><tr><td style="white-space:nowrap">3A10.1<a name="ClaimDiagnosisCodeableConceptCS-3A10.461"> </a></td><td>Haemolytic anaemia due to adenosine deaminase excess</td></tr><tr><td style="white-space:nowrap">3A20.1<a name="ClaimDiagnosisCodeableConceptCS-3A20.461"> </a></td><td>cold hemagglutinin disease</td></tr><tr><td style="white-space:nowrap">3A10.0<a name="ClaimDiagnosisCodeableConceptCS-3A10.460"> </a></td><td>Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies</td></tr><tr><td style="white-space:nowrap">3A21.2<a name="ClaimDiagnosisCodeableConceptCS-3A21.462"> </a></td><td>Glomerular disorders in haemolytic uraemic syndrome</td></tr><tr><td style="white-space:nowrap">3A10.2<a name="ClaimDiagnosisCodeableConceptCS-3A10.462"> </a></td><td>Hereditary pyropoikilocytosis</td></tr><tr><td style="white-space:nowrap">3A21.1<a name="ClaimDiagnosisCodeableConceptCS-3A21.461"> </a></td><td>Neoplastic microangiopathic haemolytic anaemia</td></tr><tr><td style="white-space:nowrap">3A21.0<a name="ClaimDiagnosisCodeableConceptCS-3A21.460"> </a></td><td>nocturnal paroxysmal haemoglobinaemia</td></tr><tr><td style="white-space:nowrap">3A50.4<a name="ClaimDiagnosisCodeableConceptCS-3A50.464"> </a></td><td>Hereditary persistence of fetal haemoglobin, non-deletional</td></tr><tr><td style="white-space:nowrap">2E65.5<a name="ClaimDiagnosisCodeableConceptCS-2E65.465"> </a></td><td>Paget disease of nipple</td></tr><tr><td style="white-space:nowrap">2E67.0<a name="ClaimDiagnosisCodeableConceptCS-2E67.460"> </a></td><td>endometrial carcinoma in situ</td></tr><tr><td style="white-space:nowrap">2E67.1<a name="ClaimDiagnosisCodeableConceptCS-2E67.461"> </a></td><td>vulvar carcinoma in situ</td></tr><tr><td style="white-space:nowrap">2E67.2<a name="ClaimDiagnosisCodeableConceptCS-2E67.462"> </a></td><td>Carcinoma in situ of vagina</td></tr><tr><td style="white-space:nowrap">2C10<a name="ClaimDiagnosisCodeableConceptCS-2C10"> </a></td><td>Malignant neoplasm of pancreas</td></tr><tr><td style="white-space:nowrap">3B81.51<a name="ClaimDiagnosisCodeableConceptCS-3B81.4651"> </a></td><td>Epithelial cyst of spleen</td></tr><tr><td style="white-space:nowrap">3B81.5Y<a name="ClaimDiagnosisCodeableConceptCS-3B81.465Y"> </a></td><td>Other specified splenic cyst</td></tr><tr><td style="white-space:nowrap">3B81.50<a name="ClaimDiagnosisCodeableConceptCS-3B81.4650"> </a></td><td>Pseudocyst of spleen</td></tr><tr><td style="white-space:nowrap">3B81.7<a name="ClaimDiagnosisCodeableConceptCS-3B81.467"> </a></td><td>Infection of spleen</td></tr><tr><td style="white-space:nowrap">3B81.6<a name="ClaimDiagnosisCodeableConceptCS-3B81.466"> </a></td><td>Subcapsular splenic haemorrhage</td></tr><tr><td style="white-space:nowrap">2B65.0<a name="ClaimDiagnosisCodeableConceptCS-2B65.460"> </a></td><td>Salivary gland-type carcinoma of palate</td></tr><tr><td style="white-space:nowrap">2B65.1<a name="ClaimDiagnosisCodeableConceptCS-2B65.461"> </a></td><td>Squamous cell carcinoma of palate</td></tr><tr><td style="white-space:nowrap">2B65.Y<a name="ClaimDiagnosisCodeableConceptCS-2B65.46Y"> </a></td><td>Carcinoma of palate</td></tr><tr><td style="white-space:nowrap">2A61<a name="ClaimDiagnosisCodeableConceptCS-2A61"> </a></td><td>Mixed phenotype acute leukaemias, T and myeloid, not elsewhere classified</td></tr><tr><td style="white-space:nowrap">1A09<a name="ClaimDiagnosisCodeableConceptCS-1A09"> </a></td><td>Infections due to other Salmonella</td></tr><tr><td style="white-space:nowrap">2B66.0<a name="ClaimDiagnosisCodeableConceptCS-2B66.460"> </a></td><td>Squamous cell carcinoma of other or unspecified parts of mouth</td></tr><tr><td style="white-space:nowrap">2B53.0<a name="ClaimDiagnosisCodeableConceptCS-2B53.460"> </a></td><td>fibromyxosarcoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2B53.1<a name="ClaimDiagnosisCodeableConceptCS-2B53.461"> </a></td><td>Fibroblastic or myofibroblastic tumour of skin</td></tr><tr><td style="white-space:nowrap">2B53.Y<a name="ClaimDiagnosisCodeableConceptCS-2B53.46Y"> </a></td><td>pigmented dermatofibrosarcoma</td></tr><tr><td style="white-space:nowrap">2B66.Y<a name="ClaimDiagnosisCodeableConceptCS-2B66.46Y"> </a></td><td>Other specified malignant neoplasms of other or unspecified parts of mouth</td></tr><tr><td style="white-space:nowrap">2B66.Z<a name="ClaimDiagnosisCodeableConceptCS-2B66.46Z"> </a></td><td>primary malignant neoplasm of oral cavity</td></tr><tr><td style="white-space:nowrap">3B21<a name="ClaimDiagnosisCodeableConceptCS-3B21"> </a></td><td>Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors</td></tr><tr><td style="white-space:nowrap">3B22<a name="ClaimDiagnosisCodeableConceptCS-3B22"> </a></td><td>Acquired factor XIII deficiency</td></tr><tr><td style="white-space:nowrap">3B20<a name="ClaimDiagnosisCodeableConceptCS-3B20"> </a></td><td>acquired fibrinogenopenia</td></tr><tr><td style="white-space:nowrap">2E65.Y<a name="ClaimDiagnosisCodeableConceptCS-2E65.46Y"> </a></td><td>Solid papillary carcinoma in situ of breast</td></tr><tr><td style="white-space:nowrap">2E65.Z<a name="ClaimDiagnosisCodeableConceptCS-2E65.46Z"> </a></td><td>Breast cancer in situ</td></tr><tr><td style="white-space:nowrap">2A20.03<a name="ClaimDiagnosisCodeableConceptCS-2A20.4603"> </a></td><td>Naegeli-type monocytic leukaemia</td></tr><tr><td style="white-space:nowrap">2A20.0Y<a name="ClaimDiagnosisCodeableConceptCS-2A20.460Y"> </a></td><td>chronic myeloid leukaemia, BCR-ABL-positive in complete remission</td></tr><tr><td style="white-space:nowrap">2A20.0Z<a name="ClaimDiagnosisCodeableConceptCS-2A20.460Z"> </a></td><td>chronic myeloid leukaemia, BCR-ABL-positive without mention of remission</td></tr><tr><td style="white-space:nowrap">2E69<a name="ClaimDiagnosisCodeableConceptCS-2E69"> </a></td><td>Carcinoma in situ of other or unspecified urinary organs</td></tr><tr><td style="white-space:nowrap">2B54.0<a name="ClaimDiagnosisCodeableConceptCS-2B54.460"> </a></td><td>malignant fibrous histiocytoma of unspecified site</td></tr><tr><td style="white-space:nowrap">2B54.Y<a name="ClaimDiagnosisCodeableConceptCS-2B54.46Y"> </a></td><td>Undifferentiated pleomorphic sarcoma, other specified primary site</td></tr><tr><td style="white-space:nowrap">2B54.1<a name="ClaimDiagnosisCodeableConceptCS-2B54.461"> </a></td><td>Undifferentiated pleomorphic sarcoma of retroperitoneum or peritoneum</td></tr><tr><td style="white-space:nowrap">1A81.Y<a name="ClaimDiagnosisCodeableConceptCS-1A81.46Y"> </a></td><td>Chlamydial colitis</td></tr><tr><td style="white-space:nowrap">1A81.1<a name="ClaimDiagnosisCodeableConceptCS-1A81.461"> </a></td><td>Male chlamydial pelviperitonitis</td></tr><tr><td style="white-space:nowrap">2A60.Y<a name="ClaimDiagnosisCodeableConceptCS-2A60.46Y"> </a></td><td>Other specified acute myeloid leukaemias and related precursor neoplasms</td></tr><tr><td style="white-space:nowrap">1A81.0<a name="ClaimDiagnosisCodeableConceptCS-1A81.460"> </a></td><td>Chlamydial cervicitis</td></tr><tr><td style="white-space:nowrap">2A60.Z<a name="ClaimDiagnosisCodeableConceptCS-2A60.46Z"> </a></td><td>Acute myeloid leukaemias and related precursor neoplasms</td></tr><tr><td style="white-space:nowrap">2A60.36<a name="ClaimDiagnosisCodeableConceptCS-2A60.4636"> </a></td><td>Acute megakaryoblastic leukaemia in complete remission</td></tr><tr><td style="white-space:nowrap">2A60.37<a name="ClaimDiagnosisCodeableConceptCS-2A60.4637"> </a></td><td>Acute basophilic leukaemia</td></tr><tr><td style="white-space:nowrap">1B41.1<a name="ClaimDiagnosisCodeableConceptCS-1B41.461"> </a></td><td>Acute rheumatic endocarditis</td></tr><tr><td style="white-space:nowrap">1B41.0<a name="ClaimDiagnosisCodeableConceptCS-1B41.460"> </a></td><td>acute rheumatic bacterial pericardium inflammation</td></tr><tr><td style="white-space:nowrap">2A60.38<a name="ClaimDiagnosisCodeableConceptCS-2A60.4638"> </a></td><td>Acute myelofibrosis in complete remission</td></tr><tr><td style="white-space:nowrap">1B41.2<a name="ClaimDiagnosisCodeableConceptCS-1B41.462"> </a></td><td>acute rheumatic toxic myocarditis</td></tr><tr><td style="white-space:nowrap">1A07.Z<a name="ClaimDiagnosisCodeableConceptCS-1A07.46Z"> </a></td><td>enteric fever NOS</td></tr><tr><td style="white-space:nowrap">1A07.0<a name="ClaimDiagnosisCodeableConceptCS-1A07.460"> </a></td><td>typhoperitonitis</td></tr><tr><td style="white-space:nowrap">1A07.Y<a name="ClaimDiagnosisCodeableConceptCS-1A07.46Y"> </a></td><td>Typhoid colitis</td></tr><tr><td style="white-space:nowrap">3A00.01<a name="ClaimDiagnosisCodeableConceptCS-3A00.4601"> </a></td><td>chronic haemorrhagic anaemia</td></tr><tr><td style="white-space:nowrap">3A00.0Z<a name="ClaimDiagnosisCodeableConceptCS-3A00.460Z"> </a></td><td>haemorrhagic anaemia</td></tr><tr><td style="white-space:nowrap">3B10.Y<a name="ClaimDiagnosisCodeableConceptCS-3B10.46Y"> </a></td><td>Other specified hereditary factor VIII deficiency</td></tr><tr><td style="white-space:nowrap">3B10.1<a name="ClaimDiagnosisCodeableConceptCS-3B10.461"> </a></td><td>Hereditary factor VIII deficiency with anti-factor VIII inhibitor</td></tr><tr><td style="white-space:nowrap">3B10.0<a name="ClaimDiagnosisCodeableConceptCS-3B10.460"> </a></td><td>Symptomatic form of haemophilia A in female carriers</td></tr><tr><td style="white-space:nowrap">3B50.Z<a name="ClaimDiagnosisCodeableConceptCS-3B50.46Z"> </a></td><td>Inherited fibrinolytic defects</td></tr><tr><td style="white-space:nowrap">3B11.Y<a name="ClaimDiagnosisCodeableConceptCS-3B11.46Y"> </a></td><td>Other specified hereditary factor IX deficiency</td></tr><tr><td style="white-space:nowrap">3B11.Z<a name="ClaimDiagnosisCodeableConceptCS-3B11.46Z"> </a></td><td>intravascular clotting defect</td></tr><tr><td style="white-space:nowrap">3B11.0<a name="ClaimDiagnosisCodeableConceptCS-3B11.460"> </a></td><td>Symptomatic form of haemophilia B in female carriers</td></tr><tr><td style="white-space:nowrap">3A50.03<a name="ClaimDiagnosisCodeableConceptCS-3A50.4603"> </a></td><td>Haemoglobin Bart hydrops fetalis</td></tr><tr><td style="white-space:nowrap">3A50.0Y<a name="ClaimDiagnosisCodeableConceptCS-3A50.460Y"> </a></td><td>Alpha thalassaemia myelodysplastic syndrome</td></tr><tr><td style="white-space:nowrap">3A50.0Z<a name="ClaimDiagnosisCodeableConceptCS-3A50.460Z"> </a></td><td>alpha thalassaemia syndrome</td></tr><tr><td style="white-space:nowrap">2B80<a name="ClaimDiagnosisCodeableConceptCS-2B80"> </a></td><td>Malignant neoplasms of small intestine</td></tr><tr><td style="white-space:nowrap">2B81<a name="ClaimDiagnosisCodeableConceptCS-2B81"> </a></td><td>Malignant neoplasms of appendix</td></tr><tr><td style="white-space:nowrap">2B90-2B9Y<a name="ClaimDiagnosisCodeableConceptCS-2B90-2B9Y"> </a></td><td>Malignant neoplasms of large intestine</td></tr><tr><td style="white-space:nowrap">1A94<a name="ClaimDiagnosisCodeableConceptCS-1A94"> </a></td><td>Anogenital herpes simplex infection</td></tr><tr><td style="white-space:nowrap">2B55.2<a name="ClaimDiagnosisCodeableConceptCS-2B55.462"> </a></td><td>Rhabdomyosarcoma of male genital organs</td></tr><tr><td style="white-space:nowrap">2B55.0<a name="ClaimDiagnosisCodeableConceptCS-2B55.460"> </a></td><td>Rhabdomyosarcoma of the oral cavity or pharynx</td></tr><tr><td style="white-space:nowrap">2B55.1<a name="ClaimDiagnosisCodeableConceptCS-2B55.461"> </a></td><td>Alveolar rhabdomyosarcoma</td></tr><tr><td style="white-space:nowrap">3A00.Z<a name="ClaimDiagnosisCodeableConceptCS-3A00.46Z"> </a></td><td>Fe - [iron] deficiency anemia NOS</td></tr><tr><td style="white-space:nowrap">3A02.Z<a name="ClaimDiagnosisCodeableConceptCS-3A02.46Z"> </a></td><td>Folic acid deficiency anaemia NOS</td></tr><tr><td style="white-space:nowrap">3A01.5<a name="ClaimDiagnosisCodeableConceptCS-3A01.465"> </a></td><td>Megaloblastic anaemia due to drug-induced vitamin B12 deficiency</td></tr><tr><td style="white-space:nowrap">3A20.3<a name="ClaimDiagnosisCodeableConceptCS-3A20.463"> </a></td><td>Donath-Landsteiner syndrome</td></tr><tr><td style="white-space:nowrap">3A10.3<a name="ClaimDiagnosisCodeableConceptCS-3A10.463"> </a></td><td>Familial pseudohyperkalaemia, Cardiff type</td></tr><tr><td style="white-space:nowrap">1A0Y<a name="ClaimDiagnosisCodeableConceptCS-1A0Y"> </a></td><td>Neonatal bacterial intestinal infection</td></tr><tr><td style="white-space:nowrap">3A10.0Z<a name="ClaimDiagnosisCodeableConceptCS-3A10.460Z"> </a></td><td>anaemia due to other disorders of glutathione metabolism</td></tr><tr><td style="white-space:nowrap">3A10.00<a name="ClaimDiagnosisCodeableConceptCS-3A10.4600"> </a></td><td>anaemia due to haemolytic nonspherocytic (hereditary), type 1</td></tr><tr><td style="white-space:nowrap">3A10.0Y<a name="ClaimDiagnosisCodeableConceptCS-3A10.460Y"> </a></td><td>anaemia due to 6-phosphogluconate dehydrogenase deficiency</td></tr><tr><td style="white-space:nowrap">3A21.Y<a name="ClaimDiagnosisCodeableConceptCS-3A21.46Y"> </a></td><td>Atypical haemolytic uraemic syndrome with anti-factor H antibodies</td></tr><tr><td style="white-space:nowrap">3A50.Y<a name="ClaimDiagnosisCodeableConceptCS-3A50.46Y"> </a></td><td>Thalassaemia minor</td></tr><tr><td style="white-space:nowrap">2E67.3<a name="ClaimDiagnosisCodeableConceptCS-2E67.463"> </a></td><td>Carcinoma in situ of other or unspecified female genital organs</td></tr><tr><td style="white-space:nowrap">2E67.2Z<a name="ClaimDiagnosisCodeableConceptCS-2E67.462Z"> </a></td><td>Squamous cell carcinoma in situ of vagina</td></tr><tr><td style="white-space:nowrap">2E67.22<a name="ClaimDiagnosisCodeableConceptCS-2E67.4622"> </a></td><td>severe vaginal dysplasia, NEC</td></tr><tr><td style="white-space:nowrap">2E67.2Y<a name="ClaimDiagnosisCodeableConceptCS-2E67.462Y"> </a></td><td>Other specified carcinoma in situ of vagina</td></tr><tr><td style="white-space:nowrap">3B81.5Z<a name="ClaimDiagnosisCodeableConceptCS-3B81.465Z"> </a></td><td>Splenic cyst or pseudocyst</td></tr><tr><td style="white-space:nowrap">2C11<a name="ClaimDiagnosisCodeableConceptCS-2C11"> </a></td><td>Malignant neoplasms of other or ill-defined digestive organs</td></tr><tr><td style="white-space:nowrap">3B81.71<a name="ClaimDiagnosisCodeableConceptCS-3B81.4671"> </a></td><td>splenic abscess</td></tr><tr><td style="white-space:nowrap">3B81.7Y<a name="ClaimDiagnosisCodeableConceptCS-3B81.467Y"> </a></td><td>Other specified infection of spleen</td></tr><tr><td style="white-space:nowrap">3B81.70<a name="ClaimDiagnosisCodeableConceptCS-3B81.4670"> </a></td><td>septic spleen</td></tr><tr><td style="white-space:nowrap">2B67.1<a name="ClaimDiagnosisCodeableConceptCS-2B67.461"> </a></td><td>Squamous cell carcinoma of parotid gland</td></tr><tr><td style="white-space:nowrap">2B67.0<a name="ClaimDiagnosisCodeableConceptCS-2B67.460"> </a></td><td>Acinar cell carcinoma of parotid gland</td></tr><tr><td style="white-space:nowrap">2B67.Y<a name="ClaimDiagnosisCodeableConceptCS-2B67.46Y"> </a></td><td>Other specified malignant neoplasms of parotid gland</td></tr><tr><td style="white-space:nowrap">2B65.Z<a name="ClaimDiagnosisCodeableConceptCS-2B65.46Z"> </a></td><td>malignant neoplasm of upper or lower labial sulcus</td></tr><tr><td style="white-space:nowrap">1A09.Y<a name="ClaimDiagnosisCodeableConceptCS-1A09.46Y"> </a></td><td>Pneumonia due to salmonella infection</td></tr><tr><td style="white-space:nowrap">1A09.Z<a name="ClaimDiagnosisCodeableConceptCS-1A09.46Z"> </a></td><td>Sepsis due to Salmonella infection with septic shock</td></tr><tr><td style="white-space:nowrap">2A70-2A7Z<a name="ClaimDiagnosisCodeableConceptCS-2A70-2A7Z"> </a></td><td>Precursor lymphoid neoplasms</td></tr><tr><td style="white-space:nowrap">1A09.0<a name="ClaimDiagnosisCodeableConceptCS-1A09.460"> </a></td><td>salmonellosis</td></tr><tr><td style="white-space:nowrap">2B53.Z<a name="ClaimDiagnosisCodeableConceptCS-2B53.46Z"> </a></td><td>Fibroblastic or myofibroblastic tumour, primary site</td></tr><tr><td style="white-space:nowrap">2B68<a name="ClaimDiagnosisCodeableConceptCS-2B68"> </a></td><td>Malignant neoplasms of submandibular or sublingual glands</td></tr><tr><td style="white-space:nowrap">3A01.Y<a name="ClaimDiagnosisCodeableConceptCS-3A01.46Y"> </a></td><td>Addison anaemia</td></tr><tr><td style="white-space:nowrap">3B2Y<a name="ClaimDiagnosisCodeableConceptCS-3B2Y"> </a></td><td>Acquired stable factor deficiency</td></tr><tr><td style="white-space:nowrap">2E6A<a name="ClaimDiagnosisCodeableConceptCS-2E6A"> </a></td><td>Carcinoma in situ of the eye or ocular adnexa</td></tr><tr><td style="white-space:nowrap">2A80-2A8Z<a name="ClaimDiagnosisCodeableConceptCS-2A80-2A8Z"> </a></td><td>Mature B-cell neoplasms</td></tr><tr><td style="white-space:nowrap">2B54.Z<a name="ClaimDiagnosisCodeableConceptCS-2B54.46Z"> </a></td><td>Undifferentiated pleomorphic sarcoma, primary site</td></tr><tr><td style="white-space:nowrap">2E6B<a name="ClaimDiagnosisCodeableConceptCS-2E6B"> </a></td><td>Carcinoma in situ of thyroglossal duct</td></tr><tr><td style="white-space:nowrap">1A81.Z<a name="ClaimDiagnosisCodeableConceptCS-1A81.46Z"> </a></td><td>other sexually transmitted chlamydial diseases</td></tr><tr><td style="white-space:nowrap">1B41.10<a name="ClaimDiagnosisCodeableConceptCS-1B41.4610"> </a></td><td>Rheumatic aortitis</td></tr><tr><td style="white-space:nowrap">2A60.39<a name="ClaimDiagnosisCodeableConceptCS-2A60.4639"> </a></td><td>Myeloid sarcoma in complete remission</td></tr><tr><td style="white-space:nowrap">1B41.1Z<a name="ClaimDiagnosisCodeableConceptCS-1B41.461Z"> </a></td><td>Acute rheumatic valvulitis</td></tr><tr><td style="white-space:nowrap">2A60.3Y<a name="ClaimDiagnosisCodeableConceptCS-2A60.463Y"> </a></td><td>Acute myeloid leukaemia, NOS by criteria of other types in complete remission</td></tr><tr><td style="white-space:nowrap">1B41.Y<a name="ClaimDiagnosisCodeableConceptCS-1B41.46Y"> </a></td><td>Acute rheumatic coronary arteritis</td></tr><tr><td style="white-space:nowrap">1B41.1Y<a name="ClaimDiagnosisCodeableConceptCS-1B41.461Y"> </a></td><td>Active or acute tricuspid endocarditis</td></tr><tr><td style="white-space:nowrap">1B41.Z<a name="ClaimDiagnosisCodeableConceptCS-1B41.46Z"> </a></td><td>acute RHD - [rheumatic heart disease]</td></tr><tr><td style="white-space:nowrap">1A0Z<a name="ClaimDiagnosisCodeableConceptCS-1A0Z"> </a></td><td>Phlegmonous colitis</td></tr><tr><td style="white-space:nowrap">3B10.Z<a name="ClaimDiagnosisCodeableConceptCS-3B10.46Z"> </a></td><td>Deficiency factor VIII with functional defect</td></tr><tr><td style="white-space:nowrap">3B61<a name="ClaimDiagnosisCodeableConceptCS-3B61"> </a></td><td>Thrombophilia</td></tr><tr><td style="white-space:nowrap">3A01.3Z<a name="ClaimDiagnosisCodeableConceptCS-3A01.463Z"> </a></td><td>Acquired megaloblastic anaemias due to vitamin B12 deficiency secondary to intrinsic factor deficiency</td></tr><tr><td style="white-space:nowrap">3A01.30<a name="ClaimDiagnosisCodeableConceptCS-3A01.4630"> </a></td><td>Pernicious anaemia associated with other autoimmune disorders</td></tr><tr><td style="white-space:nowrap">3A01.3Y<a name="ClaimDiagnosisCodeableConceptCS-3A01.463Y"> </a></td><td>Vitamin B12 deficiency anaemia associated with total gastrectomy</td></tr><tr><td style="white-space:nowrap">3A21.Z<a name="ClaimDiagnosisCodeableConceptCS-3A21.46Z"> </a></td><td>acquired haemolytic anaemia, non-immune NOS</td></tr><tr><td style="white-space:nowrap">3A50.Z<a name="ClaimDiagnosisCodeableConceptCS-3A50.46Z"> </a></td><td>thalassemia variants</td></tr><tr><td style="white-space:nowrap">2E67.11<a name="ClaimDiagnosisCodeableConceptCS-2E67.4611"> </a></td><td>Extramammary Paget disease of vulva</td></tr><tr><td style="white-space:nowrap">2E67.12<a name="ClaimDiagnosisCodeableConceptCS-2E67.4612"> </a></td><td>DVIN [Differentiated vulvar intraepithelial neoplasia]</td></tr><tr><td style="white-space:nowrap">2E67.13<a name="ClaimDiagnosisCodeableConceptCS-2E67.4613"> </a></td><td>High grade squamous intraepithelial lesion of vulva NOS</td></tr><tr><td style="white-space:nowrap">2C10.0<a name="ClaimDiagnosisCodeableConceptCS-2C10.460"> </a></td><td>Intraductal papillary-mucinous carcinoma of pancreas</td></tr><tr><td style="white-space:nowrap">2C10.Y<a name="ClaimDiagnosisCodeableConceptCS-2C10.46Y"> </a></td><td>Pancreatoblastoma</td></tr><tr><td style="white-space:nowrap">2C10.1<a name="ClaimDiagnosisCodeableConceptCS-2C10.461"> </a></td><td>Increased secretion from endocrine pancreas of pancreatic polypeptide</td></tr><tr><td style="white-space:nowrap">1A94.1<a name="ClaimDiagnosisCodeableConceptCS-1A94.461"> </a></td><td>Herpetic proctitis</td></tr><tr><td style="white-space:nowrap">1A94.0<a name="ClaimDiagnosisCodeableConceptCS-1A94.460"> </a></td><td>Herpes simplex infection of male genital tract NOS</td></tr><tr><td style="white-space:nowrap">1A94.Z<a name="ClaimDiagnosisCodeableConceptCS-1A94.46Z"> </a></td><td>anogenital HSV - [herpes simplex virus] infection</td></tr><tr><td style="white-space:nowrap">3B81.8<a name="ClaimDiagnosisCodeableConceptCS-3B81.468"> </a></td><td>Torsion of spleen</td></tr><tr><td style="white-space:nowrap">2B55.Y<a name="ClaimDiagnosisCodeableConceptCS-2B55.46Y"> </a></td><td>Myosarcoma of overlapping lesion of corpus uteri</td></tr><tr><td style="white-space:nowrap">2B55.Z<a name="ClaimDiagnosisCodeableConceptCS-2B55.46Z"> </a></td><td>Rhabdomyosarcoma, primary site</td></tr><tr><td style="white-space:nowrap">3A03<a name="ClaimDiagnosisCodeableConceptCS-3A03"> </a></td><td>Other nutritional or metabolic anaemias</td></tr><tr><td style="white-space:nowrap">3B21.0<a name="ClaimDiagnosisCodeableConceptCS-3B21.460"> </a></td><td>Haemorrhage due to thrombin inhibitor other than heparin</td></tr><tr><td style="white-space:nowrap">3B21.1<a name="ClaimDiagnosisCodeableConceptCS-3B21.461"> </a></td><td>Haemorrhage due to factor Xa inhibitor</td></tr><tr><td style="white-space:nowrap">3B21.Y<a name="ClaimDiagnosisCodeableConceptCS-3B21.46Y"> </a></td><td>Haemorrhagic disorder due to increase in anti-XIa</td></tr><tr><td style="white-space:nowrap">3A01.Z<a name="ClaimDiagnosisCodeableConceptCS-3A01.46Z"> </a></td><td>Megaloblastic anaemia due to vitamin B12 deficiency</td></tr><tr><td style="white-space:nowrap">3A20.4<a name="ClaimDiagnosisCodeableConceptCS-3A20.464"> </a></td><td>Lymphocyte passenger syndrome, following organ transplantation</td></tr><tr><td style="white-space:nowrap">3A10.Y<a name="ClaimDiagnosisCodeableConceptCS-3A10.46Y"> </a></td><td>Atypical haemolytic uraemic syndrome with thrombomodulin anomaly</td></tr><tr><td style="white-space:nowrap">2E67.4<a name="ClaimDiagnosisCodeableConceptCS-2E67.464"> </a></td><td>PIN - [penile intraepithelial neoplasia]</td></tr><tr><td style="white-space:nowrap">2E67.5<a name="ClaimDiagnosisCodeableConceptCS-2E67.465"> </a></td><td>carcinoma in situ prostate</td></tr><tr><td style="white-space:nowrap">3B81.9<a name="ClaimDiagnosisCodeableConceptCS-3B81.469"> </a></td><td>fibrotic spleen</td></tr><tr><td style="white-space:nowrap">3B81.7Z<a name="ClaimDiagnosisCodeableConceptCS-3B81.467Z"> </a></td><td>interstitial splenitis</td></tr><tr><td style="white-space:nowrap">1A95<a name="ClaimDiagnosisCodeableConceptCS-1A95"> </a></td><td>Anogenital warts</td></tr><tr><td style="white-space:nowrap">2B67.Z<a name="ClaimDiagnosisCodeableConceptCS-2B67.46Z"> </a></td><td>primary malignant neoplasm of parotid gland</td></tr><tr><td style="white-space:nowrap">2A60.3Z<a name="ClaimDiagnosisCodeableConceptCS-2A60.463Z"> </a></td><td>AML - [Acute myeloid leukaemia]</td></tr><tr><td style="white-space:nowrap">2B69<a name="ClaimDiagnosisCodeableConceptCS-2B69"> </a></td><td>Malignant neoplasms of tonsil</td></tr><tr><td style="white-space:nowrap">2A70<a name="ClaimDiagnosisCodeableConceptCS-2A70"> </a></td><td>Precursor B-lymphoblastic neoplasms</td></tr><tr><td style="white-space:nowrap">2A7Z<a name="ClaimDiagnosisCodeableConceptCS-2A7Z"> </a></td><td>Precursor lymphoid neoplasms, unspecified</td></tr></table></div>
</text>
<url
value="https://fhir.dha.go.ke/eclaims/CodeSystem/ClaimDiagnosisCodeableConceptCS"/>
<version value="0.1.0"/>
<name value="ClaimDiagnosisCodeableConceptCS"/>
<title value="Subsite Code System"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-05-19T11:26:54+00:00"/>
<publisher value="Digital Health Agency of Kenya"/>
<contact>
<name value="Digital Health Agency of Kenya"/>
<telecom>
<system value="url"/>
<value value="https://dha.go.ke"/>
</telecom>
<telecom>
<system value="email"/>
<value value="interoperability@dha.go.ke"/>
</telecom>
</contact>
<contact>
<name value="eClaims Technical Working Group"/>
<telecom>
<system value="email"/>
<value value="interoperability@dha.go.ke"/>
<use value="work"/>
</telecom>
<telecom>
<system value="url"/>
<value value="https://dha.go.ke"/>
<use value="work"/>
</telecom>
</contact>
<description value="A code system that defines Subsite"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="KE"/>
<display value="Kenya"/>
</coding>
</jurisdiction>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="1000"/>
<concept>
<code value="mms"/>
<display value="ICD-11 for Mortality and Morbidity Statistics"/>
</concept>
<concept>
<code value="1630407678"/>
<display value="Neoplasms"/>
</concept>
<concept>
<code value="1766440644"/>
<display value="Diseases of the blood or blood-forming organs"/>
</concept>
<concept>
<code value="1954798891"/>
<display value="Diseases of the immune system"/>
</concept>
<concept>
<code value="1435254666"/>
<display value="Certain infectious or parasitic diseases"/>
</concept>
<concept>
<code value="21500692"/>
<display value="Endocrine, nutritional or metabolic diseases"/>
</concept>
<concept>
<code value="2A00-2A0Z"/>
<display
value="Neoplasms of central nervous system or related structures"/>
</concept>
<concept>
<code value="2B50-2E2Z"/>
<display
value="Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues"/>
</concept>
<concept>
<code value="2A20-2B3Z"/>
<display value="Neoplasms of haematopoietic or lymphoid tissues"/>
</concept>
<concept>
<code value="2E60-2E6Z"/>
<display
value="In situ neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues"/>
</concept>
<concept>
<code value="2E80-2F3Z"/>
<display
value="Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues"/>
</concept>
<concept>
<code value="2E62"/>
<display value="Carcinoma in situ of middle ear or respiratory system"/>
</concept>
<concept>
<code value="2E61"/>
<display
value="Carcinoma in situ of other or unspecified digestive organs"/>
</concept>
<concept>
<code value="2E60"/>
<display value="Carcinoma in situ of oral cavity, oesophagus or stomach"/>
</concept>
<concept>
<code value="2E90-2F3Z"/>
<display value="Benign neoplasms except of mesenchymal origin"/>
</concept>
<concept>
<code value="2E80-2E8Z"/>
<display value="Benign mesenchymal neoplasms"/>
</concept>
<concept>
<code value="1B70-1B7Z"/>
<display
value="Pyogenic bacterial infections of the skin or subcutaneous tissues"/>
</concept>
<concept>
<code value="1B10-1B2Z"/>
<display value="Mycobacterial diseases"/>
</concept>
<concept>
<code value="1A60-1A9Z"/>
<display value="Predominantly sexually transmitted infections"/>
</concept>
<concept>
<code value="1A00-1A40.Z"/>
<display value="Gastroenteritis or colitis of infectious origin"/>
</concept>
<concept>
<code value="2E64"/>
<display value="Carcinoma in situ of skin"/>
</concept>
<concept>
<code value="2E63"/>
<display value="Melanoma in situ neoplasms"/>
</concept>
<concept>
<code value="1B40-1B5Z"/>
<display value="Certain staphylococcal or streptococcal diseases"/>
</concept>
<concept>
<code value="5B50-5C3Z"/>
<display value="Nutritional disorders"/>
</concept>
<concept>
<code value="5C50-5D2Z"/>
<display value="Metabolic disorders"/>
</concept>
<concept>
<code value="5D40-5D46"/>
<display value="Postprocedural endocrine or metabolic disorders"/>
</concept>
<concept>
<code value="5A00-5B3Z"/>
<display value="Endocrine diseases"/>
</concept>
<concept>
<code value="2E81"/>
<display value="Benign vascular neoplasms"/>
</concept>
<concept>
<code value="2E84"/>
<display value="Benign fibrogenic or myofibrogenic tumour"/>
</concept>
<concept>
<code value="2E80"/>
<display value="Benign lipomatous neoplasm"/>
</concept>
<concept>
<code value="2E92"/>
<display value="Benign neoplasm of digestive organs"/>
</concept>
<concept>
<code value="2E90"/>
<display value="Benign neoplasm of lip, oral cavity or pharynx"/>
</concept>
<concept>
<code value="2F00-2F01"/>
<display
value="Benign neoplasm of middle ear, respiratory or intrathoracic organs"/>
</concept>
<concept>
<code value="2E91"/>
<display value="Benign neoplasm of major salivary glands"/>
</concept>
<concept>
<code value="1B10-1B1Z"/>
<display value="Tuberculosis"/>
</concept>
<concept>
<code value="2F10"/>
<display value="Fibrous benign mesothelioma of omentum"/>
</concept>
<concept>
<code value="2E83"/>
<display value="Benign osteogenic tumours"/>
</concept>
<concept>
<code value="1B74"/>
<display value="Superficial bacterial folliculitis"/>
</concept>
<concept>
<code value="2D50-2E2Z"/>
<display value="Malignant neoplasm metastases"/>
</concept>
<concept>
<code value="1B70"/>
<display value="Bacterial cellulitis, erysipelas or lymphangitis"/>
</concept>
<concept>
<code value="1B71"/>
<display value="Necrotising fasciitis"/>
</concept>
<concept>
<code value="1A20-1A2Z"/>
<display value="Viral intestinal infections"/>
</concept>
<concept>
<code value="1A30-1A3Z"/>
<display value="Protozoal intestinal infections"/>
</concept>
<concept>
<code value="1B72"/>
<display value="Impetigo"/>
</concept>
<concept>
<code value="1B73"/>
<display value="Ecthyma"/>
</concept>
<concept>
<code value="2E82"/>
<display value="Benign chondrogenic tumours"/>
</concept>
<concept>
<code value="2D40-2D4Z"/>
<display
value="Malignant neoplasms of ill-defined or unspecified primary sites"/>
</concept>
<concept>
<code value="2B50-2D3Z"/>
<display
value="Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues"/>
</concept>
<concept>
<code value="1B21"/>
<display value="Infections due to non-tuberculous mycobacteria"/>
</concept>
<concept>
<code value="1B20"/>
<display value="Leprosy"/>
</concept>
<concept>
<code value="2E63.0"/>
<display value="Melanoma in situ of skin"/>
</concept>
<concept>
<code value="1B2Y"/>
<display value="Other specified mycobacterial diseases"/>
</concept>
<concept>
<code value="1B54"/>
<display value="Staphylococcal spinal meningitis"/>
</concept>
<concept>
<code value="1B50"/>
<display value="Otitis media in scarlet fever"/>
</concept>
<concept>
<code value="1B53"/>
<display value="Meningitis due to Streptococcus agalactiae"/>
</concept>
<concept>
<code value="1B40-1B42"/>
<display value="Acute rheumatic fever"/>
</concept>
<concept>
<code value="1B51"/>
<display value="acute streptococcal ulcerated sore throat"/>
</concept>
<concept>
<code value="1A00-1A0Z"/>
<display value="Bacterial intestinal infections"/>
</concept>
<concept>
<code value="1A10-1A1Z"/>
<display value="Bacterial foodborne intoxications"/>
</concept>
<concept>
<code value="2E63.1"/>
<display value="Melanoma in situ of conjunctiva"/>
</concept>
<concept>
<code value="2E63.Y"/>
<display value="Melanoma in situ neoplasms, other specified site"/>
</concept>
<concept>
<code value="1B2Z"/>
<display value="Mycobacterial diseases, unspecified"/>
</concept>
<concept>
<code value="2E63.Z"/>
<display value="precancerous melanosis of unspecified site"/>
</concept>
<concept>
<code value="1A40"/>
<display
value="Gastroenteritis or colitis without specification of infectious agent"/>
</concept>
<concept>
<code value="4A60-4A6Z"/>
<display value="Autoinflammatory disorders"/>
</concept>
<concept>
<code value="4A20"/>
<display value="Acquired immunodeficiencies"/>
</concept>
<concept>
<code value="4A80-4A8Z"/>
<display value="Allergic or hypersensitivity conditions"/>
</concept>
<concept>
<code value="4A40-4A4Z"/>
<display value="Nonorgan specific systemic autoimmune disorders"/>
</concept>
<concept>
<code value="4A00-4A0Z"/>
<display value="Primary immunodeficiencies"/>
</concept>
<concept>
<code value="2E61.3"/>
<display value="gallbladder carcinoma in situ"/>
</concept>
<concept>
<code value="2E60.2"/>
<display value="Carcinoma in situ of intraepithelium of stomach"/>
</concept>
<concept>
<code value="2E60.1"/>
<display
value="Glandular intraepithelial neoplasia of oesophagus, high grade"/>
</concept>
<concept>
<code value="2E61.0"/>
<display value="Carcinoma in situ of rectosigmoid junction"/>
</concept>
<concept>
<code value="2E61.2"/>
<display value="AIN - [anal intraepithelial neoplasia] high grade"/>
</concept>
<concept>
<code value="2E61.1"/>
<display
value="Intraepithelial neoplasia (dysplasia) of rectum, high grade"/>
</concept>
<concept>
<code value="2E61.Y"/>
<display value="Carcinoma in situ of tail of pancreas"/>
</concept>
<concept>
<code value="2E62.2"/>
<display value="pulmonary carcinoma in situ"/>
</concept>
<concept>
<code value="2E62.Z"/>
<display value="Carcinoma in situ of middle ear or respiratory system"/>
</concept>
<concept>
<code value="2E62.Y"/>
<display value="Carcinoma in situ of vestibule of nose"/>
</concept>
<concept>
<code value="2E62.0"/>
<display value="Carcinoma in situ of thyroid cartilage"/>
</concept>
<concept>
<code value="2E60.0"/>
<display value="Carcinoma in situ upper labial sulcus"/>
</concept>
<concept>
<code value="2E62.1"/>
<display
value="Intraepithelial neoplasia (dysplasia) of trachea, high grade"/>
</concept>
<concept>
<code value="2A00"/>
<display value="Primary neoplasms of brain"/>
</concept>
<concept>
<code value="2A02"/>
<display
value="Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system"/>
</concept>
<concept>
<code value="2A0Z"/>
<display value="Nonpolyposis Turcot syndrome"/>
</concept>
<concept>
<code value="2A01"/>
<display value="primary neoplasm of spinal meninges"/>
</concept>
<concept>
<code value="5B50-5B7Z"/>
<display value="Undernutrition"/>
</concept>
<concept>
<code value="5C3Y"/>
<display
value="Skin disorder attributable to food fads or unhealthy diet"/>
</concept>
<concept>
<code value="5C3Z"/>
<display value="Nutritional liver disease, not elsewhere classified"/>
</concept>
<concept>
<code value="2E64.0"/>
<display value="Intraepidermal squamous cell carcinoma"/>
</concept>
<concept>
<code value="5B80-5C1Z"/>
<display value="Overweight, obesity or specific nutrient excesses"/>
</concept>
<concept>
<code value="2E64.Z"/>
<display value="skin carcinoma in situ"/>
</concept>
<concept>
<code value="2E64.1"/>
<display value="Extramammary Paget disease of anogenital skin"/>
</concept>
<concept>
<code value="2E64.Y"/>
<display value="Apocrine adenocarcinoma in situ of unspecified site"/>
</concept>
<concept>
<code value="2E64.2"/>
<display
value="High grade squamous intraepithelial lesion of anal margin or perianal skin"/>
</concept>
<concept>
<code value="5D40"/>
<display value="Postprocedural hypothyroidism"/>
</concept>
<concept>
<code value="5D41"/>
<display value="Postpancreatectomy hyperglycaemia"/>
</concept>
<concept>
<code value="5A50-5A5Z"/>
<display
value="Disorders of the parathyroids or parathyroid hormone system"/>
</concept>
<concept>
<code value="5D42"/>
<display value="Parathyroprival tetany"/>
</concept>
<concept>
<code value="5D43"/>
<display value="Postirradiation hypopituitarism"/>
</concept>
<concept>
<code value="5D44"/>
<display value="iatrogenic ovarian failure"/>
</concept>
<concept>
<code value="5A40-5A4Z"/>
<display
value="Other disorders of glucose regulation or pancreatic internal secretion"/>
</concept>
<concept>
<code value="5A10-5A2Y"/>
<display value="Diabetes mellitus"/>
</concept>
<concept>
<code value="5A60-5A6Z"/>
<display value="Disorders of the pituitary hormone system"/>
</concept>
<concept>
<code value="5A00-5A0Z"/>
<display
value="Disorders of the thyroid gland or thyroid hormones system"/>
</concept>
<concept>
<code value="2E84.0"/>
<display value="Benign fibrogenic or myofibrogenic tumour of skin"/>
</concept>
<concept>
<code value="2E84.Z"/>
<display value="Myxoma of unspecified site"/>
</concept>
<concept>
<code value="2E84.Y"/>
<display
value="Benign fibrogenic or myofibrogenic tumour of other specified sites"/>
</concept>
<concept>
<code value="2E80.Y"/>
<display value="Other specified benign lipomatous neoplasm"/>
</concept>
<concept>
<code value="2E80.1"/>
<display value="Lipoblastoma"/>
</concept>
<concept>
<code value="2E80.0"/>
<display value="Lipoma"/>
</concept>
<concept>
<code value="2E80.Z"/>
<display value="Benign adipocytic tumour"/>
</concept>
<concept>
<code value="2E92.4"/>
<display value="Benign neoplasm of the large intestine"/>
</concept>
<concept>
<code value="2E92.2"/>
<display value="Other benign neoplasm of duodenum"/>
</concept>
<concept>
<code value="2E92.1"/>
<display value="benign tumour of pylorus"/>
</concept>
<concept>
<code value="2F00"/>
<display value="Benign neoplasm of middle ear or respiratory system"/>
</concept>
<concept>
<code value="2E90.3"/>
<display value="Benign tumour of internal cheek"/>
</concept>
<concept>
<code value="2E92.0"/>
<display value="benign tumour of upper third of oesophagus"/>
</concept>
<concept>
<code value="2E92.3"/>
<display value="benign tumour of ileal diverticulum"/>
</concept>
<concept>
<code value="2E83.2"/>
<display value="benign neoplasm of vertebra"/>
</concept>
<concept>
<code value="2E90.2"/>
<display value="benign tumour of floor of mouth"/>
</concept>
<concept>
<code value="2E83.3"/>
<display value="benign neoplasm of clavicle"/>
</concept>
<concept>
<code value="2E90.1"/>
<display value="Granular cell myoblastoma of tongue"/>
</concept>
<concept>
<code value="2E90.4"/>
<display value="benign tumour of tonsil"/>
</concept>
<concept>
<code value="1B71.0"/>
<display value="Necrotising fasciitis type 2"/>
</concept>
<concept>
<code value="2E90.0"/>
<display value="Benign tumour of upper labial mucosa"/>
</concept>
<concept>
<code value="2F01"/>
<display value="Benign neoplasm of visceral pleura"/>
</concept>
<concept>
<code value="2E83.0"/>
<display value="Upper jaw dentinoma"/>
</concept>
<concept>
<code value="2F20-2F2Z"/>
<display value="Benign cutaneous neoplasms"/>
</concept>
<concept>
<code value="2E83.1"/>
<display value="Periradicular cemental dysplasia of lower jaw"/>
</concept>
<concept>
<code value="2E83.4"/>
<display value="Benign neoplasm of sacrum"/>
</concept>
<concept>
<code value="2D70-2D7Z"/>
<display
value="Malignant neoplasm metastasis in thoracic or respiratory organs"/>
</concept>
<concept>
<code value="1B74.Z"/>
<display value="Superficial folliculitis"/>
</concept>
<concept>
<code value="1B74.0"/>
<display value="Follicular impetigo of Bockhart"/>
</concept>
<concept>
<code value="1B71.1"/>
<display value="Progressive bacterial synergistic gangrene"/>
</concept>
<concept>
<code value="1B71.2"/>
<display value="Neonatal streptococcal necrotising fasciitis"/>
</concept>
<concept>
<code value="2D52"/>
<display value="Malignant neoplasm metastasis in epidural space"/>
</concept>
<concept>
<code value="2D60-2D6Z"/>
<display value="Malignant neoplasm metastasis in lymph nodes"/>
</concept>
<concept>
<code value="2D50"/>
<display value="Malignant neoplasm metastasis in choroid plexus"/>
</concept>
<concept>
<code value="1B71.Z"/>
<display value="necrotizing fasciitis"/>
</concept>
<concept>
<code value="2D51"/>
<display value="spinal arachnoid metastasis"/>
</concept>
<concept>
<code value="1B71.Y"/>
<display value="Necrotising fasciitis, trunk"/>
</concept>
<concept>
<code value="1A31"/>
<display value="Colitis due to Giardia lamblia"/>
</concept>
<concept>
<code value="1A33"/>
<display value="Cystoisosporiasis"/>
</concept>
<concept>
<code value="1B74.Y"/>
<display value="Hot tub folliculitis"/>
</concept>
<concept>
<code value="1A34"/>
<display value="sarcosporidiasis"/>
</concept>
<concept>
<code value="2E82.0"/>
<display
value="Benign chondrogenic tumours of bone or articular cartilage of limbs"/>
</concept>
<concept>
<code value="1A32"/>
<display value="Cryptosporidial colitis"/>
</concept>
<concept>
<code value="1A30"/>
<display value="Balantidium coli anaemia"/>
</concept>
<concept>
<code value="2E82.Z"/>
<display value="giant cell chondromatous tumour of unspecified site"/>
</concept>
<concept>
<code value="2C30-2C3Z"/>
<display value="Malignant neoplasms of skin"/>
</concept>
<concept>
<code value="2B70-2C1Z"/>
<display value="Malignant neoplasms of digestive organs"/>
</concept>
<concept>
<code value="2E82.1"/>
<display
value="Benign chondrogenic tumours of bone or articular cartilage of other specified sites"/>
</concept>
<concept>
<code value="1B73.Z"/>
<display value="Ecthyma"/>
</concept>
<concept>
<code value="1B73.2"/>
<display value="Ecthyma gangrenosum"/>
</concept>
<concept>
<code value="1B73.1"/>
<display value="Staphylococcal ecthyma"/>
</concept>
<concept>
<code value="1B73.0"/>
<display value="Streptococcal ecthyma"/>
</concept>
<concept>
<code value="2B60-2B6Y"/>
<display value="Malignant neoplasms of lip, oral cavity or pharynx"/>
</concept>
<concept>
<code value="2C20-2C2Z"/>
<display
value="Malignant neoplasms of middle ear, respiratory or intrathoracic organs"/>
</concept>
<concept>
<code value="1B73.Y"/>
<display value="Other specified ecthyma"/>
</concept>
<concept>
<code value="2B50-2B5Z"/>
<display value="Malignant mesenchymal neoplasms"/>
</concept>
<concept>
<code value="1B20.2"/>
<display value="Leprosy reactions"/>
</concept>
<concept>
<code value="1B20.3"/>
<display value="Mycobacterium leprae dacryoadenitis"/>
</concept>
<concept>
<code value="1B20.Z"/>
<display value="leprosy unspecified"/>
</concept>
<concept>
<code value="1B20.1"/>
<display value="Hansen disease, diffuse lepromatous"/>
</concept>
<concept>
<code value="2E63.00"/>
<display value="Hutchinson melanotic freckle"/>
</concept>
<concept>
<code value="2E63.0Z"/>
<display value="Radial growth phase malignant melanoma"/>
</concept>
<concept>
<code value="1B5Y"/>
<display value="Staphylococcal pericarditis"/>
</concept>
<concept>
<code value="1B20.0"/>
<display value="BT - [borderline tuberculoid] leprosy"/>
</concept>
<concept>
<code value="1B40"/>
<display
value="Acute rheumatic fever without mention of heart involvement"/>
</concept>
<concept>
<code value="1B41"/>
<display value="Acute rheumatic fever with heart involvement"/>
</concept>
<concept>
<code value="1B42"/>
<display value="ST Vitus dance"/>
</concept>
<concept>
<code value="1B5Z"/>
<display
value="sepsis due to group B Strep without mention of septic shock"/>
</concept>
<concept>
<code value="4A61"/>
<display
value="SAPHO - [synovitis, acne, pustulosis, hyperostosis, osteitis] syndrome"/>
</concept>
<concept>
<code value="4A6Z"/>
<display value="Autoinflammatory disorders, unspecified"/>
</concept>
<concept>
<code value="4A6Y"/>
<display value="Juvenile chronic recurrent multifocal osteomyelitis"/>
</concept>
<concept>
<code value="4A60"/>
<display value="Monogenic autoinflammatory syndromes"/>
</concept>
<concept>
<code value="4A20.1"/>
<display value="Acquired immunodeficiency due to protein loss"/>
</concept>
<concept>
<code value="4A62"/>
<display value="Neurological complications of Behçet disease"/>
</concept>
<concept>
<code value="4A20.Z"/>
<display value="Acquired immunodeficiencies"/>
</concept>
<concept>
<code value="4A20.Y"/>
<display value="Other specified acquired immunodeficiencies"/>
</concept>
<concept>
<code value="4A84"/>
<display value="Anaphylaxis"/>
</concept>
<concept>
<code value="4A80"/>
<display
value="Allergic or hypersensitivity disorders involving the respiratory tract"/>
</concept>
<concept>
<code value="4A20.0"/>
<display value="Adult-onset immunodeficiency"/>
</concept>
<concept>
<code value="4A83"/>
<display
value="Allergic or hypersensitivity disorders involving the gastrointestinal tract"/>
</concept>
<concept>
<code value="4A82"/>
<display value="Arthus phenomenon"/>
</concept>
<concept>
<code value="4A81"/>
<display value="Ocular allergy"/>
</concept>
<concept>
<code value="4A41"/>
<display value="Idiopathic inflammatory myopathy"/>
</concept>
<concept>
<code value="4A43"/>
<display
value="Overlap or undifferentiated nonorgan specific systemic autoimmune disease"/>
</concept>
<concept>
<code value="4A42"/>
<display value="Systemic sclerosis"/>
</concept>
<concept>
<code value="4A44"/>
<display value="Vasculitis"/>
</concept>
<concept>
<code value="4A40"/>
<display value="Lupus erythematosus"/>
</concept>
<concept>
<code value="2E61.Z"/>
<display
value="Carcinoma in situ of other or unspecified digestive organs"/>
</concept>
<concept>
<code value="4A0Y"/>
<display value="Lymphocyte function antigen-1 [LFA-1] defect"/>
</concept>
<concept>
<code value="4A0Z"/>
<display value="Primary immunodeficiencies, unspecified"/>
</concept>
<concept>
<code value="4A01"/>
<display
value="Primary immunodeficiencies due to disorders of adaptive immunity"/>
</concept>
<concept>
<code value="4A00"/>
<display
value="Primary immunodeficiencies due to disorders of innate immunity"/>
</concept>
<concept>
<code value="1A90"/>
<display value="Chancroidal lymphadenitis"/>
</concept>
<concept>
<code value="1A91"/>
<display value="Osteomyelitis due to Klebsiella granuloma inguinale"/>
</concept>
<concept>
<code value="1A70-1A7Z"/>
<display value="Gonococcal infection"/>
</concept>
<concept>
<code value="1A60-1A6Z"/>
<display value="Syphilis"/>
</concept>
<concept>
<code value="1A80-1A8Z"/>
<display value="Sexually transmissible infections due to chlamydia"/>
</concept>
<concept>
<code value="2A00.3"/>
<display value="Central neurocytoma of brain"/>
</concept>
<concept>
<code value="2A00.4"/>
<display value="astroblastoma of unspecified site"/>
</concept>
<concept>
<code value="2A00.2"/>
<display value="Tumours of neuroepithelial tissue of brain"/>
</concept>
<concept>
<code value="2A00.1"/>
<display value="Embryonal tumours of brain"/>
</concept>
<concept>
<code value="2A00.0"/>
<display value="Gliomas of brain"/>
</concept>
<concept>
<code value="2A02.4"/>
<display value="Benign neoplasm of cauda equina"/>
</concept>
<concept>
<code value="2A02.0"/>
<display value="Gliomas of spinal cord, cranial or paraspinal nerves"/>
</concept>
<concept>
<code value="2A02.2"/>
<display value="primary malignant neoplasm of cauda equina"/>
</concept>
<concept>
<code value="2A01.0"/>
<display value="Meningiomas"/>
</concept>
<concept>
<code value="2A02.1"/>
<display value="Tumours of cranial or paraspinal nerves"/>
</concept>
<concept>
<code value="2A02.3"/>
<display value="acoustic neurinoma"/>
</concept>
<concept>
<code value="2A01.2"/>
<display
value="Neoplasm of uncertain or unknown behaviour of spinal meninges"/>
</concept>
<concept>
<code value="2A01.1"/>
<display value="Mesenchymal tumours of meninges"/>
</concept>
<concept>
<code value="2A20-2A2Z"/>
<display value="Myeloproliferative neoplasms"/>
</concept>
<concept>
<code value="2A40-2A4Z"/>
<display value="Myelodysplastic and myeloproliferative neoplasms"/>
</concept>
<concept>
<code value="2A60"/>
<display
value="Acute myeloid leukaemias and related precursor neoplasms"/>
</concept>
<concept>
<code value="2A30-2A3Z"/>
<display value="Myelodysplastic syndromes"/>
</concept>
<concept>
<code value="2A50-2A5Z"/>
<display
value="Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1"/>
</concept>
<concept>
<code value="2E91.0"/>
<display value="benign tumour of parotid gland"/>
</concept>
<concept>
<code value="2E91.Z"/>
<display value="Warthin tumour of unspecified site"/>
</concept>
<concept>
<code value="1B12"/>
<display value="Tuberculosis of other systems and organs"/>
</concept>
<concept>
<code value="1B13"/>
<display value="Miliary tuberculosis"/>
</concept>
<concept>
<code value="1B11"/>
<display value="Tuberculosis of the nervous system"/>
</concept>
<concept>
<code value="2E91.1"/>
<display value="Benign neoplasm of submaxillary gland"/>
</concept>
<concept>
<code value="1B14"/>
<display value="Carrier of Mycobacterium tuberculosis"/>
</concept>
<concept>
<code value="1B10"/>
<display value="Tuberculosis of the respiratory system"/>
</concept>
<concept>
<code value="1B70.0"/>
<display value="Erysipelas"/>
</concept>
<concept>
<code value="1B70.2"/>
<display value="Staphylococcal cellulitis of skin"/>
</concept>
<concept>
<code value="1B70.3"/>
<display
value="Ascending bacterial lymphangitis due to Staphylococcus aureus"/>
</concept>
<concept>
<code value="1B70.Y"/>
<display
value="Bacterial cellulitis or lymphangitis due to other specified bacterium"/>
</concept>
<concept>
<code value="1B70.1"/>
<display value="Streptococcal cellulitis of the vulva and vagina"/>
</concept>
<concept>
<code value="1A22"/>
<display value="rotaviral enteritis"/>
</concept>
<concept>
<code value="1A20"/>
<display value="Adenoviral enteritis"/>
</concept>
<concept>
<code value="1A24"/>
<display value="Gastroenteritis due to Cytomegalovirus"/>
</concept>
<concept>
<code value="1A21"/>
<display value="infections due to Astrovirus"/>
</concept>
<concept>
<code value="2D44"/>
<display value="metastatic cancer, unknown origin, so stated"/>
</concept>
<concept>
<code value="2D41"/>
<display
value="Metastatic carcinoma [primary carcinoma spreading elsewhere]"/>
</concept>
<concept>
<code value="1A23"/>
<display value="Noroviral enteritis"/>
</concept>
<concept>
<code value="2D43"/>
<display
value="Malignant neoplasms of independent, multiple primary sites"/>
</concept>
<concept>
<code value="2D40"/>
<display value="Villous adenocarcinoma in adenoma of unspecified site"/>
</concept>
<concept>
<code value="2D42"/>
<display value="calf cancer"/>
</concept>
<concept>
<code value="2E64.00"/>
<display value="Bowen type intraepidermal squamous cell carcinoma"/>
</concept>
<concept>
<code value="2E64.0Y"/>
<display value="Other specified intraepidermal squamous cell carcinoma"/>
</concept>
<concept>
<code value="2E64.01"/>
<display
value="Intraepidermal squamous cell carcinoma arising from actinic keratosis"/>
</concept>
<concept>
<code value="2E64.0Z"/>
<display value="IEC - [intraepidermal carcinoma]"/>
</concept>
<concept>
<code value="5B90-5B9Z"/>
<display value="Certain specified nutrient excesses"/>
</concept>
<concept>
<code value="5B80-5B81.Z"/>
<display value="Overweight or obesity"/>
</concept>
<concept>
<code value="5C1Z"/>
<display
value="Overweight, obesity or specific nutrient excesses, unspecified"/>
</concept>
<concept>
<code value="5C1Y"/>
<display value="late effect of hyperalimentation"/>
</concept>
<concept>
<code value="5D40.Y"/>
<display value="Other specified postprocedural hypothyroidism"/>
</concept>
<concept>
<code value="5D40.0"/>
<display value="Postirridation hypothyroidism"/>
</concept>
<concept>
<code value="5D40.Z"/>
<display value="hypothyroidism due to absence of thyroid"/>
</concept>
<concept>
<code value="5D45"/>
<display value="Postprocedural testicular hypofunction"/>
</concept>
<concept>
<code value="5D46"/>
<display value="adrenalectomy status"/>
</concept>
<concept>
<code value="5A60"/>
<display value="Hyperfunction of pituitary gland"/>
</concept>
<concept>
<code value="5A61"/>
<display value="hypothalamic lesion"/>
</concept>
<concept>
<code value="5A6Z"/>
<display value="Disorders of the pituitary hormone system, unspecified"/>
</concept>
<concept>
<code value="5A11"/>
<display value="insulin resistant diabetes"/>
</concept>
<concept>
<code value="5A10"/>
<display
value="SPIDDM - [Slowly progressive insulin-dependent diabetes mellitus]"/>
</concept>
<concept>
<code value="5A13"/>
<display
value="Other specified Diabetes mellitus, not Type 1 and not Type 2"/>
</concept>
<concept>
<code value="5A14"/>
<display value="Diabetes without mention of type of diabetes mellitus"/>
</concept>
<concept>
<code value="5A00"/>
<display value="Hypothyroidism"/>
</concept>
<concept>
<code value="5A02"/>
<display value="Thyrotoxicosis"/>
</concept>
<concept>
<code value="5A12"/>
<display
value="malnutrition-related diabetes mellitus without complications"/>
</concept>
<concept>
<code value="5A04"/>
<display value="C-cell hyperplasia of thyroid"/>
</concept>
<concept>
<code value="5A03"/>
<display value="Thyroiditis"/>
</concept>
<concept>
<code value="5A01"/>
<display value="Nontoxic goitre"/>
</concept>
<concept>
<code value="2E85"/>
<display value="Benign fibrohistiocytic tumour"/>
</concept>
<concept>
<code value="2E80.00"/>
<display value="Superficial subcutaneous lipoma"/>
</concept>
<concept>
<code value="2E80.0Y"/>
<display value="Lipoma, other specified site"/>
</concept>
<concept>
<code value="2E80.01"/>
<display value="Benign lipoma of spermatic cord"/>
</concept>
<concept>
<code value="2E80.02"/>
<display value="Deep internal benign lipoma of retroperitoneum"/>
</concept>
<concept>
<code value="2E80.0Z"/>
<display value="Spindle cell lipoma of unspecified site"/>
</concept>
<concept>
<code value="2E92.4Z"/>
<display value="benign tumor of large intestine"/>
</concept>
<concept>
<code value="2E92.40"/>
<display value="HMPS - [hereditary mixed polyposis syndrome]"/>
</concept>
<concept>
<code value="2E92.4Y"/>
<display value="Tubular adenoma of sigmoid"/>
</concept>
<concept>
<code value="2F00.Z"/>
<display value="Benign neoplasm of middle ear or respiratory system"/>
</concept>
<concept>
<code value="2F00.0"/>
<display value="Middle ear neuroendocrine tumour"/>
</concept>
<concept>
<code value="2F00.1"/>
<display value="Recurrent respiratory papillomatosis"/>
</concept>
<concept>
<code value="2E92.5"/>
<display value="Benign anorectal neoplasm"/>
</concept>
<concept>
<code value="2E92.6"/>
<display
value="Other benign neoplasms of gallbladder, extrahepatic bile duct or ampulla of Vater"/>
</concept>
<concept>
<code value="2F00.2"/>
<display value="Laryngeal neuroendocrine tumour"/>
</concept>
<concept>
<code value="2E92.7"/>
<display value="biliary ductal cystadenoma"/>
</concept>
<concept>
<code value="2F00.Y"/>
<display
value="Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia"/>
</concept>
<concept>
<code value="2E90.5"/>
<display value="Benign tumour of mesopharynx"/>
</concept>
<concept>
<code value="2E83.5"/>
<display value="Benign neoplasm of patella"/>
</concept>
<concept>
<code value="2E90.6"/>
<display value="Benign neoplasm of the pharyngeal tonsil"/>
</concept>
<concept>
<code value="2F21"/>
<display value="Benign keratinocytic acanthomas"/>
</concept>
<concept>
<code value="2F20"/>
<display value="Benign cutaneous melanocytic neoplasms"/>
</concept>
<concept>
<code value="2F23"/>
<display value="Benign dermal fibrous or fibrohistiocytic neoplasms"/>
</concept>
<concept>
<code value="2F24"/>
<display value="Cellular neurothekeoma"/>
</concept>
<concept>
<code value="2E83.Y"/>
<display value="Benign osteogenic tumour of other specified site"/>
</concept>
<concept>
<code value="2D71"/>
<display value="mediastinum metastasis"/>
</concept>
<concept>
<code value="2D72"/>
<display value="pleural metastasis"/>
</concept>
<concept>
<code value="2D7Y"/>
<display value="tracheal cartilage metastasis"/>
</concept>
<concept>
<code value="2F22"/>
<display value="Tubular papillary adenoma"/>
</concept>
<concept>
<code value="2D70"/>
<display value="Metastatic carcinoma in lung"/>
</concept>
<concept>
<code value="2D73"/>
<display value="Malignant neoplasm metastasis in false vocal cord"/>
</concept>
<concept>
<code value="2E83.Z"/>
<display value="Osteoma of unspecified site"/>
</concept>
<concept>
<code value="2D90-2D91"/>
<display
value="Malignant neoplasm metastasis in retroperitoneum or peritoneum"/>
</concept>
<concept>
<code value="2D80-2D8Z"/>
<display value="Malignant neoplasm metastasis in digestive system"/>
</concept>
<concept>
<code value="2E00-2E0Y"/>
<display value="Malignant neoplasm metastasis in other specified sites"/>
</concept>
<concept>
<code value="1A33.0"/>
<display value="Infection due to Isopora belli"/>
</concept>
<concept>
<code value="1A33.1"/>
<display value="coccidial colitis"/>
</concept>
<concept>
<code value="1B75"/>
<display
value="Deep bacterial folliculitis or pyogenic abscess of the skin"/>
</concept>
<concept>
<code value="1A35"/>
<display value="Blastocystosis"/>
</concept>
<concept>
<code value="1A33.Y"/>
<display value="Other specified cystoisosporiasis"/>
</concept>
<concept>
<code value="1A36"/>
<display value="Amoebiasis"/>
</concept>
<concept>
<code value="1A33.Z"/>
<display value="Isosporiasis"/>
</concept>
<concept>
<code value="1A3Z"/>
<display value="Protozoal intestinal infections, unspecified"/>
</concept>
<concept>
<code value="1A3Y"/>
<display value="embadomonas dysentery"/>
</concept>
<concept>
<code value="2E86"/>
<display value="Benign smooth muscle or skeletal muscle tumour"/>
</concept>
<concept>
<code value="1B7Y"/>
<display
value="Skin infection classified elsewhere due to hospital-acquired MRSA"/>
</concept>
<concept>
<code value="1B20.20"/>
<display value="Leprosy upgrading reaction"/>
</concept>
<concept>
<code value="1B20.21"/>
<display value="Lucio phenomenon"/>
</concept>
<concept>
<code value="2E65"/>
<display value="Carcinoma in situ of breast"/>
</concept>
<concept>
<code value="1B40.0"/>
<display value="acute articular rheumatism"/>
</concept>
<concept>
<code value="1B40.Z"/>
<display value="subacute rheumatic fever"/>
</concept>
<concept>
<code value="1B40.Y"/>
<display value="rheumatic pneumonitis"/>
</concept>
<concept>
<code value="2E81.Y"/>
<display value="Other specified benign vascular neoplasms"/>
</concept>
<concept>
<code value="2E81.2"/>
<display value="Benign vascular neoplasms of infancy or childhood"/>
</concept>
<concept>
<code value="2E81.0"/>
<display value="Neoplastic haemangioma"/>
</concept>
<concept>
<code value="2E81.Z"/>
<display value="Benign vascular neoplasms"/>
</concept>
<concept>
<code value="2E81.1"/>
<display value="Benign lymphatic neoplasms"/>
</concept>
<concept>
<code value="4A60.2"/>
<display
value="Tumour necrosis factor receptor 1 associated periodic syndrome with amyloidosis"/>
</concept>
<concept>
<code value="4A60.1"/>
<display value="Muckle Wells Syndrome with neurosensorial hearing loss"/>
</concept>
<concept>
<code value="4A60.0"/>
<display value="Familial Mediterranean fever with amyloidosis"/>
</concept>
<concept>
<code value="4A60.Z"/>
<display value="Monogenic autoinflammatory syndromes"/>
</concept>
<concept>
<code value="4A60.Y"/>
<display value="NLRP12-associated hereditary periodic fever syndrome"/>
</concept>
<concept>
<code value="4A84.0"/>
<display value="Anaphylactic shock due to allergic food reaction"/>
</concept>
<concept>
<code value="4A84.3"/>
<display value="Anaphylaxis provoked by physical factors"/>
</concept>
<concept>
<code value="4A84.2"/>
<display value="Insect venom allergen-induced anaphylaxis"/>
</concept>
<concept>
<code value="4A84.4"/>
<display value="Inhaled allergen-induced anaphylaxis"/>
</concept>
<concept>
<code value="4A84.1"/>
<display value="medicament-induced anaphylaxis"/>
</concept>
<concept>
<code value="4B00-4B0Z"/>
<display value="Immune system disorders involving white cell lineages"/>
</concept>
<concept>
<code value="4A80.Y"/>
<display
value="Other specified allergic or hypersensitivity disorders involving the respiratory tract"/>
</concept>
<concept>
<code value="4A80.1"/>
<display value="Food-induced wheezing"/>
</concept>
<concept>
<code value="4A80.Z"/>
<display
value="Allergic or hypersensitivity disorders involving the respiratory tract"/>
</concept>
<concept>
<code value="4A80.0"/>
<display value="medicament-induced bronchospasm"/>
</concept>
<concept>
<code value="4A83.1"/>
<display value="Food-induced eosinophilic oesophagitis"/>
</concept>
<concept>
<code value="4A83.Y"/>
<display
value="Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract"/>
</concept>
<concept>
<code value="4A83.Z"/>
<display
value="Allergic or hypersensitivity disorders involving the gastrointestinal tract"/>
</concept>
<concept>
<code value="4A83.0"/>
<display value="Food-induced eosinophilic gastroenteritis"/>
</concept>
<concept>
<code value="4A85"/>
<display value="Complex allergic or hypersensitivity conditions"/>
</concept>
<concept>
<code value="4A8Y"/>
<display
value="Allergic or hypersensitivity conditions of other specified type"/>
</concept>
<concept>
<code value="4A41.0"/>
<display value="Dermatomyositis"/>
</concept>
<concept>
<code value="4A41.Y"/>
<display value="Focal myositis"/>
</concept>
<concept>
<code value="4A41.2"/>
<display value="Inclusion body myopathy"/>
</concept>
<concept>
<code value="4A41.1"/>
<display value="Polymyositis"/>
</concept>
<concept>
<code value="4A41.Z"/>
<display value="Idiopathic inflammatory myopathy"/>
</concept>
<concept>
<code value="4A43.2"/>
<display value="Sjögren syndrome"/>
</concept>
<concept>
<code value="4A43.3"/>
<display
value="Paediatric-onset MCTD - [mixed connective tissue disease]"/>
</concept>
<concept>
<code value="4A44.2"/>
<display value="Giant cell arteritis without polymyalgia rheumatica"/>
</concept>
<concept>
<code value="4A43.1"/>
<display value="Mikulicz disease"/>
</concept>
<concept>
<code value="4A43.0"/>
<display value="Cholangitis of IgG4-related sclerosing disease"/>
</concept>
<concept>
<code value="4A43.4"/>
<display value="Diffuse fasciitis"/>
</concept>
<concept>
<code value="4A40.1"/>
<display value="drug-induced systemic lupus erythematosus"/>
</concept>
<concept>
<code value="4A44.0"/>
<display value="Rhizomelic pseudopolyarthritis"/>
</concept>
<concept>
<code value="4A44.3"/>
<display value="Single organ vasculitis"/>
</concept>
<concept>
<code value="4A40.Y"/>
<display value="Lupus erythematosus of oral mucosa"/>
</concept>
<concept>
<code value="4A40.0"/>
<display value="Systemic lupus erythematosus"/>
</concept>
<concept>
<code value="4A44.4"/>
<display value="Periarteritis nodosa with necrosis"/>
</concept>
<concept>
<code value="4A44.1"/>
<display value="young female aortic arch arteritis syndrome"/>
</concept>
<concept>
<code value="4A40.Z"/>
<display value="LE - [lupus erythematosus]"/>
</concept>
<concept>
<code value="4A01.1"/>
<display value="Combined immunodeficiencies"/>
</concept>
<concept>
<code value="4A01.2"/>
<display value="Diseases of immune dysregulation"/>
</concept>
<concept>
<code value="4A01.0"/>
<display value="Immunodeficiencies with predominantly antibody defects"/>
</concept>
<concept>
<code value="4A01.Z"/>
<display
value="Primary immunodeficiencies due to disorders of adaptive immunity"/>
</concept>
<concept>
<code value="4A01.3"/>
<display
value="Other well-defined immunodeficiency syndromes due to defects in adaptive immunity"/>
</concept>
<concept>
<code value="4A00.1"/>
<display value="Defects in the complement system"/>
</concept>
<concept>
<code value="4A00.3"/>
<display
value="Immunodeficiency with NK-cell - [natural-killer cell] deficiency"/>
</concept>
<concept>
<code value="4A00.Y"/>
<display
value="Warts - hypogammaglobulinaemia - infections - myelokathexis"/>
</concept>
<concept>
<code value="4A00.2"/>
<display value="Pyogenic bacterial infections due to MyD88 deficiency"/>
</concept>
<concept>
<code value="4A00.0"/>
<display value="Functional neutrophil defects"/>
</concept>
<concept>
<code value="1A93"/>
<display value="Sexually transmissible infestations"/>
</concept>
<concept>
<code value="1A92"/>
<display value="Trichomonal cervicitis"/>
</concept>
<concept>
<code value="1A60"/>
<display value="Congenital syphilis"/>
</concept>
<concept>
<code value="1A61"/>
<display value="Early syphilis"/>
</concept>
<concept>
<code value="1A63"/>
<display value="Positive Wassermann test"/>
</concept>
<concept>
<code value="1A6Z"/>
<display value="Female syphilitic pelvic inflammatory disease"/>
</concept>
<concept>
<code value="1A62"/>
<display value="Late syphilis"/>
</concept>
<concept>
<code value="1B72.0"/>
<display value="Blistering distal dactylitis"/>
</concept>
<concept>
<code value="1B72.Y"/>
<display value="Other specified impetigo"/>
</concept>
<concept>
<code value="1B72.1"/>
<display value="Non-bullous impetigo"/>
</concept>
<concept>
<code value="1B21.1"/>
<display value="Non-tuberculous mycobacterial lymphadenitis"/>
</concept>
<concept>
<code value="1B21.0"/>
<display value="Pulmonary infection due to Mycobacterium malmoense"/>
</concept>
<concept>
<code value="1B21.4"/>
<display value="Non-tuberculous mycobacterial colitis"/>
</concept>
<concept>
<code value="2A00.20"/>
<display value="Pineocytoma"/>
</concept>
<concept>
<code value="2A00.21"/>
<display value="Lhermitte-Duclos disease"/>
</concept>
<concept>
<code value="2A00.22"/>
<display value="choroid plexus carcinoma (grade 3 lesion)"/>
</concept>
<concept>
<code value="2A00.2Y"/>
<display
value="Other specified tumours of neuroepithelial tissue of brain"/>
</concept>
<concept>
<code value="2A00.0Z"/>
<display value="glioma NOS"/>
</concept>
<concept>
<code value="2A00.2Z"/>
<display value="Tumours of neuroepithelial tissue of brain"/>
</concept>
<concept>
<code value="2A00.5"/>
<display value="benign brain tumour NOS"/>
</concept>
<concept>
<code value="2A00.1Y"/>
<display value="Yolk sac tumour of the central nervous system"/>
</concept>
<concept>
<code value="1B21.3"/>
<display
value="DMAC - [disseminated mycobacterium avium-intracellulare complex infection]"/>
</concept>
<concept>
<code value="2A02.00"/>
<display
value="Glioblastoma of spinal cord, cranial or paraspinal nerves"/>
</concept>
<concept>
<code value="2A02.0Z"/>
<display value="Gliomas of spinal cord, cranial or paraspinal nerves"/>
</concept>
<concept>
<code value="2A02.0Y"/>
<display
value="Malignant astrocytomas of spinal cord, cranial or paraspinal nerves"/>
</concept>
<concept>
<code value="2A00.00"/>
<display value="Spongioblastoma multiforme of unspecified site"/>
</concept>
<concept>
<code value="2A00.10"/>
<display value="Neuroepithelioma"/>
</concept>
<concept>
<code value="2A00.1Z"/>
<display value="Embryonal tumours of brain"/>
</concept>
<concept>
<code value="2A00.0Y"/>
<display value="Subependymal glioma, unspecified site"/>
</concept>
<concept>
<code value="2A02.10"/>
<display value="neurofibrosarcoma"/>
</concept>
<concept>
<code value="2A00.11"/>
<display value="Teratoid medulloepithelioma of unspecified site"/>
</concept>
<concept>
<code value="2A20"/>
<display value="Non mast cell myeloproliferative neoplasms"/>
</concept>
<concept>
<code value="2A60.4"/>
<display value="Myeloid proliferation associated with Down syndrome"/>
</concept>
<concept>
<code value="2A60.1"/>
<display
value="Acute myeloid leukaemia with multilineage dysplasia in complete remission"/>
</concept>
<concept>
<code value="2A60.2"/>
<display value="Therapy-related myeloid neoplasms"/>
</concept>
<concept>
<code value="2A40"/>
<display value="CMML-2 - [chronic myelomonocytic leukaemia Type 2]"/>
</concept>
<concept>
<code value="2A60.0"/>
<display
value="Acute myeloid leukemia with t(8;21)(q22;q22) translocation"/>
</concept>
<concept>
<code value="2A41"/>
<display
value="Atypical chronic myeloid leukaemia, BCR-ABL1-negative in complete remission"/>
</concept>
<concept>
<code value="1B12.2"/>
<display value="Tuberculosis of inner ear"/>
</concept>
<concept>
<code value="1B12.0"/>
<display value="tuberculous pericarditis"/>
</concept>
<concept>
<code value="2A01.0Z"/>
<display value="benign meningioma (deprecated)"/>
</concept>
<concept>
<code value="2A2Z"/>
<display value="myeloproliferative disorder"/>
</concept>
<concept>
<code value="1B1Y"/>
<display value="Disorders of kidney or ureter in tuberculosis"/>
</concept>
<concept>
<code value="1B11.1"/>
<display value="Tuberculous meningoencephalitis"/>
</concept>
<concept>
<code value="2A60.3"/>
<display
value="Acute myeloid leukaemia, not elsewhere classified by criteria of other types"/>
</concept>
<concept>
<code value="1B11.2"/>
<display value="Tuberculoma of spinal meninges"/>
</concept>
<concept>
<code value="2A43"/>
<display
value="RARS-T [Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis](provisional)"/>
</concept>
<concept>
<code value="2A42"/>
<display value="Juvenile myelomonocytic leukaemia"/>
</concept>
<concept>
<code value="2A44"/>
<display
value="Myeloproliferative and myelodysplastic disease, unclassifiable in complete remission"/>
</concept>
<concept>
<code value="2A51"/>
<display value="Myeloid neoplasms with PDGFRB rearrangement"/>
</concept>
<concept>
<code value="2A02.Z"/>
<display value="Epidural cancer NOS"/>
</concept>
<concept>
<code value="1B13.2"/>
<display value="Acute miliary tuberculosis, unspecified site"/>
</concept>
<concept>
<code value="1B13.1"/>
<display value="tuberculous polyserositis"/>
</concept>
<concept>
<code value="1B13.Y"/>
<display value="Chronic multiple tuberculosis"/>
</concept>
<concept>
<code value="1B13.Z"/>
<display value="disseminated tuberculosis"/>
</concept>
<concept>
<code value="1B11.3"/>
<display value="tuberculoma of brain"/>
</concept>
<concept>
<code value="1B11.0"/>
<display value="spinal meningeal TBC - [tuberculosis]"/>
</concept>
<concept>
<code value="1B11.Y"/>
<display value="tuberculous cerebrum arteritis"/>
</concept>
<concept>
<code value="2A01.0Y"/>
<display value="Syncytial meningioma of unspecified site"/>
</concept>
<concept>
<code value="2A2Y"/>
<display value="chronic myeloproliferative disease NOS"/>
</concept>
<concept>
<code value="1A40.0"/>
<display value="jejunal inflammation"/>
</concept>
<concept>
<code value="2E92.8"/>
<display value="benign tumour of tail of pancreas"/>
</concept>
<concept>
<code value="1A40.Z"/>
<display
value="intestinal infections without specification of infectious agent"/>
</concept>
<concept>
<code value="1B13.0"/>
<display value="Acute miliary lung TBC - [tuberculosis]"/>
</concept>
<concept>
<code value="2F30"/>
<display value="Benign neoplasm of breast"/>
</concept>
<concept>
<code value="1B10.0"/>
<display
value="Tuberculous sinusitis of any sinus, with bacteriological and histological confirmation"/>
</concept>
<concept>
<code value="1B7Z"/>
<display value="suppurative dermatitis"/>
</concept>
<concept>
<code value="1B12.5"/>
<display value="Tuberculosis of breast"/>
</concept>
<concept>
<code value="1B10.Z"/>
<display value="Tuberculous pansinusitis"/>
</concept>
<concept>
<code value="2D61"/>
<display
value="Malignant neoplasm metastasis in lymph nodes of multiple regions by adenocarcinoma"/>
</concept>
<concept>
<code value="2D6Z"/>
<display value="lymphatic vessel metastasis"/>
</concept>
<concept>
<code value="1B70.Z"/>
<display value="Cellulitis not otherwise specified"/>
</concept>
<concept>
<code value="2E81.2Y"/>
<display value="Diffuse neonatal haemangiomatosis"/>
</concept>
<concept>
<code value="2E90.7"/>
<display value="Benign tumour of pharyngoesophageal junction"/>
</concept>
<concept>
<code value="1A2Z"/>
<display value="Viral gastroenteropathy NOS"/>
</concept>
<concept>
<code value="2E81.21"/>
<display value="Multiple strawberry haemangiomata"/>
</concept>
<concept>
<code value="1B12.6"/>
<display value="TB - [tuberculosis] axillary gland"/>
</concept>
<concept>
<code value="2B63"/>
<display value="Malignant neoplasms of gum"/>
</concept>
<concept>
<code value="2B64"/>
<display value="Malignant neoplasms of floor of mouth"/>
</concept>
<concept>
<code value="2B61"/>
<display value="Malignant neoplasms of base of tongue"/>
</concept>
<concept>
<code value="2E66"/>
<display value="Carcinoma in situ of cervix uteri"/>
</concept>
<concept>
<code value="2D60"/>
<display
value="Malignant neoplasm metastasis in lymph node of a single region"/>
</concept>
<concept>
<code value="5B80"/>
<display value="Overweight or localised adiposity"/>
</concept>
<concept>
<code value="5B81"/>
<display value="Obesity"/>
</concept>
<concept>
<code value="5B90"/>
<display value="Vitamin excesses"/>
</concept>
<concept>
<code value="1A2Y"/>
<display value="Enteritis due to coxsackievirus"/>
</concept>
<concept>
<code value="1B12.8"/>
<display value="Tuberculous gumma"/>
</concept>
<concept>
<code value="5A05"/>
<display value="Refetoff syndrome"/>
</concept>
<concept>
<code value="2F20.Y"/>
<display
value="Unclassifiable benign cutaneous melanocytic proliferation"/>
</concept>
<concept>
<code value="5B91"/>
<display value="Mineral excesses"/>
</concept>
<concept>
<code value="5B9Z"/>
<display value="Nutrient excesses, unspecified"/>
</concept>
<concept>
<code value="2D4Z"/>
<display value="Cancer in polyp"/>
</concept>
<concept>
<code value="2B60"/>
<display value="Malignant neoplasms of lip"/>
</concept>
<concept>
<code value="2B62"/>
<display
value="Malignant neoplasms of other or unspecified parts of tongue"/>
</concept>
<concept>
<code value="5A00.0"/>
<display value="Congenital hypothyroidism"/>
</concept>
<concept>
<code value="5A00.Z"/>
<display value="Subclinical hypothyroidism"/>
</concept>
<concept>
<code value="5A00.1"/>
<display
value="Iodine-deficiency-related thyroid disorders or allied conditions"/>
</concept>
<concept>
<code value="5A20-5A2Y"/>
<display value="Acute complications of diabetes mellitus"/>
</concept>
<concept>
<code value="4A43.Y"/>
<display
value="Other specified non-organ specific systemic autoimmune disorders, not elsewhere classified, associated with anti-RNP antibodies"/>
</concept>
<concept>
<code value="2E87"/>
<display value="GIST - [gastrointestinal stromal tumour] of appendix"/>
</concept>
<concept>
<code value="5D40.0Z"/>
<display value="Postirridation hypothyroidism"/>
</concept>
<concept>
<code value="2F20.2"/>
<display value="Congenital melanocytic naevus"/>
</concept>
<concept>
<code value="2F20.3"/>
<display value="Generalised eruptive melanocytic naevi"/>
</concept>
<concept>
<code value="2F20.1"/>
<display value="Melanocytic naevus with mild to moderate dysplasia"/>
</concept>
<concept>
<code value="2F20.Z"/>
<display value="Naevus pigmentosus"/>
</concept>
<concept>
<code value="5B9Y"/>
<display value="Other specified nutrient excesses"/>
</concept>
<concept>
<code value="2E92.Y"/>
<display value="Benign neoplasm of other specified digestive organs"/>
</concept>
<concept>
<code value="4A42.Z"/>
<display value="Myopathy in scleroderma"/>
</concept>
<concept>
<code value="2F21.0"/>
<display value="Traumatized seborrhoeic keratosis"/>
</concept>
<concept>
<code value="2F25"/>
<display value="de Morgan's spots"/>
</concept>
<concept>
<code value="2F23.0"/>
<display value="Subepidermal nodular fibrosis"/>
</concept>
<concept>
<code value="2F23.Y"/>
<display value="Fibrous papule of nose"/>
</concept>
<concept>
<code value="2E90.8"/>
<display value="benign tumour of Waldeyer ring"/>
</concept>
<concept>
<code value="2E88"/>
<display value="Stromal nodule"/>
</concept>
<concept>
<code value="2E92.Z"/>
<display value="benign tumour of intestine NOS"/>
</concept>
<concept>
<code value="4A42.2"/>
<display
value="CRST - [calcinosis, Raynaud phenomenon, sclerodactyly and telangiectasia] syndrome"/>
</concept>
<concept>
<code value="2D80"/>
<display
value="Secondary malignant neoplasm of liver or intrahepatic bile duct"/>
</concept>
<concept>
<code value="2D84"/>
<display value="duodenal metastasis"/>
</concept>
<concept>
<code value="2D82"/>
<display value="metastasis to ductus choledochus"/>
</concept>
<concept>
<code value="2F26"/>
<display value="Pyogenic granuloma"/>
</concept>
<concept>
<code value="1A70"/>
<display value="Gonococcal genitourinary infection"/>
</concept>
<concept>
<code value="2D90"/>
<display value="secondary malignant neoplasm of retroperitoneum"/>
</concept>
<concept>
<code value="1B75.0"/>
<display value="Boil"/>
</concept>
<concept>
<code value="1B75.2"/>
<display value="Furunculosis"/>
</concept>
<concept>
<code value="2D91"/>
<display value="malignant ascites NOS"/>
</concept>
<concept>
<code value="4A01.30"/>
<display value="Immunodeficiency due to absence of thymus"/>
</concept>
<concept>
<code value="4A01.32"/>
<display value="Schimke syndrome"/>
</concept>
<concept>
<code value="2E86.2"/>
<display value="Glycogenic rhabdomyoma"/>
</concept>
<concept>
<code value="1A72"/>
<display value="Gonococcal infection of other sites"/>
</concept>
<concept>
<code value="1A36.Z"/>
<display value="amoebiasis, unspecified"/>
</concept>
<concept>
<code value="1A7Z"/>
<display value="Infection due to Neisseria gonorrhoeae"/>
</concept>
<concept>
<code value="2D7Z"/>
<display value="thorax metastasis"/>
</concept>
<concept>
<code value="4A01.33"/>
<display
value="VODI - [Veno-occlusive disease immunodeficiency] syndrome"/>
</concept>
<concept>
<code value="4A01.31"/>
<display value="ATLD - [Ataxia-telangiectasia-like disorder]"/>
</concept>
<concept>
<code value="4A01.34"/>
<display value="Hyperimmunoglobulin E syndrome due to TYK2 deficiency"/>
</concept>
<concept>
<code value="2E86.Z"/>
<display value="myoma of unspecified site"/>
</concept>
<concept>
<code value="1A36.0"/>
<display value="Intestinal infections due to Entamoeba"/>
</concept>
<concept>
<code value="2D86"/>
<display value="anal canal metastasis"/>
</concept>
<concept>
<code value="1B75.3"/>
<display value="abscess NOS"/>
</concept>
<concept>
<code value="1B75.1"/>
<display value="Carbuncle"/>
</concept>
<concept>
<code value="3A00-3A9Z"/>
<display value="Anaemias or other erythrocyte disorders"/>
</concept>
<concept>
<code value="2A30"/>
<display value="refractory anaemia without sideroblasts"/>
</concept>
<concept>
<code value="3B10-3B6Z"/>
<display
value="Coagulation defects, purpura or other haemorrhagic or related conditions"/>
</concept>
<concept>
<code value="3B80-3B8Z"/>
<display value="Diseases of spleen"/>
</concept>
<concept>
<code value="2A01.00"/>
<display value="Familial multiple meningioma"/>
</concept>
<concept>
<code value="1A10"/>
<display value="staphylococcus poisoning"/>
</concept>
<concept>
<code value="1A00"/>
<display value="Cholera due to Vibrio cholerae O139"/>
</concept>
<concept>
<code value="1B21.2"/>
<display value="Cutaneous non-tuberculous mycobacterial infection"/>
</concept>
<concept>
<code value="1A71"/>
<display value="Gonococcal ovarian abscess"/>
</concept>
<concept>
<code value="1A12"/>
<display value="pigbel"/>
</concept>
<concept>
<code value="2B50"/>
<display value="Chondrosarcoma, primary site"/>
</concept>
<concept>
<code value="2A32"/>
<display value="Refractory thrombocytopenia"/>
</concept>
<concept>
<code value="2A31"/>
<display value="Refractory neutropaenia"/>
</concept>
<concept>
<code value="2B52"/>
<display value="Ewing sarcoma, primary site"/>
</concept>
<concept>
<code value="1A70.0"/>
<display
value="Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess"/>
</concept>
<concept>
<code value="2A21"/>
<display value="Mastocytosis"/>
</concept>
<concept>
<code value="1A70.1"/>
<display value="Gonococcal abscess of penis"/>
</concept>
<concept>
<code value="1A02"/>
<display value="Sepsis due to shigella with septic shock"/>
</concept>
<concept>
<code value="1A81"/>
<display
value="Non-ulcerative sexually transmitted chlamydial infection"/>
</concept>
<concept>
<code value="1A60.1"/>
<display value="Early congenital syphilis, latent"/>
</concept>
<concept>
<code value="1A8Y"/>
<display
value="Other specified sexually transmissible infections due to chlamydia"/>
</concept>
<concept>
<code value="1A01"/>
<display value="Infections due to Vibrio vulnificus"/>
</concept>
<concept>
<code value="1A80"/>
<display value="chlamydial lymphogranuloma venereum"/>
</concept>
<concept>
<code value="1B10.1"/>
<display value="tuberculous pleural effusion, not confirmed"/>
</concept>
<concept>
<code value="1A11"/>
<display value="Botulism"/>
</concept>
<concept>
<code value="1A72.1"/>
<display value="Infection of the rectum due to Neisseria gonorrhoeae"/>
</concept>
<concept>
<code value="1A72.2"/>
<display value="Infection of the anus due to Neisseria gonorrhoeae"/>
</concept>
<concept>
<code value="2A02.11"/>
<display value="paraspinous neuroblastoma"/>
</concept>
<concept>
<code value="1A70.Y"/>
<display value="Chronic gonococcal prostatitis"/>
</concept>
<concept>
<code value="2B71"/>
<display value="Malignant neoplasms of oesophagogastric junction"/>
</concept>
<concept>
<code value="1A72.0"/>
<display value="Gonococcal spondylitis"/>
</concept>
<concept>
<code value="1A61.1"/>
<display value="primary syphilis of anus"/>
</concept>
<concept>
<code value="2B72"/>
<display value="Malignant neoplasms of stomach"/>
</concept>
<concept>
<code value="2A02.12"/>
<display value="Other specified malignant neoplasms of optic nerve"/>
</concept>
<concept>
<code value="2B70"/>
<display value="Malignant neoplasms of oesophagus"/>
</concept>
<concept>
<code value="2A42.0"/>
<display value="Juvenile myelomonocytic leukaemia in complete remission"/>
</concept>
<concept>
<code value="2A20.0"/>
<display value="Chronic myelogenous leukaemia, BCR-ABL1-positive"/>
</concept>
<concept>
<code value="1A61.2"/>
<display value="primary syphilitic tonsils"/>
</concept>
<concept>
<code value="1B21.Y"/>
<display value="mycobacteriosis NOS"/>
</concept>
<concept>
<code value="2A20.1"/>
<display value="Chronic neutrophilic leukaemia"/>
</concept>
<concept>
<code value="2A20.2"/>
<display value="megakaryocytic myeloid metaplasia"/>
</concept>
<concept>
<code value="2A4Y"/>
<display
value="Other specified myelodysplastic and myeloproliferative neoplasms"/>
</concept>
<concept>
<code value="2A02.1Y"/>
<display value="Olfactory groove meningioma"/>
</concept>
<concept>
<code value="2D4Y"/>
<display value="Small cell carcinoma of unspecified site"/>
</concept>
<concept>
<code value="2A4Z"/>
<display
value="Myelodysplastic and myeloproliferative neoplasms, unspecified"/>
</concept>
<concept>
<code value="2B62.0"/>
<display value="Squamous cell carcinoma of tongue NOS"/>
</concept>
<concept>
<code value="2B51"/>
<display value="Osteosarcoma, primary site"/>
</concept>
<concept>
<code value="2D60.2"/>
<display value="spleen lymph gland metastasis"/>
</concept>
<concept>
<code value="1A60.2"/>
<display value="Late congenital syphilitic chorioretinitis"/>
</concept>
<concept>
<code value="1B12.4"/>
<display value="Tuberculosis of the musculoskeletal system"/>
</concept>
<concept>
<code value="2D81"/>
<display value="secondary malignant neoplasm of pancreas"/>
</concept>
<concept>
<code value="1B21.Z"/>
<display value="MOTT - [mycobacteria other than tubercle bacilli]"/>
</concept>
<concept>
<code value="1A61.0"/>
<display value="Urethral chancre"/>
</concept>
<concept>
<code value="1A60.0"/>
<display value="Early congenital visceral syphilis"/>
</concept>
<concept>
<code value="2A42.Z"/>
<display
value="juvenile myelomonocytic leukaemia without mention of remission"/>
</concept>
<concept>
<code value="2A42.Y"/>
<display value="Other specified juvenile myelomonocytic leukaemia"/>
</concept>
<concept>
<code value="2B61.Y"/>
<display value="Other specified malignant neoplasms of base of tongue"/>
</concept>
<concept>
<code value="1B12.1"/>
<display value="Tuberculous chorioretinitis"/>
</concept>
<concept>
<code value="1A62.1"/>
<display value="Syphilitic pulmonary aneurysm"/>
</concept>
<concept>
<code value="2B61.0"/>
<display value="Squamous cell carcinoma of the base of the tongue"/>
</concept>
<concept>
<code value="2D60.0"/>
<display value="Supraclavicular lymph gland metastasis"/>
</concept>
<concept>
<code value="2B62.1"/>
<display value="Malignant neoplasms of lingual tonsil"/>
</concept>
<concept>
<code value="1A62.2"/>
<display value="Symptomatic late syphilis of other sites"/>
</concept>
<concept>
<code value="1A62.0"/>
<display value="Neurosyphilis"/>
</concept>
<concept>
<code value="2B60.1"/>
<display value="Squamous cell carcinoma of lip"/>
</concept>
<concept>
<code value="2D60.1"/>
<display value="Pulmonary lymph gland metastasis"/>
</concept>
<concept>
<code value="2B61.Z"/>
<display
value="malignant neoplasm of anterior two-thirds of tongue, dorsal surface"/>
</concept>
<concept>
<code value="2D83"/>
<display
value="secondary malignant neoplasm of hepatopancreatic ampulla"/>
</concept>
<concept>
<code value="2B60.0"/>
<display value="Basal cell carcinoma of lip"/>
</concept>
<concept>
<code value="2B62.Y"/>
<display
value="Other specified malignant neoplasms of other or unspecified parts of tongue"/>
</concept>
<concept>
<code value="1A36.1"/>
<display value="Extraintestinal infections due to Entamoeba"/>
</concept>
<concept>
<code value="2D80.0"/>
<display value="hepatic metastases"/>
</concept>
<concept>
<code value="2D80.1"/>
<display value="intrahepatic gall ductal metastasis"/>
</concept>
<concept>
<code value="2B60.Y"/>
<display value="Other specified malignant neoplasms of lip"/>
</concept>
<concept>
<code value="1B11.Z"/>
<display value="CNS - [central nervous system] TB - [tuberculosis]"/>
</concept>
<concept>
<code value="1B12.3"/>
<display value="Tuberculosis of pituitary gland"/>
</concept>
<concept>
<code value="2E00"/>
<display value="renal pelvis metastasis"/>
</concept>
<concept>
<code value="2E02"/>
<display value="ureteral metastasis"/>
</concept>
<concept>
<code value="1A36.00"/>
<display value="Acute nondysenteric amebic enteritis"/>
</concept>
<concept>
<code value="2E01"/>
<display value="urinary bladder metastasis"/>
</concept>
<concept>
<code value="1A36.01"/>
<display value="Amoeboma of large intestine"/>
</concept>
<concept>
<code value="1A36.0Y"/>
<display value="nondysenteric amebic diarrhoea"/>
</concept>
<concept>
<code value="3A00-3A03.Y"/>
<display value="Nutritional or metabolic anaemias"/>
</concept>
<concept>
<code value="3A10-3A4Z"/>
<display value="Haemolytic anaemias"/>
</concept>
<concept>
<code value="3A50"/>
<display value="Thalassaemias"/>
</concept>
<concept>
<code value="2A33"/>
<display value="Refractory anaemia with hemochromatosis"/>
</concept>
<concept>
<code value="1A13"/>
<display value="Foodborne intoxication due to Bacillus cereus"/>
</concept>
<concept>
<code value="3B81"/>
<display value="Acquired disorders of spleen"/>
</concept>
<concept>
<code value="3B8Z"/>
<display value="splenopathy"/>
</concept>
<concept>
<code value="3B80"/>
<display value="Congenital disorders of spleen"/>
</concept>
<concept>
<code value="2A21.0"/>
<display value="Systemic mastocytosis"/>
</concept>
<concept>
<code value="1A1Y"/>
<display value="Foodborne Vibrio parahaemolyticus intoxication"/>
</concept>
<concept>
<code value="2A21.1"/>
<display value="Cutaneous mastocytosis"/>
</concept>
<concept>
<code value="1A60.3"/>
<display value="Late congenital syphilitic polyneuropathy"/>
</concept>
<concept>
<code value="2A21.2"/>
<display value="Mast cell sarcoma"/>
</concept>
<concept>
<code value="1A70.Z"/>
<display value="Gonococcal genitourinary infection"/>
</concept>
<concept>
<code value="1A03"/>
<display value="Intestinal infections due to Escherichia coli"/>
</concept>
<concept>
<code value="1A04"/>
<display value="megacolon due to Clostridium difficile"/>
</concept>
<concept>
<code value="2A34"/>
<display
value="refractory anaemia with sideroblasts with transformation"/>
</concept>
<concept>
<code value="1A8Z"/>
<display
value="Sexually transmissible infections due to chlamydia, unspecified"/>
</concept>
<concept>
<code value="2B52.1"/>
<display value="Ewing sarcoma of bone or articular cartilage of pelvis"/>
</concept>
<concept>
<code value="2A35"/>
<display
value="RAEB 2 - [Refractory anaemia with excess of blasts type 2]"/>
</concept>
<concept>
<code value="2B52.0"/>
<display value="Ewing sarcoma of bone or articular cartilage of limbs"/>
</concept>
<concept>
<code value="2B52.2"/>
<display value="Ewing sarcoma of bone or articular cartilage of ribs"/>
</concept>
<concept>
<code value="1A05"/>
<display value="Colitis due to Yersinia enterocolitica"/>
</concept>
<concept>
<code value="1A72.3"/>
<display value="Acute gonococcal pharyngitis"/>
</concept>
<concept>
<code value="1A72.4"/>
<display value="Keratitis blennorrhagica"/>
</concept>
<concept>
<code value="1A11.1"/>
<display value="Toxin-mediated infectious botulism"/>
</concept>
<concept>
<code value="2A02.1Z"/>
<display value="Primary malignant neoplasm of vagus nerve"/>
</concept>
<concept>
<code value="1A11.Z"/>
<display value="Disorders of the neuromuscular junction in botulism"/>
</concept>
<concept>
<code value="1A11.0"/>
<display value="Foodborne Clostridium botulinum toxin intoxication"/>
</concept>
<concept>
<code value="1A61.3"/>
<display value="Syphilitic alopecia"/>
</concept>
<concept>
<code value="1B1Z"/>
<display value="Tuberculosis attributable to Mycobacterium tuberculosis"/>
</concept>
<concept>
<code value="1A61.4"/>
<display value="Secondary syphilitic lymphadenitis"/>
</concept>
<concept>
<code value="2A20.3"/>
<display
value="Chronic eosinophilic leukaemia, not elsewhere classified"/>
</concept>
<concept>
<code value="2B51.0"/>
<display
value="Osseous sarcomas of bone and articular cartilage of mandible"/>
</concept>
<concept>
<code value="2B51.2"/>
<display
value="Osseous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx"/>
</concept>
<concept>
<code value="2B62.Z"/>
<display value="primary malignant neoplasm of tongue"/>
</concept>
<concept>
<code value="2B51.1"/>
<display value="Osteosarcoma of bone or articular cartilage of limbs"/>
</concept>
<concept>
<code value="1B12.4Y"/>
<display
value="Tuberculosis of other specified part of the musculoskeletal system"/>
</concept>
<concept>
<code value="1A60.4"/>
<display value="Congenital syphilitic stigmata"/>
</concept>
<concept>
<code value="1B12.41"/>
<display value="Tuberculosis of skeletal muscle"/>
</concept>
<concept>
<code value="2D60.3"/>
<display
value="Malignant neoplasm metastasis in axillary or arm lymph nodes by other or unspecified epithelial neoplasm"/>
</concept>
<concept>
<code value="1A61.5"/>
<display
value="latent syphilis, positive serology, early or less than 2 years after infection"/>
</concept>
<concept>
<code value="2D85"/>
<display value="ileocecum metastasis"/>
</concept>
<concept>
<code value="1A60.5"/>
<display value="Late congenital syphilis, latent"/>
</concept>
<concept>
<code value="2A50"/>
<display
value="Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement"/>
</concept>
<concept>
<code value="2A52"/>
<display value="Myeloid or lymphoid neoplasms with FGFR1 abnormalities"/>
</concept>
<concept>
<code value="1B12.40"/>
<display value="Tuberculous rheumatism"/>
</concept>
<concept>
<code value="2A5Z"/>
<display
value="Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified"/>
</concept>
<concept>
<code value="2D60.4"/>
<display
value="Malignant neoplasm metastasis in inguinal or leg lymph nodes by other or unspecified epithelial neoplasm"/>
</concept>
<concept>
<code value="2B62.10"/>
<display value="Squamous cell carcinoma of lingual tonsil"/>
</concept>
<concept>
<code value="2B62.1Z"/>
<display value="primary malignant neoplasm of lingual tonsil"/>
</concept>
<concept>
<code value="1A62.20"/>
<display value="Late syphilitic chorioretinitis"/>
</concept>
<concept>
<code value="1A62.00"/>
<display value="Asymptomatic neurosyphilis"/>
</concept>
<concept>
<code value="1A62.0Z"/>
<display value="tertiary central nervous system syphilis"/>
</concept>
<concept>
<code value="1A62.22"/>
<display value="Syphilitic gumma"/>
</concept>
<concept>
<code value="2D60.5"/>
<display value="Iliac lymph gland metastasis"/>
</concept>
<concept>
<code value="1A62.01"/>
<display value="Syphilitic paraplegia"/>
</concept>
<concept>
<code value="1A62.21"/>
<display value="Syphilis, stage unspecified, of synovium"/>
</concept>
<concept>
<code value="2B60.Z"/>
<display value="malignant neoplasm of lip, unspecified"/>
</concept>
<concept>
<code value="2D8Z"/>
<display
value="Malignant neoplasm metastasis in unspecified digestive system organ"/>
</concept>
<concept>
<code value="2B63.0"/>
<display value="Squamous cell carcinoma of gum"/>
</concept>
<concept>
<code value="2D8Y"/>
<display value="submandibular glandular metastasis"/>
</concept>
<concept>
<code value="2B63.Y"/>
<display value="Malignant neoplasm of alveolar ridge mucosa"/>
</concept>
<concept>
<code value="2B63.Z"/>
<display value="primary malignant neoplasm of gum"/>
</concept>
<concept>
<code value="1A36.10"/>
<display value="amoebic hepatitis"/>
</concept>
<concept>
<code value="1A36.11"/>
<display value="Amoebic abscess of lung and liver"/>
</concept>
<concept>
<code value="1A36.12"/>
<display value="Amoebic ulcer of skin"/>
</concept>
<concept>
<code value="3B50-3B51"/>
<display value="Fibrinolytic defects"/>
</concept>
<concept>
<code value="3B10-3B4Z"/>
<display value="Coagulation defects"/>
</concept>
<concept>
<code value="3B60"/>
<display value="Non-thrombocytopenic purpura"/>
</concept>
<concept>
<code value="2E04"/>
<display
value="Malignant neoplasm metastasis in soft tissue of abdominal wall"/>
</concept>
<concept>
<code value="2E03"/>
<display value="Metastatic fracture of unspecified site"/>
</concept>
<concept>
<code value="1A36.0Z"/>
<display value="Intestinal infections due to Entamoeba"/>
</concept>
<concept>
<code value="2E05"/>
<display
value="Malignant neoplasm metastasis in female reproductive system"/>
</concept>
<concept>
<code value="2B50.0"/>
<display value="Chondrosarcoma of bone or articular cartilage of limbs"/>
</concept>
<concept>
<code value="2B50.1"/>
<display
value="Chondromatous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx"/>
</concept>
<concept>
<code value="2B50.2"/>
<display
value="Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle"/>
</concept>
<concept>
<code value="1A70.00"/>
<display value="Gonococcal lymphangitis of penis"/>
</concept>
<concept>
<code value="1A70.0Z"/>
<display value="gonorrhoeal condyloma"/>
</concept>
<concept>
<code value="3A00"/>
<display value="Iron deficiency anaemia"/>
</concept>
<concept>
<code value="1A70.0Y"/>
<display value="Gonococcal vulvovaginitis"/>
</concept>
<concept>
<code value="3A02"/>
<display value="Folate deficiency anaemia"/>
</concept>
<concept>
<code value="3A01"/>
<display value="Megaloblastic anaemia due to vitamin B12 deficiency"/>
</concept>
<concept>
<code value="3A10-3A1Y"/>
<display value="Congenital haemolytic anaemia"/>
</concept>
<concept>
<code value="3A20-3A2Z"/>
<display value="Acquired haemolytic anaemia"/>
</concept>
<concept>
<code value="3A4Z"/>
<display value="Haemolytic anaemias, unspecified"/>
</concept>
<concept>
<code value="2B71.0"/>
<display value="Adenocarcinoma of oesophagogastric junction"/>
</concept>
<concept>
<code value="2B71.Z"/>
<display value="primary malignant neoplasm of cardia of stomach"/>
</concept>
<concept>
<code value="3A50.1"/>
<display
value="Alpha-thalassaemia intellectual disability syndrome linked to chromosome 16"/>
</concept>
<concept>
<code value="3A50.0"/>
<display value="Alpha thalassaemia"/>
</concept>
<concept>
<code value="3A50.2"/>
<display value="Beta-thalassemia-X-linked thrombocytopenia syndrome"/>
</concept>
<concept>
<code value="2B70.1"/>
<display
value="Squamous cell carcinomas of overlapping lesion of oesophagus"/>
</concept>
<concept>
<code value="2B70.0"/>
<display value="Adenocarcinoma of oesophagus"/>
</concept>
<concept>
<code value="1A1Z"/>
<display value="food infection"/>
</concept>
<concept>
<code value="2B71.Y"/>
<display
value="Other specified malignant neoplasm of oesophagogastric junction"/>
</concept>
<concept>
<code value="2A36"/>
<display value="5 q- syndrome"/>
</concept>
<concept>
<code value="2B72.Y"/>
<display
value="metastatic gastric carcinoma [primary gastric carcinoma spreading elsewhere]"/>
</concept>
<concept>
<code value="2B72.0"/>
<display value="Adenocarcinoma involving overlapping sites of stomach"/>
</concept>
<concept>
<code value="2B72.1"/>
<display value="Gastrointestinal APUDomas"/>
</concept>
<concept>
<code value="2B70.Y"/>
<display
value="Metastatic oesophageal carcinoma [primary oesophageal carcinoma spreading elsewhere]"/>
</concept>
<concept>
<code value="3B81.1"/>
<display value="acquired absence of spleen"/>
</concept>
<concept>
<code value="3B81.0"/>
<display value="SANT - [Sclerosing angiomatoid nodular transformation]"/>
</concept>
<concept>
<code value="3B81.2"/>
<display value="Degenerative diseases of the spleen"/>
</concept>
<concept>
<code value="2A20.4"/>
<display value="primary polycythaemia"/>
</concept>
<concept>
<code value="2A21.00"/>
<display value="Mast cell leukaemia in complete remission"/>
</concept>
<concept>
<code value="2A21.0Y"/>
<display value="Lymphoadenopathic mastocytosis with eosinophilia"/>
</concept>
<concept>
<code value="2A21.3"/>
<display value="Extracutaneous mastocytoma"/>
</concept>
<concept>
<code value="2A21.0Z"/>
<display value="systemic tissue mast cell disease"/>
</concept>
<concept>
<code value="2A21.10"/>
<display value="Maculopapular cutaneous mastocytosis"/>
</concept>
<concept>
<code value="2A21.1Z"/>
<display value="Cutaneous mastocytosis"/>
</concept>
<concept>
<code value="3B80.0"/>
<display value="Splenomegaly in storage diseases"/>
</concept>
<concept>
<code value="2A21.1Y"/>
<display value="Pseudoxanthomatous nodular cutaneous mastocytosis"/>
</concept>
<concept>
<code value="1A60.Z"/>
<display value="Late congenital syphilis"/>
</concept>
<concept>
<code value="1A03.0"/>
<display value="Colitis in enteropathogenic Escherichia coli infection"/>
</concept>
<concept>
<code value="2A37"/>
<display value="Myelodysplastic syndrome, unclassifiable"/>
</concept>
<concept>
<code value="1A03.1"/>
<display value="Colitis in enterotoxigenic Escherichia coli infection"/>
</concept>
<concept>
<code value="1A03.2"/>
<display value="Colitis in enteroinvasive Escherichia coli infection"/>
</concept>
<concept>
<code value="2B52.3"/>
<display
value="Malignant peripheral neuroectodermal tumour of cervix uteri"/>
</concept>
<concept>
<code value="2B52.Y"/>
<display value="Extraosseous Ewing sarcoma"/>
</concept>
<concept>
<code value="2B52.Z"/>
<display
value="Ewing's sarcoma/peripheral neuroectodermal tumour [PNET]"/>
</concept>
<concept>
<code value="2A38"/>
<display value="Refractory cytopenia of childhood"/>
</concept>
<concept>
<code value="1A72.Y"/>
<display value="Gonococcal skin lesions"/>
</concept>
<concept>
<code value="2E65.1"/>
<display
value="Lobular carcinoma in situ of breast, pleomorphic subtype"/>
</concept>
<concept>
<code value="1A61.Y"/>
<display value="Other specified early syphilis"/>
</concept>
<concept>
<code value="2E65.0"/>
<display value="Lobular carcinoma in situ of right breast"/>
</concept>
<concept>
<code value="2E65.2"/>
<display value="Intraductal carcinoma in situ of left breast"/>
</concept>
<concept>
<code value="2E66.Y"/>
<display
value="Squamous cell carcinoma in situ with questionable stromal invasion of unspecified site"/>
</concept>
<concept>
<code value="2E66.Z"/>
<display value="Carcinoma in situ of other parts of cervix"/>
</concept>
<concept>
<code value="2E67"/>
<display
value="Carcinoma in situ of other or unspecified genital organs"/>
</concept>
<concept>
<code value="2E66.2"/>
<display value="cervical intraepithelial neoplasia grade II"/>
</concept>
<concept>
<code value="2A20.5"/>
<display
value="Non mast cell myeloproliferative neoplasm, unclassifiable"/>
</concept>
<concept>
<code value="1A61.Z"/>
<display value="general syphilis"/>
</concept>
<concept>
<code value="1A73"/>
<display value="Disseminated infection due to Neisseria gonorrhoeae"/>
</concept>
<concept>
<code value="2B51.Y"/>
<display value="Li-Fraumeni syndrome"/>
</concept>
<concept>
<code value="2B51.Z"/>
<display value="osteogenic sarcoma"/>
</concept>
<concept>
<code value="1B12.4Z"/>
<display value="Tuberculosis of the musculoskeletal system"/>
</concept>
<concept>
<code value="2D60.Y"/>
<display
value="Other specified malignant neoplasm metastasis in lymph node of a single region"/>
</concept>
<concept>
<code value="2A60.20"/>
<display
value="Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor"/>
</concept>
<concept>
<code value="2A60.2Z"/>
<display value="therapy-related myelodysplastic syndromes"/>
</concept>
<concept>
<code value="2A60.2Y"/>
<display value="Other specified therapy-related myeloid neoplasms"/>
</concept>
<concept>
<code value="2A60.31"/>
<display value="Acute myeloblastic leukaemia without maturation"/>
</concept>
<concept>
<code value="2A60.30"/>
<display value="Minimally differentiated acute myeloblastic leukaemia"/>
</concept>
<concept>
<code value="2A60.40"/>
<display value="Transient abnormal myelopoiesis"/>
</concept>
<concept>
<code value="2A60.32"/>
<display value="Acute myeloblastic leukaemia with maturation"/>
</concept>
<concept>
<code value="2A60.41"/>
<display value="Myeloid leukaemia associated with Down syndrome"/>
</concept>
<concept>
<code value="2A60.4Y"/>
<display
value="Other specified myeloid proliferation associated with Down syndrome"/>
</concept>
<concept>
<code value="2D60.Z"/>
<display
value="Malignant neoplasm metastasis in lymph node of a single region"/>
</concept>
<concept>
<code value="1B21.20"/>
<display value="Buruli ulcer"/>
</concept>
<concept>
<code value="1B21.2Z"/>
<display value="Atypical mycobacterial infection of the skin"/>
</concept>
<concept>
<code value="1B21.2Y"/>
<display value="Cutaneous Mycobacterium kansasii infection"/>
</concept>
<concept>
<code value="2B64.0"/>
<display value="Squamous cell carcinoma of floor of mouth"/>
</concept>
<concept>
<code value="2B64.Z"/>
<display value="primary malignant neoplasm of floor of mouth"/>
</concept>
<concept>
<code value="2B64.Y"/>
<display value="Other specified malignant neoplasm of floor of mouth"/>
</concept>
<concept>
<code value="1A62.2Z"/>
<display value="Symptomatic late syphilis of other sites"/>
</concept>
<concept>
<code value="1A62.2Y"/>
<display value="Late syphilitic peritonitis"/>
</concept>
<concept>
<code value="1A62.Y"/>
<display
value="Syphilis positive serology, late or 2 years or more after infection"/>
</concept>
<concept>
<code value="2B65"/>
<display value="Malignant neoplasms of palate"/>
</concept>
<concept>
<code value="2B66"/>
<display
value="Malignant neoplasms of other or unspecified parts of mouth"/>
</concept>
<concept>
<code value="1A36.1Y"/>
<display value="Amoebic vulvovaginitis"/>
</concept>
<concept>
<code value="3B50"/>
<display value="Inherited fibrinolytic defects"/>
</concept>
<concept>
<code value="3B51"/>
<display
value="Fibrinolytic disorder due to administration of other drugs"/>
</concept>
<concept>
<code value="3B10-3B1Z"/>
<display value="Congenital or constitutional haemorrhagic condition"/>
</concept>
<concept>
<code value="3B20-3B2Y"/>
<display
value="Haemorrhagic diseases due to acquired coagulation factor defects"/>
</concept>
<concept>
<code value="3B4Z"/>
<display value="coagulopathy NOS"/>
</concept>
<concept>
<code value="2E06"/>
<display value="Malignant neoplasm metastasis in penis"/>
</concept>
<concept>
<code value="2E05.Z"/>
<display
value="Malignant neoplasm metastasis in female reproductive system"/>
</concept>
<concept>
<code value="2E05.0"/>
<display value="Secondary mucinous adenocarcinoma of ovary"/>
</concept>
<concept>
<code value="2E05.Y"/>
<display value="vaginovesical septum metastasis"/>
</concept>
<concept>
<code value="2E07"/>
<display value="suprarenal gland metastasis"/>
</concept>
<concept>
<code value="1B12.7"/>
<display value="Tuberculous ascites"/>
</concept>
<concept>
<code value="2B50.Z"/>
<display value="chondrosarcoma NOS"/>
</concept>
<concept>
<code value="2B50.Y"/>
<display
value="Chondromatous sarcomas of bone and articular cartilage of vertebral column"/>
</concept>
<concept>
<code value="3A00.0"/>
<display value="Acquired iron deficiency anaemia due to blood loss"/>
</concept>
<concept>
<code value="3A00.1"/>
<display value="Iron deficiency anaemia due to malnutrition"/>
</concept>
<concept>
<code value="3A00.2"/>
<display value="Acquired iron deficiency anaemia due to coeliac disease"/>
</concept>
<concept>
<code value="1A06"/>
<display value="Colitis due to Campylobacter"/>
</concept>
<concept>
<code value="3A02.0"/>
<display value="Hereditary folate deficiency anaemia"/>
</concept>
<concept>
<code value="3A02.2"/>
<display
value="Acquired megaloblastic anaemia associated with psoriasis"/>
</concept>
<concept>
<code value="3A02.1"/>
<display value="megaloblastic anaemia due to poor nutrition"/>
</concept>
<concept>
<code value="3A01.1"/>
<display
value="Nutritional vitamin B12 deficiency due to maternal vitamin B12 deficiency in breast-fed infants"/>
</concept>
<concept>
<code value="3A01.0"/>
<display
value="Anaemia due to selective hereditary vitamin B12 malabsorption with proteinuria"/>
</concept>
<concept>
<code value="3A01.2"/>
<display value="vegan anaemia NOS"/>
</concept>
<concept>
<code value="3A1Y"/>
<display value="congenital heinz body haemolytic anaemia"/>
</concept>
<concept>
<code value="3A10"/>
<display value="Hereditary haemolytic anaemia"/>
</concept>
<concept>
<code value="3A20"/>
<display value="Acquired haemolytic anaemia, immune"/>
</concept>
<concept>
<code value="3A21"/>
<display value="Acquired haemolytic anaemia, non-immune"/>
</concept>
<concept>
<code value="3A2Z"/>
<display value="haemoglobinaemia"/>
</concept>
<concept>
<code value="3A50.3"/>
<display value="Haemoglobin Lepore"/>
</concept>
<concept>
<code value="2B70.Z"/>
<display
value="Metastatic oesophageal cancer [primary oesophageal cancer spreading elsewhere]"/>
</concept>
<concept>
<code value="2B70.00"/>
<display value="Barrett adenocarcinoma"/>
</concept>
<concept>
<code value="2B70.0Z"/>
<display value="oesophageal adenocarcinoma"/>
</concept>
<concept>
<code value="2B70.0Y"/>
<display
value="Adenocarcinoma involving overlapping sites of oesophagus"/>
</concept>
<concept>
<code value="2B80-2C0Z"/>
<display value="Malignant neoplasms of intestine"/>
</concept>
<concept>
<code value="2A3Y"/>
<display value="Refractory anaemia with excess blasts in childhood"/>
</concept>
<concept>
<code value="2B72.Z"/>
<display value="cancer of pylorus of stomach"/>
</concept>
<concept>
<code value="3B81.5"/>
<display value="Splenic cyst or pseudocyst"/>
</concept>
<concept>
<code value="3B81.3"/>
<display value="Nontraumatic laceration or rupture of spleen"/>
</concept>
<concept>
<code value="3B81.4"/>
<display value="Splenosis"/>
</concept>
<concept>
<code value="2A20.Y"/>
<display
value="Other specified non mast cell myeloproliferative neoplasms"/>
</concept>
<concept>
<code value="2A21.Y"/>
<display value="Other specified mastocytosis"/>
</concept>
<concept>
<code value="2A21.Z"/>
<display value="malignant mastocytosis"/>
</concept>
<concept>
<code value="1A03.3"/>
<display
value="Colitis in enterohaemorrhagic Escherichia coli infection"/>
</concept>
<concept>
<code value="2A3Z"/>
<display value="preleukaemic syndrome"/>
</concept>
<concept>
<code value="1A03.Y"/>
<display value="EAEC - [Enteroaggregative Escherichia coli] infection"/>
</concept>
<concept>
<code value="1A03.Z"/>
<display value="Escherichia coli enteritis, not otherwise specified"/>
</concept>
<concept>
<code value="2B53"/>
<display value="Fibroblastic or myofibroblastic tumour, primary site"/>
</concept>
<concept>
<code value="2E65.3"/>
<display value="Ductal carcinoma in situ of breast, comedo subtype"/>
</concept>
<concept>
<code value="2E65.4"/>
<display value="lobular with intraductal carcinoma in situ"/>
</concept>
<concept>
<code value="2A20.02"/>
<display value="Chronic myelogenous leukaemia, t(9:22)(q34; q11)"/>
</concept>
<concept>
<code value="2A20.01"/>
<display
value="Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive"/>
</concept>
<concept>
<code value="2A20.00"/>
<display value="Chronic myelogenous leukaemia with blast crisis"/>
</concept>
<concept>
<code value="2A20.Z"/>
<display value="Non mast cell myeloproliferative neoplasms"/>
</concept>
<concept>
<code value="2E68"/>
<display value="carcinoma in situ of urinary bladder"/>
</concept>
<concept>
<code value="2B54"/>
<display value="Undifferentiated pleomorphic sarcoma, primary site"/>
</concept>
<concept>
<code value="1B12.Y"/>
<display
value="Tuberculosis of adenoids, with bacteriological and histological confirmation"/>
</concept>
<concept>
<code value="2A60.5"/>
<display value="agranular CD4+ NK leukaemia"/>
</concept>
<concept>
<code value="2A60.33"/>
<display value="Acute myelomonocytic leukaemia in complete remission"/>
</concept>
<concept>
<code value="2A60.4Z"/>
<display value="Myeloid proliferation associated with Down syndrome"/>
</concept>
<concept>
<code value="2A60.34"/>
<display value="AML M5b"/>
</concept>
<concept>
<code value="2A60.35"/>
<display value="Acute erythroid leukaemia in complete remission"/>
</concept>
<concept>
<code value="2E2Z"/>
<display value="Secondary carcinoma of unspecified site"/>
</concept>
<concept>
<code value="2B67"/>
<display value="Malignant neoplasms of parotid gland"/>
</concept>
<concept>
<code value="1A62.Z"/>
<display value="late tertiary syphilis"/>
</concept>
<concept>
<code value="1A07"/>
<display value="Typhoid fever"/>
</concept>
<concept>
<code value="3B10"/>
<display value="Hereditary factor VIII deficiency"/>
</concept>
<concept>
<code value="3B50.0"/>
<display value="Congenital alpha2 antiplasmin deficiency"/>
</concept>
<concept>
<code value="3B11"/>
<display value="Hereditary factor IX deficiency"/>
</concept>
<concept>
<code value="3B50.Y"/>
<display
value="Excessive release of tPA - [tissue-type plasminogen activator]"/>
</concept>
<concept>
<code value="3B50.1"/>
<display
value="Congenital PAI-1 - [plasminogen activator inhibitor type 1] deficiency"/>
</concept>
<concept>
<code value="3B12"/>
<display value="Von Willebrand disease type 3"/>
</concept>
<concept>
<code value="2E08"/>
<display
value="Malignant metastasis neoplasm involving skin of abdominal wall"/>
</concept>
<concept>
<code value="3A50.02"/>
<display value="Alpha thalassaemia intermedia"/>
</concept>
<concept>
<code value="3A50.00"/>
<display
value="Heterozygous non-deletional alpha thalassaemia (αTα/αα and ααT/αα included)"/>
</concept>
<concept>
<code value="3A50.01"/>
<display value="Haemoglobin Constant Spring"/>
</concept>
<concept>
<code value="2E09"/>
<display
value="Malignant neoplasm metastasis in peripheral nervous system"/>
</concept>
<concept>
<code value="2E0Y"/>
<display value="orbit metastasis"/>
</concept>
<concept>
<code value="2B55"/>
<display value="Rhabdomyosarcoma, primary site"/>
</concept>
<concept>
<code value="3A00.3"/>
<display
value="Acquired iron deficiency anaemia due to increased requirement in pregnancy"/>
</concept>
<concept>
<code value="3A00.Y"/>
<display value="microcytic anaemia NOS"/>
</concept>
<concept>
<code value="3A02.3"/>
<display
value="Megaloblastic anaemia due to decreased intestinal absorption of folate"/>
</concept>
<concept>
<code value="3A02.4"/>
<display
value="megaloblastic anaemia due to drug-induced folate deficiency"/>
</concept>
<concept>
<code value="1A08"/>
<display value="Colitis due to paratyphoid fever C"/>
</concept>
<concept>
<code value="3A01.3"/>
<display
value="Vitamin B12 deficiency anaemia due to intrinsic factor deficiency"/>
</concept>
<concept>
<code value="3A02.Y"/>
<display value="Tropical macrocytic anaemia"/>
</concept>
<concept>
<code value="3A20.2"/>
<display
value="Autoimmune haemolytic anaemia, mixed type, cold and warm"/>
</concept>
<concept>
<code value="3A01.4"/>
<display
value="Acquired megaloblastic anaemia due to vitamin B12 deficiency secondary to intestinal disease"/>
</concept>
<concept>
<code value="3A20.0"/>
<display value="acute Lederer haemolytic anaemia"/>
</concept>
<concept>
<code value="3A10.1"/>
<display value="Haemolytic anaemia due to adenosine deaminase excess"/>
</concept>
<concept>
<code value="3A20.1"/>
<display value="cold hemagglutinin disease"/>
</concept>
<concept>
<code value="3A10.0"/>
<display
value="Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies"/>
</concept>
<concept>
<code value="3A21.2"/>
<display value="Glomerular disorders in haemolytic uraemic syndrome"/>
</concept>
<concept>
<code value="3A10.2"/>
<display value="Hereditary pyropoikilocytosis"/>
</concept>
<concept>
<code value="3A21.1"/>
<display value="Neoplastic microangiopathic haemolytic anaemia"/>
</concept>
<concept>
<code value="3A21.0"/>
<display value="nocturnal paroxysmal haemoglobinaemia"/>
</concept>
<concept>
<code value="3A50.4"/>
<display
value="Hereditary persistence of fetal haemoglobin, non-deletional"/>
</concept>
<concept>
<code value="2E65.5"/>
<display value="Paget disease of nipple"/>
</concept>
<concept>
<code value="2E67.0"/>
<display value="endometrial carcinoma in situ"/>
</concept>
<concept>
<code value="2E67.1"/>
<display value="vulvar carcinoma in situ"/>
</concept>
<concept>
<code value="2E67.2"/>
<display value="Carcinoma in situ of vagina"/>
</concept>
<concept>
<code value="2C10"/>
<display value="Malignant neoplasm of pancreas"/>
</concept>
<concept>
<code value="3B81.51"/>
<display value="Epithelial cyst of spleen"/>
</concept>
<concept>
<code value="3B81.5Y"/>
<display value="Other specified splenic cyst"/>
</concept>
<concept>
<code value="3B81.50"/>
<display value="Pseudocyst of spleen"/>
</concept>
<concept>
<code value="3B81.7"/>
<display value="Infection of spleen"/>
</concept>
<concept>
<code value="3B81.6"/>
<display value="Subcapsular splenic haemorrhage"/>
</concept>
<concept>
<code value="2B65.0"/>
<display value="Salivary gland-type carcinoma of palate"/>
</concept>
<concept>
<code value="2B65.1"/>
<display value="Squamous cell carcinoma of palate"/>
</concept>
<concept>
<code value="2B65.Y"/>
<display value="Carcinoma of palate"/>
</concept>
<concept>
<code value="2A61"/>
<display
value="Mixed phenotype acute leukaemias, T and myeloid, not elsewhere classified"/>
</concept>
<concept>
<code value="1A09"/>
<display value="Infections due to other Salmonella"/>
</concept>
<concept>
<code value="2B66.0"/>
<display
value="Squamous cell carcinoma of other or unspecified parts of mouth"/>
</concept>
<concept>
<code value="2B53.0"/>
<display value="fibromyxosarcoma of unspecified site"/>
</concept>
<concept>
<code value="2B53.1"/>
<display value="Fibroblastic or myofibroblastic tumour of skin"/>
</concept>
<concept>
<code value="2B53.Y"/>
<display value="pigmented dermatofibrosarcoma"/>
</concept>
<concept>
<code value="2B66.Y"/>
<display
value="Other specified malignant neoplasms of other or unspecified parts of mouth"/>
</concept>
<concept>
<code value="2B66.Z"/>
<display value="primary malignant neoplasm of oral cavity"/>
</concept>
<concept>
<code value="3B21"/>
<display
value="Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors"/>
</concept>
<concept>
<code value="3B22"/>
<display value="Acquired factor XIII deficiency"/>
</concept>
<concept>
<code value="3B20"/>
<display value="acquired fibrinogenopenia"/>
</concept>
<concept>
<code value="2E65.Y"/>
<display value="Solid papillary carcinoma in situ of breast"/>
</concept>
<concept>
<code value="2E65.Z"/>
<display value="Breast cancer in situ"/>
</concept>
<concept>
<code value="2A20.03"/>
<display value="Naegeli-type monocytic leukaemia"/>
</concept>
<concept>
<code value="2A20.0Y"/>
<display
value="chronic myeloid leukaemia, BCR-ABL-positive in complete remission"/>
</concept>
<concept>
<code value="2A20.0Z"/>
<display
value="chronic myeloid leukaemia, BCR-ABL-positive without mention of remission"/>
</concept>
<concept>
<code value="2E69"/>
<display
value="Carcinoma in situ of other or unspecified urinary organs"/>
</concept>
<concept>
<code value="2B54.0"/>
<display value="malignant fibrous histiocytoma of unspecified site"/>
</concept>
<concept>
<code value="2B54.Y"/>
<display
value="Undifferentiated pleomorphic sarcoma, other specified primary site"/>
</concept>
<concept>
<code value="2B54.1"/>
<display
value="Undifferentiated pleomorphic sarcoma of retroperitoneum or peritoneum"/>
</concept>
<concept>
<code value="1A81.Y"/>
<display value="Chlamydial colitis"/>
</concept>
<concept>
<code value="1A81.1"/>
<display value="Male chlamydial pelviperitonitis"/>
</concept>
<concept>
<code value="2A60.Y"/>
<display
value="Other specified acute myeloid leukaemias and related precursor neoplasms"/>
</concept>
<concept>
<code value="1A81.0"/>
<display value="Chlamydial cervicitis"/>
</concept>
<concept>
<code value="2A60.Z"/>
<display
value="Acute myeloid leukaemias and related precursor neoplasms"/>
</concept>
<concept>
<code value="2A60.36"/>
<display value="Acute megakaryoblastic leukaemia in complete remission"/>
</concept>
<concept>
<code value="2A60.37"/>
<display value="Acute basophilic leukaemia"/>
</concept>
<concept>
<code value="1B41.1"/>
<display value="Acute rheumatic endocarditis"/>
</concept>
<concept>
<code value="1B41.0"/>
<display value="acute rheumatic bacterial pericardium inflammation"/>
</concept>
<concept>
<code value="2A60.38"/>
<display value="Acute myelofibrosis in complete remission"/>
</concept>
<concept>
<code value="1B41.2"/>
<display value="acute rheumatic toxic myocarditis"/>
</concept>
<concept>
<code value="1A07.Z"/>
<display value="enteric fever NOS"/>
</concept>
<concept>
<code value="1A07.0"/>
<display value="typhoperitonitis"/>
</concept>
<concept>
<code value="1A07.Y"/>
<display value="Typhoid colitis"/>
</concept>
<concept>
<code value="3A00.01"/>
<display value="chronic haemorrhagic anaemia"/>
</concept>
<concept>
<code value="3A00.0Z"/>
<display value="haemorrhagic anaemia"/>
</concept>
<concept>
<code value="3B10.Y"/>
<display value="Other specified hereditary factor VIII deficiency"/>
</concept>
<concept>
<code value="3B10.1"/>
<display
value="Hereditary factor VIII deficiency with anti-factor VIII inhibitor"/>
</concept>
<concept>
<code value="3B10.0"/>
<display value="Symptomatic form of haemophilia A in female carriers"/>
</concept>
<concept>
<code value="3B50.Z"/>
<display value="Inherited fibrinolytic defects"/>
</concept>
<concept>
<code value="3B11.Y"/>
<display value="Other specified hereditary factor IX deficiency"/>
</concept>
<concept>
<code value="3B11.Z"/>
<display value="intravascular clotting defect"/>
</concept>
<concept>
<code value="3B11.0"/>
<display value="Symptomatic form of haemophilia B in female carriers"/>
</concept>
<concept>
<code value="3A50.03"/>
<display value="Haemoglobin Bart hydrops fetalis"/>
</concept>
<concept>
<code value="3A50.0Y"/>
<display value="Alpha thalassaemia myelodysplastic syndrome"/>
</concept>
<concept>
<code value="3A50.0Z"/>
<display value="alpha thalassaemia syndrome"/>
</concept>
<concept>
<code value="2B80"/>
<display value="Malignant neoplasms of small intestine"/>
</concept>
<concept>
<code value="2B81"/>
<display value="Malignant neoplasms of appendix"/>
</concept>
<concept>
<code value="2B90-2B9Y"/>
<display value="Malignant neoplasms of large intestine"/>
</concept>
<concept>
<code value="1A94"/>
<display value="Anogenital herpes simplex infection"/>
</concept>
<concept>
<code value="2B55.2"/>
<display value="Rhabdomyosarcoma of male genital organs"/>
</concept>
<concept>
<code value="2B55.0"/>
<display value="Rhabdomyosarcoma of the oral cavity or pharynx"/>
</concept>
<concept>
<code value="2B55.1"/>
<display value="Alveolar rhabdomyosarcoma"/>
</concept>
<concept>
<code value="3A00.Z"/>
<display value="Fe - [iron] deficiency anemia NOS"/>
</concept>
<concept>
<code value="3A02.Z"/>
<display value="Folic acid deficiency anaemia NOS"/>
</concept>
<concept>
<code value="3A01.5"/>
<display
value="Megaloblastic anaemia due to drug-induced vitamin B12 deficiency"/>
</concept>
<concept>
<code value="3A20.3"/>
<display value="Donath-Landsteiner syndrome"/>
</concept>
<concept>
<code value="3A10.3"/>
<display value="Familial pseudohyperkalaemia, Cardiff type"/>
</concept>
<concept>
<code value="1A0Y"/>
<display value="Neonatal bacterial intestinal infection"/>
</concept>
<concept>
<code value="3A10.0Z"/>
<display
value="anaemia due to other disorders of glutathione metabolism"/>
</concept>
<concept>
<code value="3A10.00"/>
<display
value="anaemia due to haemolytic nonspherocytic (hereditary), type 1"/>
</concept>
<concept>
<code value="3A10.0Y"/>
<display
value="anaemia due to 6-phosphogluconate dehydrogenase deficiency"/>
</concept>
<concept>
<code value="3A21.Y"/>
<display
value="Atypical haemolytic uraemic syndrome with anti-factor H antibodies"/>
</concept>
<concept>
<code value="3A50.Y"/>
<display value="Thalassaemia minor"/>
</concept>
<concept>
<code value="2E67.3"/>
<display
value="Carcinoma in situ of other or unspecified female genital organs"/>
</concept>
<concept>
<code value="2E67.2Z"/>
<display value="Squamous cell carcinoma in situ of vagina"/>
</concept>
<concept>
<code value="2E67.22"/>
<display value="severe vaginal dysplasia, NEC"/>
</concept>
<concept>
<code value="2E67.2Y"/>
<display value="Other specified carcinoma in situ of vagina"/>
</concept>
<concept>
<code value="3B81.5Z"/>
<display value="Splenic cyst or pseudocyst"/>
</concept>
<concept>
<code value="2C11"/>
<display
value="Malignant neoplasms of other or ill-defined digestive organs"/>
</concept>
<concept>
<code value="3B81.71"/>
<display value="splenic abscess"/>
</concept>
<concept>
<code value="3B81.7Y"/>
<display value="Other specified infection of spleen"/>
</concept>
<concept>
<code value="3B81.70"/>
<display value="septic spleen"/>
</concept>
<concept>
<code value="2B67.1"/>
<display value="Squamous cell carcinoma of parotid gland"/>
</concept>
<concept>
<code value="2B67.0"/>
<display value="Acinar cell carcinoma of parotid gland"/>
</concept>
<concept>
<code value="2B67.Y"/>
<display value="Other specified malignant neoplasms of parotid gland"/>
</concept>
<concept>
<code value="2B65.Z"/>
<display value="malignant neoplasm of upper or lower labial sulcus"/>
</concept>
<concept>
<code value="1A09.Y"/>
<display value="Pneumonia due to salmonella infection"/>
</concept>
<concept>
<code value="1A09.Z"/>
<display value="Sepsis due to Salmonella infection with septic shock"/>
</concept>
<concept>
<code value="2A70-2A7Z"/>
<display value="Precursor lymphoid neoplasms"/>
</concept>
<concept>
<code value="1A09.0"/>
<display value="salmonellosis"/>
</concept>
<concept>
<code value="2B53.Z"/>
<display value="Fibroblastic or myofibroblastic tumour, primary site"/>
</concept>
<concept>
<code value="2B68"/>
<display
value="Malignant neoplasms of submandibular or sublingual glands"/>
</concept>
<concept>
<code value="3A01.Y"/>
<display value="Addison anaemia"/>
</concept>
<concept>
<code value="3B2Y"/>
<display value="Acquired stable factor deficiency"/>
</concept>
<concept>
<code value="2E6A"/>
<display value="Carcinoma in situ of the eye or ocular adnexa"/>
</concept>
<concept>
<code value="2A80-2A8Z"/>
<display value="Mature B-cell neoplasms"/>
</concept>
<concept>
<code value="2B54.Z"/>
<display value="Undifferentiated pleomorphic sarcoma, primary site"/>
</concept>
<concept>
<code value="2E6B"/>
<display value="Carcinoma in situ of thyroglossal duct"/>
</concept>
<concept>
<code value="1A81.Z"/>
<display value="other sexually transmitted chlamydial diseases"/>
</concept>
<concept>
<code value="1B41.10"/>
<display value="Rheumatic aortitis"/>
</concept>
<concept>
<code value="2A60.39"/>
<display value="Myeloid sarcoma in complete remission"/>
</concept>
<concept>
<code value="1B41.1Z"/>
<display value="Acute rheumatic valvulitis"/>
</concept>
<concept>
<code value="2A60.3Y"/>
<display
value="Acute myeloid leukaemia, NOS by criteria of other types in complete remission"/>
</concept>
<concept>
<code value="1B41.Y"/>
<display value="Acute rheumatic coronary arteritis"/>
</concept>
<concept>
<code value="1B41.1Y"/>
<display value="Active or acute tricuspid endocarditis"/>
</concept>
<concept>
<code value="1B41.Z"/>
<display value="acute RHD - [rheumatic heart disease]"/>
</concept>
<concept>
<code value="1A0Z"/>
<display value="Phlegmonous colitis"/>
</concept>
<concept>
<code value="3B10.Z"/>
<display value="Deficiency factor VIII with functional defect"/>
</concept>
<concept>
<code value="3B61"/>
<display value="Thrombophilia"/>
</concept>
<concept>
<code value="3A01.3Z"/>
<display
value="Acquired megaloblastic anaemias due to vitamin B12 deficiency secondary to intrinsic factor deficiency"/>
</concept>
<concept>
<code value="3A01.30"/>
<display
value="Pernicious anaemia associated with other autoimmune disorders"/>
</concept>
<concept>
<code value="3A01.3Y"/>
<display
value="Vitamin B12 deficiency anaemia associated with total gastrectomy"/>
</concept>
<concept>
<code value="3A21.Z"/>
<display value="acquired haemolytic anaemia, non-immune NOS"/>
</concept>
<concept>
<code value="3A50.Z"/>
<display value="thalassemia variants"/>
</concept>
<concept>
<code value="2E67.11"/>
<display value="Extramammary Paget disease of vulva"/>
</concept>
<concept>
<code value="2E67.12"/>
<display value="DVIN [Differentiated vulvar intraepithelial neoplasia]"/>
</concept>
<concept>
<code value="2E67.13"/>
<display value="High grade squamous intraepithelial lesion of vulva NOS"/>
</concept>
<concept>
<code value="2C10.0"/>
<display value="Intraductal papillary-mucinous carcinoma of pancreas"/>
</concept>
<concept>
<code value="2C10.Y"/>
<display value="Pancreatoblastoma"/>
</concept>
<concept>
<code value="2C10.1"/>
<display
value="Increased secretion from endocrine pancreas of pancreatic polypeptide"/>
</concept>
<concept>
<code value="1A94.1"/>
<display value="Herpetic proctitis"/>
</concept>
<concept>
<code value="1A94.0"/>
<display value="Herpes simplex infection of male genital tract NOS"/>
</concept>
<concept>
<code value="1A94.Z"/>
<display value="anogenital HSV - [herpes simplex virus] infection"/>
</concept>
<concept>
<code value="3B81.8"/>
<display value="Torsion of spleen"/>
</concept>
<concept>
<code value="2B55.Y"/>
<display value="Myosarcoma of overlapping lesion of corpus uteri"/>
</concept>
<concept>
<code value="2B55.Z"/>
<display value="Rhabdomyosarcoma, primary site"/>
</concept>
<concept>
<code value="3A03"/>
<display value="Other nutritional or metabolic anaemias"/>
</concept>
<concept>
<code value="3B21.0"/>
<display
value="Haemorrhage due to thrombin inhibitor other than heparin"/>
</concept>
<concept>
<code value="3B21.1"/>
<display value="Haemorrhage due to factor Xa inhibitor"/>
</concept>
<concept>
<code value="3B21.Y"/>
<display value="Haemorrhagic disorder due to increase in anti-XIa"/>
</concept>
<concept>
<code value="3A01.Z"/>
<display value="Megaloblastic anaemia due to vitamin B12 deficiency"/>
</concept>
<concept>
<code value="3A20.4"/>
<display
value="Lymphocyte passenger syndrome, following organ transplantation"/>
</concept>
<concept>
<code value="3A10.Y"/>
<display
value="Atypical haemolytic uraemic syndrome with thrombomodulin anomaly"/>
</concept>
<concept>
<code value="2E67.4"/>
<display value="PIN - [penile intraepithelial neoplasia]"/>
</concept>
<concept>
<code value="2E67.5"/>
<display value="carcinoma in situ prostate"/>
</concept>
<concept>
<code value="3B81.9"/>
<display value="fibrotic spleen"/>
</concept>
<concept>
<code value="3B81.7Z"/>
<display value="interstitial splenitis"/>
</concept>
<concept>
<code value="1A95"/>
<display value="Anogenital warts"/>
</concept>
<concept>
<code value="2B67.Z"/>
<display value="primary malignant neoplasm of parotid gland"/>
</concept>
<concept>
<code value="2A60.3Z"/>
<display value="AML - [Acute myeloid leukaemia]"/>
</concept>
<concept>
<code value="2B69"/>
<display value="Malignant neoplasms of tonsil"/>
</concept>
<concept>
<code value="2A70"/>
<display value="Precursor B-lymphoblastic neoplasms"/>
</concept>
<concept>
<code value="2A7Z"/>
<display value="Precursor lymphoid neoplasms, unspecified"/>
</concept>
</CodeSystem>